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SUMMARY
Pasteurella haemolytica, a Gram-negative bacterium, is the principal 
causative agent of pneumonic pasteurellosis in cattle and sheep, The 
presence of plasmids in various isolates of this species and their 
relationship to antibiotic resistance and to the health status of the 
source animal were investigated. Plasmids conferring resistance to 
ampicillin were analyzed and the plasmid-encoded p-lactamase enzymes 
characterized. A suitable plasmid was identified for the construction of 
shuttle cloning vectors for P. haemolytica.
Thirty five typable and untypable isolates of P. haemolytica from 
cattle or sheep were screened for the presence of plasmids and for 
resistance to a range of antibiotics. Eight strains (four of serotype Al, 
three of serotype A2 and one untypable) contained plasmid DNA. Isolates of 
the same serotype had similar plasmid profiles, which were different from 
those of the other serotypes. All but one of the plasmid-bearing strains 
were isolated from pneumonic, or from animals in contact with pneumonic, 
cattle or sheep. In A2 and untypable strains, there was no obvious 
correlation between antibiotic resistance and the presence of a specific 
plasmid. In contrast, all plasmid-bearing Al strains exhibited ampicillin 
resistance, which was shown by transfer studies (transformation and 
conjugation) to be plasmid-mediated.
Plasmid DNA prepared from ampicillin-resistant E. coli transformants 
was not routinely detected on ethidium-bromide-stained agarose gels, but 
could be amplified to detectable levels by treatment of cultures with 
chloramphenicol or by modifying the growth conditions. Terrific broth or 
broth supplemented with 1% yeast nitrogen base was found to be the best
XXI
growth medium for plasmid amplification, All Ap*^  plasmids had a similar 
size ("4.3 kb), and one of them (pPH843) was highly amplifiable and more 
stable in E. coll compared to the other plasmids (pPH2, pPH33 and pPH821).
An improved method was developed for the large-scale purification of 
covalently closed circular plasmid DNA molecules over a wide size range. 
The protocol used an alkaline-lysis procedure followed by acid-phenol 
extraction and included several modifications to previously reported 
methods. Two principal modifications were the replacement of NaCl by MgCl^ 
in the extraction buffer and vortexing instead of shaking the crude DNA 
suspensions to more efficiently remove chromosomal and other non-CCC 
plasmid DNA and to improve yield of purified CCC DNA forms.
The Ap"^  plasmids from P. haemolytica were identical by restriction 
enzyme analysis. Restriction analysis and hybridization data indicated that 
these plasmids were closely related to the prototype ROB-1 p-lactamase- 
encoding plasmid, originally isolated from Haemophilus influenzae, but a 
part of the DNA sequence ("0.7 kb) from the Haemophilus plasmid was not 
present in the Pasteurella plasmid. This suggested that one plasmid had 
been derived from the other during the course of evolution. From substrate 
profiles and isoelectric focusing data, the p-lactaraases encoded by the P. 
haemolytica plasmids were found to be indistinguishable from the ROB-1 p- 
lactamase.
A restriction map of plasmid pPH843 was constructed and the putative 
Ap^ , oriV, and mob regions of the plasmid were located by deletion and 
fusion experiments. The plasmid was converted into a series of possible 
cloning vectors (pAKA15, pAKA15-l, pAKA16, pAKA16-l and pAKA17) by 
insertion at different points in the plasmid of the JacZ a-peptide-coding 
gene and a multiple cloning site (for insertional inactivation of p-
XXll
galactosidase activity) from the E. coli vector pIC20H and an IncP 
mobilization function from plasmid RK2. Transconjugants obtained by 
transfer of the constructs from E, coli to P. haemolytlca were found to be 
unstable on subculture, although they were stable upon transfer to another 
E, coll strain. This indicated that P. haemolytlca might have a 
restriction/modification system which affected plasmid DNA previously 
propagated in E, coll.
1. INTRODUCTION
1.1. Pasteur el losl s - The Disease.
Pasteurellosis is a broad term relating to the bacterial diseases caused by 
members of the genus Pasteurella, Diseases caused by Pasteurella
haemolytlca are predominant in domestic ruminant animals. The most
important is an acute respiratory-tract disease (pneumonic pasteurellosis) 
in cattle, associated with a condition known as "shipping fever" in North 
America or "transit fever" in Europe (Collier, 1968a; 1968b; Lillie, 1974;
Frank, 1979; Thomson, 1980; Rehmtulla & Thomson, 1981; Yates, 1982; Allan
et al., 1983; Gibbs et al., 1983; Frank, 1989). Young calves, especially
when gathered under crowded conditions in closed buildings with
insufficient ventilation, can develop a respiratory syndrome known as 
* enzootic pneumonia' which may eventually lead to shipping fever or 
pneumonic pasteurellosis (Frank, 1989). P. haemolytlea also causes 
septicaemia and pneumonia in lambs and sheep (Gilmour, 1980; Gilmour &
Gilmour, 1989). The other animal hosts in which this organism may 
occasionally cause disease are; goats, swine, chickens and turkeys (Carter,
1981). Apart from respiratory and septicaemic diseases, other P.
haemolytlca infections are: mastitis in ewes, arthritis and meningitis in
sheep and lambs (Gilmour, 1980), and salpingitis in poultry (Carter, 1981). 
P. haemolytlca infections are rare in human hosts and only a few cases of 
such infections are evident from the annual reports of the Public Health 
Laboratory Service in London (Frederiksen, 1989).
Pasteurelloses caused by Pasteurella multocida are widespread among 
different avian and animal species, and among human hosts. These diseases 
include: fowl cholera in birds, haeraorrhagic septicaemia in cattle and
buffaloes (Carter, 1984), atrophic rhinitis and pneumonia in pigs (Chanter
& Rutter, 1989) and a variety of sporadic infections such as bite-wound 
infections, pneumonia, pleural empyemia, meningitis and encephalitis in man 
(Frederiksen, 1989).
1.1. 1. Historical background of Pasteurella and Pasteurellosis.
In 1887, Trevisan first established the genus Pasteurella^ in recognition 
of the work of Louis Pasteur on fowl cholera caused by a bacterium (later 
identified as P, multocida) of this group (cited by Zinnemann, 1981). The 
name ' Pasteurella haemolytlca* was first given by Newsom & Cross (1932) to 
the species of this genus for its haemolytic nature on blood agar. They 
isolated this organism from sheep with pneumonia. Bacillus bovlseptlcus 
Group 1 found in bovine diseases (Jones, 1921) and Pasteurella mastldls 
isolated from ewes with mastitis (Marsh, 1932) were eventually identified 
as the same organism, P, haemolytlca,
P. multocida was first isolated in France in 1879 by Toussaint and then 
in 1880 by Louis Pasteur, while working on fowl cholera in chickens. The 
organism has had many names including Pasteurella cholerae-galllnarum and 
Pasteurella septlca. The name Pasteurella multocida was finally introduced 
by Rosenbusch & Merchant (1939).
Pasteurellosis in cattle was first described as haemorrhagic septi­
caemia (Marshall, 1922), a syndrome which was characterized by fibrinous 
pleuropneumonia. The pneumonic form of this disease was subsequently 
referred to as bovine pasteurellosis rather than haemorrhagic septicaemia 
(Shirlaw, 1938).
Early reports of pneumonic pasteurellosis in housed sheep were obtained 
from Iceland (Dungal, 1931), Australia (Beveridge, 1937) and England
(Montgomerie et al,, 1938). A septicaemic form of the fatal disease in 
lambs, caused by P, haemolytlca, was described by Stamp et al, (1955) in 
Scotland and this was probably the first report on the so-called 
septicaemic pasteurellosis. Septicaemia in lambs was also reported from 
North America at about this time (Biberstein & Kennedy, 1959).
1.1.2. Definitions and clinical symptoms of pneumonie pasteurellosis.
Though pneumonic pasteurellosis refers to both cattle and sheep as the 
hosts, the disease in cattle has been investigated most extensively. 
Shipping fever is the most important component of 'bovine respiratory 
disease complex' (BRDC) and defined as a fibrinous pneumonia resulting from 
an interaction between Pasteurella spp. , various stresses (e.g. transport) 
and predisposing factors (e.g. viral infection) (Collier, 1968a; Yates,
1982). Different authors presented definitions of this disease on the basis 
of clinical symptoms and pathological parameters observed in infected 
animals. Several investigators defined shipping fever as an acute 
infectious disease of cattle characterized by fever, dyspnoea, and 
fibrinous pneumonia of unknown cause (Adams et al,, 1959), which is usually 
seen several days after shipment and in adverse weather conditions (Sinha & 
Abinanti, 1962). Another definition is "an acute infection of the 
respiratory tract in young cattle characterized by fever, depression, nasal 
discharge, and referred bronchial and pleuritic sounds in ventral parts of 
the lungs" (Jensen & Mackey, 1979). Yates (1982), however, accumulated 
opinions from different authors and set down a definition as follows: 
"Shipping fever is an entity within the BRDC. It is a pneumonic condition 
of cattle which is of undetermined though multifactorial aetiology, and is
usually associated with P. haemolytlca or, less commonly, P. multocida, in 
which instances the term 'pneumonic pasteurellosis* can be used 
synonymously. Shipping fever is characterized pathologically by lobar, 
anteroventrally distributed, exudative pneumonia in which fibrin is usually 
a prominent part of the exudate and fibrinous pleuritis is common".
Throughout his review, Yates (1982) mentioned this bovine disease as 
'shipping fever pneumonia'. Pneumonic pasteurellosis appears to be the 
appropriate term, now being widely used, to indicate pneumonia caused by 
Pasteurella spp. That pneumonic pasteurellosis is the synonym for BRDC 
(Maheswaran et al, , 1980) is not true, because the latter also includes
diseases caused by microorganisms other than pasteurellae. Rehmtulla & 
Thomson (1981) agreed that the terra pneumonic pasteurellosis has attained 
recognition as a distinct disease entity and they used the terms pneumonic 
pasteurellosis and shipping fever interchangeably, the latter being often 
put within quotation marks.
Bovine pneumonic pasteurellosis in Britain is primarily a disease of 
recently weaned, newly housed, single-suckled beef calves (Allan et al, ,
1983) and is associated with the clinical symptoms of sudden onset of 
dullness, anorexia, pyrexia (106-107^F), tachypnoea, rare adventitious 
respiratory sounds and/or serous nasal discharge (Dalgleish, 1990).
1.1.3. Aetiology of pneumonic pasteurellosis.
There can be no reasonable doubt that P. haemolytlca is an essential 
component in the aetiology of shipping fever and that pasteurellosis is 
responsible for the clinical signs and death of cattle (Collier, 1968b). 
Pneumonic pasteurellosis is often promoted by stress and preinfections with
respiratory viruses. The putative stressing factors may include: weaning,
prolonged transport with consequent anxiety and fatigue, temperature 
extremes, inadequate and irregular feeding and watering, changes in diet, 
increased humidity, crowding, inhalation of dust, draughts, dehorning, 
castration or vaccinations (Yates, 1992).
The probable aetiological agents involved in the disease have been
extensively investigated. In one experiment, Lopez et al, (1975) used 
parainfluenzae-type 3 (PI-3) virus which depressed bacterial clearance from 
lungs. In other experiments, the use of aerosols of bovine herpes virus 1 
(BHV 1) prior to P, haemolytlca infection caused fibrinous pneumonia
similar to field conditions (Jericho et al., 1976; Jericho & Langford,
1978). On the other hand, Thomson (1980) believed that P, haemolytlea could 
cause shipping fever by itself, although PI-3 and infectious bovine
rhinotracheitis (IBR) viruses may facilitate the process (Rehmtulla & 
Thomson, 1981). It is now known that preinfecting bovine lungs with an
agent like IBR virus, PI-3 virus, bovine respiratory syncytial virus (BRSV) 
or Mycoplasma bovis increases susceptibility to challenge with P.
haemolytlca Al. But such preinfection is not necessarily required in all 
cases to develop pneumonia, and the severity of this disease is a function
of the dose and virulence of P. haemolyt lea Al and not of the other
infectious agents (Yates et al., 1983a; Gourlay & Houghton, 1985). Several
other workers produced similar results whereby P, haemolytlca Al caused 
pneumonic pasteurellosis independently of viral or other microbial agents 
when virulent, rapidly growing bacteria were injected intrabronchially 
(Friend et al, , 1977) or transthoracically (Newman et al,, 1982). Gibbs et
al, (1984) reproduced typical pneumonic pasteurellosis in carefully 
selected, unstressed, conventionally-reared calves by intranasal and
intratracheal inoculation of a virulent strain of P. haemolytica Al alone.
Frank (1988), however, suggested that P, haemolytica remains as part of 
the normal flora in low numbers in the nasopharynx of healthy calves until 
transport stress, viral respiratory disease or a climatic change triggers a 
population explosion of P. haemolytlca which heavily colonizes the 
nasopharynx. In one such study, calves exposed to an aerosol infection and 
then subjected to an abrupt change from a cold and dry to a hot and humid 
climate were found to be rapidly colonized by P. haemolytlea (Jones, 1987).
1.1.4. Pathogenesis of pneumonic pasteurellosis.
Although the involvement of P. haemolytlca in pneumonic pasteurellosis has 
been studied for many years, the pathogenesis of this disease is still not 
well understood. The mechanism has remained obscure because of the
difficulty in producing the disease under laboratory conditions (Frank,
1979). However, recent research on experimental infections in cattle and
sheep has provided some understanding of the pathogenesis of pneumonic 
pasteurellosis.
It is now established that P. haemolytlca Al plays a key role in the 
pathogenesis of pneumonic pasteurellosis in cattle. In the course of 
assembling, shipping and processing cattle for entry into the feedlot, the 
animals are stressed, resulting in the overgrowth of P. haemolytlca Al in 
the nasal passages and tracheal airways (Frank & Smith, 1983; Wilkie &
Shewen, 1988). The organisms travel from the upper respiratory tract to the 
lungs via aerosolized droplets (Grey & Thomson, 1971; Jericho ei al, ,
1986). Once in the lung, several pathophysiological events occur, that 
combine to cause severe pneumonia (Wilkie à Shewen, 1988).
It was assumed that inhaled droplets were important in the pathogenesis 
and that the lesions of fibrinous pneumonia start at the level of the 
respiratory bronchiole and spread within the lung primarily through the 
connective tissue around blood and lymph vessels and respiratory airways
(Jubb & Kennedy, 1970). These authors, in the final analysis of their
study, stated that "it is the breakdown of the phagocytic barrier which
allows the infection to be established", Alveolar macrophages in the lungs 
are considered to be the primary phagocytic cells which can phagocytose P, 
haemolytica, especially when the bacteria are present in small numbers. 
However, if a large number of bacteria are present, many escape 
phagocytosis and produce a cytotoxin (leukotoxin) which can destroy the
macrophages (Frank, 1989). Moreover, P. haemolytica cells are readily 
phagocytosed during the stationary phase, but not during active growth in 
the logarithmic phase (Walker et al, , 1984) when the bacteria produce the
potent leukotoxin (Shewen & Wilkie, 1985).
During P, haemolytica infections, neutrophils have been demonstrated to 
be responsible for acute lung injury in cattle and thereby play an 
important role in the pathogenesis of pneumonic pasteurellosis (Solocombe 
et al, , 1985). These workers showed that calves depleted of neutrophils by
prior administration of hydroxyurea were resistant to intratracheal 
challenge with live P, haemolytlca Al, while neutrophil-sufficient normal 
calves developed severe exudative and necrotizing bronchopneumonia.
Alveolar macrophages and neutrophils can engulf and kill P. haemolyt ica 
organisms, but eventually both are killed by the leukotoxin produced by 
actively-growing bacteria (Czuprynski et al, , 1987). Neutrophils are more
sensitive than alveolar macrophages to destruction by the leukotoxin 
(Czuprinski et al,, 1987; O'Brien & Duffas, 1987). Walker et al, (1985)
argued that the leukotoxin is indirectly responsible for pneumonia, because 
it kills neutrophils, the principal defensive blood cells, which enter the 
lung in response to P. haemolytica infections and become the predominant 
cell type in the alveolar spaces within four hours of infection. The 
cytolytic effect of leukotoxin is initiated by the formation of pores in 
the cell membrane which allows the influx of calcium and results in a 
sequence of cell-damaging events (Clinkenbeard et ai., 1989). Leukotoxin 
thus contributes to the pathogenesis of pneumonia by inducing lysis of 
neutrophils and macrophages and liberating, from these leukocytes, 
intracellular contents such as lysosomal enzymes and oxygen-derived toxic 
free radicals which are responsible for the acute lesions of fibrinous 
pneumonia CSibille & Reynolds, 1990; Czuprynski et al, , 1991; Maheswaran et
ai,, 1992).
A flow diagram of the pathogenesis of bovine pneumonic pasteurellosis 
involving the leukotoxin is shown in Figure 1.
In addition to leukotoxin, endotoxin (lipopolysaccharide), derived from 
P. haemolytica, was also implicated in the pathogenesis of bovine pneumonic 
pasteurellosis (Walker et al, , 1985; Confer & Simons, 1986). Deposition of
lipopolysaccharide (LPS) into sheep's lungs caused an influx of a huge 
number of neutrophils and contributed to the lesions of pneumonic 
pasteurellosis (Brogden et al, , 1984). An intratracheal inoculation of LPS
was found to cause significant pulmonary lesions in cattle (Solocombe et 
al, , 1990). Recent in vitro studies by Braider et al, (1990, 1991) have
shown that LPS was a major toxic factor which caused damage to a bovine 
pulmonary endothelial cell line and that the addition of bovine neutrophils 
could prevent endothelial cell damage. These in vitro findings contrast
FIGURE 1. FLOW DIAGRAM SHOWING THE PROPOSED MECHANISM OF THE PATHOGENESIS 
OF BOVINE PNEUMONIC PASTEURELLOSIS CAUSED BY P. HAEMOLYTICA Al.
The diagram was adapted from Frank (1989) and Dalgleish (1990),
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with the primary role attributed to the leukotoxin in the pathogenesis of 
bovine pneumonic pasteurellosis,
1.1.5, Prevalence and significance of pneumonic pasteurellosis.
Pneumonic pasteurellosis, caused by P. haemolytica^ is an economically 
important disease of food-producing animals because it causes substantial 
economic loss to the farming (especially, feedlot cattle and sheep) 
industries (McKercher, 1978; Blood et ai., 1979; Thomson, 1980; Gilmour,
1980; Yates, 1982; Wilkie & Shewen, 1988; Donachie, 1988). The disease is 
most prevalent in North America and severe morbidity and mortality due to 
respiratory illness in North American feedlot cattle result mainly from P. 
haemolytlca infections (Roth, 1988). The economic losses to the beef and 
dairy industries have been estimated to be about 800 million dollars 
annually in the United States (Frank, 1989), Two-thirds of sickness and 
deaths in Alberta feedlots were due to bovine respiratory diseases, 
including IBR and shipping fever, which caused an annual loss of 9,6 
million dollars in Alberta (Church & Radostits, 1981). In specific survey 
results, Jensen et al, (1976) found that 64% of 1988 necropsy diagnoses 
were respiratory disease and, of these, 75% were shipping fever pneumonia. 
The results of Rothwell et al, (1979) on 168 deaths from a large 
Saskatchewan feedlot were remarkably similar, with respiratory disease 
causing 71% of deaths, and 73% of these being pneumonic pasteurellosis or 
shipping fever. In an Ontario feedlot study, fibrinous pneumonia was found 
to be the most frequent diagnosis at post-mortem, accounting for 41% of 168 
deaths in one year (Martin et al, , 1980) and 45% of 167 deaths the next
(Martin et al, , 1981).
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Relatively few references are available on P, haemolyt ica infections in 
Europe, though Blood et al, (1979) stated that pneumonic pasteurellosis is 
common in Europe including the United Kingdom. Allan et al, (1983) and 
Gibbs et al, (1983) described a series of field outbreaks of pneumonic 
pasteurellosis in Scotland which seriously affected recently weaned, 
single-suckled calves, Gilmour (1978a, 1980) considered pasteurellosis as
the most significant and fatal disease of sheep in Britain, The author 
highlighted the importance of this disease in Britain by presenting the 
results of two surveys reported from the Ministry of Agriculture, Fisheries 
and Food, In one survey in 1964, pneumonia was found in 82% of 9550 sheep 
submitted to the Veterinary Investigation Centres in England and Wales, and 
in another survey during 1976-78, Pasteurella infections were diagnosed in 
sheep much more than any other bacterial diseases at the UK Veterinary 
Investigation Centres,
1. 1.6. Vaccines for P, haemolytica infections.
P. haemolytlca infections in cattle and sheep have long been considered to 
be multifactorial with regard to the different serotypes and the virulence 
factors involved. The most efficient and practical means of control of 
infection depends upon the development of an effective vaccine against the 
various antigens involved.
Since the late 1950s, bacterins (killed bacteria) from P. haemolytlca 
(or P, multocida) have been used as the primary type of vaccine (Rice at 
al, t 1955; Palotay et ai., 1963), but these vaccines have been shown to be 
of questionable protective value. When viruses were found to be associated 
with the pathogenesis of pneumonic pasteurellosis, attempts were made to
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prevent the disease with viral vaccines. Use of vaccines containing PI-3 
virus (Mohanty & Lillie, 1964), IBR virus (Jericho et al. , 1976) or a
combination of PI-3 and IBR viruses (Hamdy et al,, 1965) protected calves
against experimental challenge with the respective virus and P, 
haemolytica. However, protection was variable with viral vaccines alone. 
Combinations of bacterins and viral vaccines were also developed and 
evaluated. Vaccination of calves with a combination of inactivated PI-3 
virus and P, haemolytica bacterins provided protection against a combined 
experimental challenge infection (Matsuoka et ai., 1966). In field trials, 
however, this combined vaccine had no effect on reducing the incidence of 
respiratory disease (Hamdy et al, , 1965).
The experimental production of pneumonic pasteurellosis in calves with 
P, haemolytlca in the absence of other infectious agents (Friend et ai., 
1977; Gibbs et al, , 1984; Wiseman et al, , 1984) stimulated interest in
evaluating the effects of bacterins or live bacteria, when used alone. Use 
of formalin-killed P, haemolytlca bacterin produced adverse effects in an 
experimental study (Wilkie et ai., 1980), while in a field trial, use of a 
commercial bacterin did not produce any significant effects (Martin et ai., 
1984), P, haemolytlca bacterins with different adjuvants have been shown to 
stimulate high antibody responses to somatic antigens but low titres to 
leukotoxin (Confer et al, , 1987), Since both capsule and leukotoxin
production are associated with rapidly growing bacteria, the use of live 
vaccines has yielded some promising results in reducing the incidence of 
pneumonic pasteurellosis (Newman et ai., 1982), Henry (1984) used live, 
lyophilized preparations of P, haemolytica which protected feeder calves 
from disease under field conditions. Modified live vaccines containing 
chemically-altered strains (Kucera et al, , 1983) or streptomycin-dependent
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strains (Catt et al, , 1985) of P. haemolyt ica have also been used to obtain 
an enhanced protection. Dosage of organism, culture age and route of 
administration were, however, important for live vaccines (Confer et al. ,
1987). Vaccines prepared from various surface antigen extracts have been 
evaluated for their protective role. Potassium thiocyanate or sodium 
salicylate extracts of P. haemolytica have been used as experimental 
vaccines but gave inconsistent results (Yates et al, , 1983b; Gilmour et
al, , 1987). It appears to be necessary to immunize calves and sheep with
both leukotoxin and serotype-specific antigens for consistent protection 
against pneumonic pasteurellosis (Shewen & Wilkie, 1988; Sutherland et al, , 
1989; Hosier et al., 1989). The failure of P, haemolytica bacterins to
protect cattle against this disease is due to the fact that they induce 
bacterial surface antigen-specific antibody but not toxin neutralizing
(anti-leukotoxin) antibody (Wilkie & Shewen, 1988). In one study, a vaccine 
containing a crude leukotoxin preparation, which is believed to contain
some other soluble antigens, from P, haemolytica A2 was found to protect 
sheep (86%) against a homologous challenge infection (Sutherland et al, , 
1989). A similar preparation from serotype Al protected two of three calves 
in another experimental study (Shewen & Wilkie, 1988).
Current research on vaccine development is, therefore, aimed at 
identifying the bacterial surface components responsible for adhesion and 
colonization of P, haemolyt ica and at inducing neutralizing antibodies
against the leukotoxin. A crude vaccine called "Presponse" (Langford 
Laboratories, Guelph, Ontario), derived from the supernate of a log-phase 
culture of P. haemolytica and containing both leukotoxin and certain 
soluble antigens, is now commercially available in Canada (Dalgleish, 1990; 
Conlon et al, , 1991). This type of vaccine has already shown promise in
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reducing the incidence and severity of pneumonia following experimental 
challenge (Shewen et al,, 1988) and field trials are currently underway to
assess its general efficacy.
In a recent experimental study, the recombinant leukotoxin has been 
used as a component of a vaccine against P. haemolytica infections in 
cattle (Conlon et al, , 1991). Use of the recombinant leukotoxin alone in
the vaccine did not give any protection; however, it enhanced the efficacy 
of the culture supernate vaccine, Presponse, when used in combination.
A vaccine consisting of sodium salicylate extracts of P. haemolyt ica 
A2, which harboured inducible iron-regulated proteins (IRPs) (see Section 
1.2,5.8) has been recently shown to confer protection against experimental 
infection with serotype A2 in specific pathogen-free (SPP) lambs (Gilmour 
et al, , 1991).
Thus, most studies indicate that several cellular and extracellular 
components of P. haemolytica are likely to be required in an efficient and 
successful acellular vaccine.
No molecular genetic approach is yet available towards the development 
of attenuated Pasteurella strains, defective in individual antigens, which 
could be used as whole-cell or live vaccines.
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1.2. Pasteurella haemolytica - The Organism.
1.2. 1. Taxonomic atatiip;.
P, haemolytica is one of six species of the genus Pasteurella belonging to 
the family Pasteurellaceae, which has been mentioned as family III under
the section 'facultatively anaerobic Gram-negative rods' in Bergey's Manual 
of Systemic Bacteriology [Holt & Kreig Ceds. ), 19841, Other recognized
genera under this family include Haemophilus and Actinohacillus, The other 
five member» species of the genus Pasteurella are; Pasteurella multocida, 
Pasteurella pneumotropica, Pasteurella ureae, Pasteurella aerogenes and 
Pasteurella gallinarum. The mole percent G+C of the DNA of P. haemolytica 
is 42.3-43.6. It is interesting to note that P. haemolytica (biotype A) and 
P. ureae appear to be closer to the genus Actinobacillus than to
Pasteurella on the basis of the results of DNA-DNA hybridization studies 
(Pohl, 1981).
Among the members of the genus Pasteurella, P. haemolytica and P.
multocida are the most widely studied species from the clincal point of 
view, because the pathological effects of these organisms are evident 
within a wide variety of hosts including animals, birds and humans,
1.2.2. Definition and characteristics.
The definition and relevant characteristics of P, haemolytica were 
described in detail by Carter (1981, 1984), The bacterium is a Gram-
negative, non-motile, facultatively anaerobic small rod whose colonies show 
characteristically weak haemolysis on sheep blood agar, This is the only 
species of Pasteurella to produce a distinct zone of p-haemolysis. Wider
16
zones of haemolysis were obtained with avian strains than with strains from 
cattle and sheep (Heddleston, 1975). P. t^molytica is catalase and oxidase 
positive, and fermentative in nature by producing acid but not gas from a 
number of carbohydrates. The growth of this organism occurs between 25*^  and 
40°C; 3 7 0 c being the optimum growth temperature. Blood agar, brain heart
infusion agar and dextrose agar are used for isolation of P. haemolytica. 
Growth also occurs on MacConkey's agar. Complete mature colonies develop 
after 18-24 h of incubation and are round and greyish. Lactose-fermenting 
strains of P. haemolytica (predominantly Al serotype) yield small, round, 
pink to red colonies on MacConkey’s agar (Biberstein et al, , 1960).
Capsules are commonly seen in cultures from diseased tissue.
Microscopically, cells of P. haemolytica are slightly larger than those 
of P. multocida. Carter (1967) stated that these two organisms are not 
different in morphology. P, haemolyt ica strains can be differentiated from 
P. multocida strains by their ability to grow on MacConkey's agar and to 
cause haemolysis on blood agar media, and by their inability to produce 
indole from tryptophan.
1.2.3. Biotype and serotype.
Strains of P. haemolyt ica can be divided into two biotypes: A and T, on the 
basis of several in vitro criteria including carbohydrate fermentation 
reactions (Smith, 1961). Biotype A includes strains which usually ferment 
arabinose but not trehalose, whereas, all biotype T strains ferment 
trehalose. Both biotypes were further differentially characterized by 
nucleic acid homology (Biberstein & Francis, 1968) and antibiotic 
sensitivity (Biberstein & Kirkham, 1979). The differential characteristics
17
of A and T biotypes of P. haemolytlca are presented in Table 1.
P. haemolyt ica biotype A is predominantly associated with the pneumonic 
form and biotype T with the septicaemic form of pasteurellosis in sheep 
(Gilmour, 1978a). Biotype A also causes septicaemia in young lambs (Smith, 
1961; Gilmour, 1980). In cattle, biotype A is associated with pneumonia and 
biotype T has not been reported to cause disease (Yates, 1982), but Allan
et al. (1985a) reported the isolation of biotype T strains from cases of
pneumonic pasteurellosis in calves.
Currently 16 serotypes of P. haemolytica are known, which have been 
differentiated on the basis of their specific capsular antigens, as
determined by the indirect haemagglutination test. Twelve serotypes were 
described first (Biberstein et al, , 1960). Two other serotypes were
identified from sheep isolates in Ethiopia (Pegram et al, , 1979), another
serotype (of biotype T) from sheep in Scotland (Fraser et al, , 1982a) and
also one from Hungary (Fodor et al, , 1987). Serologically untypable strains 
also occur in both sheep (Fraser et al, , 1982b) and cattle (Quirie et al. ,
1986). Such strains are presumably uncapsulated variants of P. haemolyt ica 
(Biberstein, 1978).
On the basis of a relationship between serotypes and biotypes
established by Biberstein & Gills (1962), serotypes 1, 2, 5, 6, 7, 8, 9, 11,
12, 13, 14, and 16 have been placed under biotype A and serotypes 3, 4, 10,
and 15 under biotype T.
P, haemolytica biotype A serotype 1 (Al) has been found predominantly 
to be associated with pasteurellosis of cattle and biotype A serotype 2 
(A2) with that of sheep (Wray & Thomson, 1971; Thomson et al, , 1977; Fraser
et al. , 1982b; Allan et al, , 1983, 1985a; Quirie et al, , 1986; Donachie,
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TABLE 1. DIFFERENTIAL CHARACTERISTICS OF THE TWO BIOTYPES (A & T> OF
PASTEURELLA HAEMOLYTICA*
Characteristics Biotype A Biotype T
Acid production from arabinose 
and xylose
+ —
Acid production from trehalose 
and salicin
- +
Susceptibility to penicillin 
(In vitro)
High Low
Survival period of culture Short Long
Colonies Small, grey Large with 
brownish centre
Capsular serotypes I, 2, 5, 6, 7, 8, 9,
II, 12, 13, 14, 16
3, 4, 10, 15
Principal location in natural 
host (cattle and sheep)
Nasopharynx Tonsils
Principal disease association Pneumonia of 
cattle and sheep; 
septicaemia of 
new-born lambs
Septicaemia of 
feeder lambs(3 
months of age 
or more)
«■Adapted from Carter (1981, 1984).
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1988). Biotype T serotype 10 (TIO) has been identified as the most common 
pathogen in sheep (Biberstein & Thomson, 1966; Fraser et al, , 1982b),
1 .2 .4 .  Source and frequency of I s o la t io n .
Numerous investigators have reported the presence of Pasteurella spp. in 
the upper respiratory tract of apparently healthy cattle (Collier, 1968a; 
Wessman & Hilker, 1968; Gilmour, 1978b; Wilkie & Shewen, 1988). Several 
other workers stated that Pasteurella spp. were not normal microflora of 
the lower respiratory tract including the lungs (Collier & Rossow, 1964; 
Grey & Thomson, 1971), although both P, haemolytica and P, multocida have 
been found in normal bovine lungs in one study (Allan, 1978), In fact, 
these organisms can be present in both pneumonic and non-pneumonic calves 
(Allan, 1978; Allan et al, , 1985a), but the numbers are large in the
former and small in the latter (Firie, 1978). In general, P. haemolytica 
occurred more frequently than P. multocida in pneumonic calves, and equal 
percentages of the two bacteria were found in non-pneumonic animals (Allan,
1978). It was unusual to isolate both P, haemolytica Al and P. multocida 
from the same infected animal (Allan et al, , 1985a),
Gilmour (1978a) considered P. haemolytica to be an opportunistic 
pathogen as he recovered the organism from 95% of tonsils and 64% of 
nasopharyngeal swabs from apparently healthy sheep. The organism is 
commonly recovered from the nasal passages of cattle with respiratory tract 
disease and from pneumonic lungs (Wray & Thomson, 1971; 1973; Reggiardo,
1979; Frank & Smith, 1983). The occurrence and overgrowth of the bacterium 
in the respiratory tract often depend on the stressful situations 
experienced by the animals. In a study of 356 transported calves, samples
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were collected from the nasal passages of calves at three different and 
distant places Ce. g, farm, auction barn, and feedyard) at different 
intervals of time (Frank & Smith, 1983). These workers isolated P. 
haemolytica at a low frequency from calves when they were at the farm of 
origin, at a greater frequency at the auction barn, and at a markedly 
higher frequency at the feedyard.
P. haemolytica Al is the predominant serotype consistently isolated 
from cattle with pneumonic pasteurellosis, both in Britain (Wray & Thomson, 
1971; Gibbs et al, , 1983; Allan et al, , 1983; 1985a; Quirie et al, , 1986)
and in North America (Jubb & Kennedy, 1970; Biberstein, 1978; Reggiardo,
1979). Of 16 bovine P. haemolytica strains tested for typing, 14 (88%) were 
identified as serotype Al (Biberstein et al, , 1960). In a case study, 94%
of P. haemolytica isolates from cattle dying of shipping fever in Texas 
were found to be type 1 (Reggiardo, 1979). Quirie et al, (1986) observed 
that 63% of lung isolates and 48% of nasal swab isolates were serotype Al 
and that untypable strains predominantly occurred in the female genital 
tract (including the foetus and placenta), udder, milk, and intestinal 
tract of cattle. Al strains were isolated from each of the cases of acute 
exudative fibrinous pneumonia in recently housed, weaned, single-suckled 
calves (Allan et al, , 1983; Gibbs et al, , 1983) and also from apparently
healthy calves in houses adjacent to the infected groups (Wray & Thomson, 
1973).
1.2.5. Virulence factors.
Several potential virulence factors in P. haemolytica have been identified, 
some of which have been examined intensively, while some others demand
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further investigation. These factors are described as follows;
1.2.5.1. Cvtotoxin (Leukotoxin).
The cytotoxin has been considered as the most important virulence 
determinant of P. haemolytlca and has been studied extensively. Benson et 
al. (1978) first observed cytotoxic changes in bovine alveolar macrophages, 
which were ultimately killed in the presence of live P, haemolytlca Al. The 
toxic factor was present in bacteria-free culture filtrates and sublethal 
concentrations of crude toxin were found to induce impaired phagocytosis 
(Markham & Wilkie, 1980), to reduce chemotaxin production in pulmonary 
macrophages (Markham et al, , 1982), and to inhibit the luminol-dependent
chemiluminescent response of bovine neutrophils (Chang et al,, 1985). The
cytotoxin from P. haemolytica has been shown to be a true exotoxin (Baljyut 
et al, , 1981; Sutherland et al, , 1983). Shewen & Wilkie (1985) confirmed
that the toxin is an extracellular product of metabolically-active 
bacteria, since it is produced in vitro during the logarithmic growth phase 
and is not found in bacterial lysates or sonic extracts. The presence of 
iron on a suitable carrier molecule, such as transferrin, encourages the 
optimal production of cytotoxin (Gentry et al, , 1986). The cytotoxin is a
protein and the immuno-chemical properties of this toxin appeared to be 
common to all serotypes of P, haemolytica (Himmel et al, , 1982). All
serotypable and non-serotypable strains of this species are toxigenic 
(Shewen & Wilkie, 1985; Sutherland & Donachie, 1986; Chang et ai., 1987), 
although not all are pathogenic. The activity of the cytotoxin is specific 
for ruminant leukocytes including alveolar macrophages, cultured blood 
monocytes, lymphocytes, and neutrophils (Kaehler et al, , 1980; Shewen &
Wilkie, 1982; Sutherland et ai., 1983); hence the more current reference to
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this virulence factor as a leukotoxin.
Currently, P, haemolytlca leukotoxin is considered to be an important 
member of the RTX (repeats in toxin) toxin family from Gram-negative 
bacteria. The structural and functional relationships of these toxins have 
been reviewed recently (Coote, 1992).
1.2.5. 2. Haemolysin.
Production of haemolysin is a distinguishing feature of P. haemolytica, and 
although haemolytic activity on blood agar is not prominent, it may be 
enhanced in vivo. One possible role of haemolysin in vivo is that it may 
liberate iron from the host red blood cells (RBCs) for use by the bacterium 
(Chengappa et al, , 1983). However, except in cases of septicaemia, it is
difficult to visualize such a role in respiratory infection. The importance 
of iron for the production of leukotoxin (Gentry et al, , 1986) and in the
pathogenesis of P. haemolytica infections in mice (Al-Sultan & Aitken, 
1984) has been described.
Forestier & Welch (1990) believed that P. haemolytica haemolysin could 
be the leukotoxin, because they detected a weak haemolytic activity for the 
active form of leukotoxin against sheep RBCs, but this activity was not 
present if an inactive form of the toxin was examined. Haemolysin, however, 
is not generally considered as a potential virulence factor for P. 
haemolyt ica,
1.2. 5. 3. Capsule.
Production of a surface capsule in P. haemolytica is dependent on the age 
of the culture. Corstvet et al. (1982) demonstrated that young, rapidly 
growing cultures of P. haemolyt ica Al produced large amounts of capsular
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material compared to older cultures. Capsular size is likely to be 
important in resistance to phagocytosis.
The capsule carries the serotype-specific antigens (Adlam et ai.,
1984), which probably mediate surface adherence between the bacterium and 
the epithelium of the host's respiratory tract. Once adhered, P, 
haemolytica can colonize, grow, and liberate exotoxin. Capsular 
polysaccharide, which is the basis of the serotyping scheme, has long been 
known as a virulence determinant (Biberstein et al, , 1960). Capsule-free,
non-typable strains of P, haemolytica were found to be avirulent for lambs 
in an aerosol challenge experiment CDonachie et al., 1984). Purified 
capsular polysaccharide from A1 serotypes reacts with sheep lung surfactant 
in vitro to form a precipitate, which is thought to facilitate bacterial 
attachment to the lining of the lung alveoli (Adlam, 1989). The 
composition, structure and immunogenicity of purified capsules from P, 
haemolytica serotypes A1 and A2 have been described by Adlam et al, (1984,
1987).
1.2. 5. 4. Lipopolysaccharide (LPS).
LPS is a major outer-membrane component of P. haemolytica and appears to 
possess the same endotoxic activities as the LPS from other Gram-negative 
bacteria (Rimsay et al,, 1981). It may be responsible for the high rate of 
morbidity and mortality in infected cattle and sheep (Adlam, 1989). 
Endotoxin has long been blamed for increased capillary permeability, 
thrombosis and coagulation necrosis in pneumonic pasteurellosis (Jensen & 
Mackey, 1979).
The effects of serotype A1 LPS on bovine peripheral blood leukocyte 
function were strictly dose-dependent (Confer & Simons, 1986). Low
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concentrations of LPS decreased and high concentrations increased the 
phagocytic activity of polymorphonuclear leukocytes, and moderate 
concentrations were mitogenic for mononuclear cells, Solocombe et al, 
(1990) found significant lung lesions in cattle following intratracheal 
inoculation of LPS, Recent studies have demonstrated that P, haemolytica 
LPS was a predominant toxic factor which mediated bovine pulmonary 
endothelial cell damage in vitro (Breider et ai,, 1990; 1991), In studies
by Brogden et ai. (1984, 1986), direct introduction of purified A1 LPS into
sheep lungs caused a variety of clinical and pathological changes. The LPS 
bound tightly to and formed a complex with ovine lung surfactant, a natural 
lung lubricant, and produced lesions very similar to those found in disease 
under field conditions. Moreover, the bactericidal activity of immune sheep 
sera to P, haemolytica A2 could be eliminated by absorption with purified 
LPS, suggesting that LPS may be important in immunity as well as in 
pathogenesis (Sutherland, 1988).
The structure of P. haemolytica LPS is not known in detail. The LPS 
profiles of P. haemolytica serotype A1 indicate that they possess the 
typical LPS composition of 0-side chain, core-oligosaccharide and lipid A 
component, whereas serotype A2 lacks 0-side chain (Davies et al. , 1991).
Heterogeneity of LPS between serotypes and among strains of the same 
serotype (A1 or A2) has also been described recently (Ali et al,, 1992), A 
study by crossed Immunoelectrophoresis has shown distinct immunological 
differences between LPS molecules derived from different serotypes of P. 
haemolytica (Tsai et al,, 1988).
Expression of LPS and outer-membrane proteins (OMPs) in P. haemolytica 
A1 has been shown to vary with different growth conditions (Davies et al..
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1992).
1. 2. 5. 5. Fimbriae.
By electron microscopy, fimbriae (pili), in association with glycocalyx 
(capsule), were found on the surface of a serotype A1 strain of P,
haemolytica isolated from a bovine lung lesion (Morck et al. , 1987).
Fimbriae are surface structures that help the bacterium attach to 
epithelial cells and thereby aid colonization. Two types of fimbriae were 
identified from A1 strains grown on agar (Potter et al., 1988). These
workers isolated the larger of the two types, which was 12 nm in diameter 
and up to 560 nm in length. The pilin subunit had a molecular mass of 35 
kilodalton (kDa) and an isoelectric point of about 4. 7.
1.2.5. 6. Neurami ni daae.
A majority of the P. haemolytica A isolates have been reported to produce 
large amounts of neuraminidase, when grown overnight on blood agar, and the 
enzyme appeared to be cell-associated in most cases (Frank & Tabatabai,
1981). Serotype A2 was found to be the highest producer of neuraminidase
which was present in crude cytotoxin preparations or culture supernates of 
this organism (Otulakowski et al., 1983).
Neuraminidase acts by hydrolyzing the host cell glycoproteins and 
glycolipids and aids in the spread of some infectious agents. Although 
neuraminidase plays an important role in the pathogenesis of several viral 
and bacterial diseases (Murray et al., 1990), the significance of this 
enzyme in P. haemolytica infections is not clear. However, a possible role 
of neuraminidase in virulence of P. haemolytica may still exist.
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1. 2. 5. 7. SlalQglvcoprotease.
Sialoglycoprotease is a proteolytic enzyme (protease) from P. haemolytica, 
and is so named because of its ability to release sialoglycopeptides from
human RBCs (Otulakowski et al,, 1983). Its enzymic activity was tested by
using culture supernates that were cytotoxic for bovine alveolar
macrophages, Sialoglycoprotease activity can be demonstrated in strains of 
most of the serotypes of P. haemolytica (Adlam, 1989). The
sialoglycoprotease gene from P. haemolytica A1 has been recently cloned and 
sequenced (Abdullah et al., 1991). However, the role of this enzyme in 
disease is still unknown.
1.2. 5. 8. Iron-regulated proteins (IRPs).
Iron acquisition in pathogenic bacteria is an important virulence attribute 
(Weinberg, 1978). IRPs are bacterial outer-membrane proteins which serve as 
receptors for iron-containing compounds such as transferrins or iron- 
siderophore(iron-chelator) complexes.
IRPs with apparent molecular weights of 70 and 100 kDa have been 
identified in serotype A2 (Donachie & Gilmour, 1988) and those of 71, 77,
and 100 kDa in serotype A1 (Denser & Potter, 1989) of P. haemolytica, when 
grown under iron-limited conditions. Subsequent study has demonstrated that 
the 100-kDa IRP from an A1 isolate served as the specific receptor for 
bovine transferrin (Ogunnariwo & Schryvers, 1990), Very recently, P. 
haemolytica IRPs have been described for binding transferrins from 
ruminants including sheep, goat and cattle (Yu et al., 1992). These IRPs, 
by direct binding of host transferrins, aid bacteria in iron uptake in 
order to multiply quickly enough to establish infection. The availability
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of iron to P. haemolytica also influences the expression of leukotoxin 
(Gentry et al. , 198G).
1.2.6. Experiments in animal models.
P, haemolytica shows a low pathogenicity for laboratory animals including 
mice and rabbits (Carter, 1984). The organism was found to be pathogenic 
for mice only when inoculated intraperitoneally with gastric mucin or 
intracerebrally (Smith, 1958). Intraperitoneal inoculation of P. 
haemolyt ica also produced infections in mice after they had received 
haemoglobin (Chengappa et al., 1983) or an aqueous iron solution (Al-Sultan
& Aitken, 1984), It has not been possible to develop a suitable small 
animal model for pneumonic pasteurellosis because of the fact that the 
natural host range of P. haemolyt ica as a respiratory pathogen is confined 
to ruminants (Donachie, 1988).
Pneumonic pasteurellosis has been reproduced by various investigators, 
using different ruminant models and combinations of aetiological agents. 
Experimental infections have been established in calves and lambs by 
stress, infection with viruses and by intratracheal inoculation of P. 
haemolytica. In one study, a combination of stress, infection with IBR 
virus, and P. haemolytica was used in young calves to produce a typical 
pneumonic pasteurellosis (Jericho et al., 1976), In a subsequent study, 
infection with PI-3 virus followed by exposure to P. haemolytica produced 
severe purulent pneumonia in calves (Jericho et al., 1982). Smith (1988) 
produced respiratory infections in calves stressed by fasting, acetic acid 
instillation and cold-water spray prior to intratracheal injection of live 
P. haemolytica. However, several other workers reproduced in young.
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unstressed calves a respiratory condition identical to the field disease, 
using strains of P. haemolytica alone (Friend et al, , 1977; Gibbs et al, , 
1984; Wiseman et al,, 1984; Allan et al., 1985b; Vestweber et al., 1990). 
These authors confirmed the disease clinically, pathologically and 
microbiologically, and their success in experimental production of 
pneumonic pasteurellosis was likely to have been the result of a 
combination of the selection criteria applied in choosing the experimental 
calves (i.e. those lacking antibodies to P. haemolytica), the virulent 
strain of organism used, the use of log-phase cultures, and the size and 
route of the challenge doses. These studies strongly support the fact that 
P. haemolytica acts as a primary pathogen in the bovine respiratory tract 
and that pneumonic pasteurellosis may be caused by P, haemolyt ica alone, 
This concept is important from the view point of vaccine development.
SPF lambs were used in experimental reproduction of sheep pasteurello­
sis. The intratracheal injection of PI-3 virus, one week before the use of 
a bacterial aerosol, produced pasteurellosis in over 90% of lambs as 
opposed to 40% of those exposed to P. haemolytica alone (Gilmour, 1978a; 
Sharp et al., 1978).
1.3. Resistance to Antimicrobials.
Watanabe (1963) has described the early history of drug (antimicrobial) 
resistance in bacteria. At the end of the World War II and until about 
1950, sulphonamide was the drug of choice for the Shigella spp, that caused 
outbreaks of bacillary dysentery in Japan. This drug rapidly became less 
effective and, by 1952, more than 80% of Shigella isolates were highly 
resistant to sulphonamide. The use of tetracycline, streptomycin and
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chloramphenicol for treating dysentery started in 1950. Some resistance to 
these agents also gradually began to develop. Initially strains were 
resistant to either tetracycline or streptomycin alone but Kitamoto, in 
1956, reported the isolation of Shigella flexneri 4a strain resistant to 
streptomycin, tetracycline, chloramphenicol and sulphonamide. By 1957, a 
significant number of multiple-resistant strains of Shigella were isolated.
Multiple drug resistance is also prevalent in Staphylococcus aureus, a 
Gram-positive bacterium. Penicillin-resistant strains of S, aureus were 
rapidly selected after penicillin came into use in the 1940s. The 
proportion of resistant strains gradually rose to 14% in 1946, 38% in 1947 
and 59% in 1949 in the hospital environment where penicillin was 
extensively used (Barber, 1957). Resistance to other antimicrobial agents 
such as raethicillin, erythromycin, aminoglycosides and toxic metal ions is 
now commonly found in S. aureus (Lacey, 1984).
Due to the increasing incidence of infections caused by bacteria, 
multiple antimicrobial resistance has now become a problem of prime 
importance in the clinical and pharmaceutical sciences (Falkow, 1975).
1. 3. 1. Antimicrobial resistance in P. haeaolvtlca.
P, haemolytlea infections of cattle are often treated with antibiotics to 
reduce death and economic losses; this has undoubtedly led to an increased 
antimicrobial resistance in this bacterium. It is now apparent that 
multiple drug resistance in P. haemolytica is becoming an increasingly 
common phenomenon in feedlot cattle with respiratory disease in North 
America (Amstutz et al., 1982; Fales et al., 1982; Morter, 1983) as well as 
in Britain (Wray & Morrison, 1983; Allan et al., 1985a; Shoo, 1989). The
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prevalence of antimicrobial resistance has made it difficult to decide 
promptly as to which drug or dosage will be effective in treating cattle 
with pasteurellosis (Fales et al., 1982). Multiple drug resistance in P. 
haemolytica reported from different countries is summarized in Table 2.
Chang & Carter (1976) first described multiple drug resistance in 
Pasteurella isolates from cattle and swine. They showed that about 92% of 
P. haemolytica isolates were resistant to a number of clinically important 
antimicrobial drugs including streptomycin, penicillin, tetracycline and 
chloramphenicol. Streptomycin resistance was most frequent, followed by 
penicillin and tetracycline resistance. An increasingly high resistance to 
antimicrobials in bovine isolates of P. haemolytica was reported in North 
America from two studies in the same year (Amstutz et al., 1982; Fales et 
al., 1982). In the former report, the resistance was shown in order of 
decreasing prevalence as: streptomycin, tetracycline (90%) > ampicillin
(41%) > sulphonamides (23. 5%) and, in the latter report, the order was:
sulphonaraides (84%) > streptomycin (70%) > ampicillin (58%) > penicillin
(57%) > tetracycline (21%). The obvious differences in the incidence rates 
of tetracycline and sulphonamide resistance between these two studies may 
be due to antibiotic therapy of animals (untreated vs. treated), sample 
size (65 vs. 386), source of samples (nasal vs. lungs) or concentrations of 
drugs in the disks used in the drug-sensitivity tests. A high level of 
resistance to sulphonamides, tetracycline and ampicillin in cattle isolates 
of P, haemolytica was also reported by Morter (1983). In an investigation 
of plasmid profiles of P. haemolytica serotypes, plasmid-containing A1 
isolates were shown to be multiply-resistant to ampicillin, penicillin, 
tetracycline, lincomycin, streptomycin and/or sulphonamides (Boyce & 
Morter, 1986). Chang et al. (1987) found that typable and untypable
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TABLE 2. MULTIPLE DRUG RESISTANCE AND PLASMID INVESTIGATION IN 
P, HAEMOLYTICA ISOLATES FROM DIFFERENT COUNTRIES
Ref erence Country
Drug-resistance
phenotypes*
Plasmid 
invest igated
Chang Sf Carter (1976) USA Pe, Tc, Cm, Sm No
Zimmerman & Hirsh (1980) USA Ap, Pe, Tc, Sm Yes
Amstutz et al, (1982) USA Ap, Tc, Sm, Su No
Fales et al, (1982) USA Ap, Pe, Tc, Sm, Su No
Morter (1983) USA Ap, Tc, Su No
Boyce & Morter (1986) USA Ap, Pe, Tc, Lm, Sm, Su Yes
Chang et al, (1987) USA Ap, Pe, Tc, Bac, Lm, Sm Yes
Rossmanith et al, (1991) USA Ap, Pe, Tc, Ak, Em, Sm, Su Yes
Haghour et al, (1987) Germany Ap, Pe, Tc, Oxa, Em, Sm, SxT Yes
Schwarz et al, (1989b) Germany Ap, Pe, Carb, Tic, Tc, Sm, SxT Y es
Livrelli et al, (1988a) France Amo,, Tic, Tc, Sm, Su Yes
Wray & Morrison (1983) UK Ap, Pe, Amo,, Carb, Sm, Su No
Allan et al, (1985^ UK Ap, Pe, Tc, Lm, Sm No
Shoo (1989) UK Ap, Pe, Lm, Sm No
Craig et al, (1989) UK Ap, Pe, Sm, Su Yes
* Abbreviations: Ap = ampicillin, Pe = penicillin, Tc - tetracycline, Cm 
chloramphenicol, Sm = streptomycin. Su = sulphonamides, Lm " lincomycin, 
Bac = bacitracin, Ak = amikacin, Em - erythromycin, Oxa = oxacillin, SxT 
sulphamethoxazole-trimethoprim, Carb = carbenicillin. Tic = ticarcillin, 
Amo = amoxycillin.
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isolates of P. haemolytica, regardless of plasmid content, were resistant 
to bacitracin, lincomycin, streptomycin, ampicillin, penicillin or 
tetracycline. More recently, multiple antibiotic resistance was observed in 
76% of P. haemolytica strains examined in a study of twenty strains which 
included representatives of most serotypes together with field isolates, 
where resistance to streptomycin was most common followed by amikacin, 
erythromycin, sulphonamides, ampicillin, penicillin or tetracycline 
resistance; but no isolate was resistant to chloramphenicol (Rossmanith et 
al, , 1991 ).
In a report from Germany, all P. haemolytica isolates from cattle and 
sheep of different countries of origin were shown to be resistant to one or 
more of nine drugs including ampicillin, penicillin, oxacillin, 
cephalothin, erythromycin, tetracycline, chloramphenicol, streptomycin, and 
sulphamethoxazole-trimethoprim (Haghour et al,, 1987). A French isolate of 
P, haemolytlea, obtained from a bovine source, showed production of ROB-1 
p-lactamase (see following section) and multiple resistance to amoxycillin, 
ticarcillin, tetracycline, streptomycin, and sulphonamide (Livrelli et al., 
1988a). In Britain, one strain of P. haemolytica Al, isolated from a calf 
with pneumonia, was found to be resistant to penicillin, ampicillin, 
amoxycillin, carbenicillin, streptomycin and sulphonamide, and produced a 
p-lactamase enzyme (Wray & Morrison, 1983). Allan et al, (1985a) found that 
almost all bovine isolates 097%) of P, haemolytlea Al they examined were 
resistant to streptomycin and lincomycin. Oxytetracycline, penicillin, and 
ampicillin were associated with resistance in 20%, 18%, and 15% of the
isolates respectively. Notable differences were found between the 
antibiotic resistance patterns of isolates from the upper and lower 
respiratory tracts of the same animal, with the nasopharyngeal isolates
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having greater resistance to penicillin, ampicillin and tetracycline. The 
reason for such differences was not explained but might be due to prolonged 
exposure of the upper respiratory tract of cattle to subclinical doses of 
antibiotics, used as growth-promoters in feeds. However, no consistent 
difference was observed in the resistance patterns between the isolates 
from antibiotic-treated and untreated animals. Shoo (1989) reported an 
almost similar pattern of drug resistance to that of Allan et al. (1985a) 
in P, haemolytlea isolates from both healthy and pneumonic calves, and no 
significant difference in resistance patterns was detected in isolates of 
Al and A2 serotypes or in isolates from healthy and diseased animals.
Different authors (Chang & Carter, 1976; Amstutz et al, , 1982) proposed
that the emergence of drug resistance in pasteurellae may have been due to; 
i) frequent use of antibiotics in the treatment of animal disease, ii) 
inadequate use of antibiotics in terms of dosage, duration of therapy, and 
route of administration, iii) addition of antibiotics as growth-promoters 
to animal feeds, and iv) the presence, in Pasteurella spp., of resistance 
plasmids which might have been acquired from other bacteria and which 
conferred the property of antibiotic resistance upon the host bacteria.
1.3.2. Beta-1 actamases.
The most important biochemical mechanism for p-lactam antibiotic resistance 
in Gram-negative bacteria is the production of p-lactamases. These enzymes 
cleave the p-lactam ring of penicillins and cephalosporins to give products 
devoid of antibacterial activity (Sykes 8r Matthew, 1976).
Beta-lactamases are encoded by genes present on either the bacterial 
chromosome or on a plasmid. Matthew (1979) described and differentiated 11
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types of plasmid-determined p-lactamases on the basis of substrate profile 
<i. e, hydrolysis rate of penicillins vs. cephalosporins), reaction with 
inhibitors, isoelectric point (pi), and molecular weight (MW), Since then 
additional plasmid-mediated enzymes have been discovered, bringing their 
number to more than 20 in 1986 (Medeiros et al, , 1985; Livermore & Jones,
1986), and new enzymes are still being added to the existing list, Beta-
lactamases described by Matthew (1979) fall into three broad classes; i) 
the ' broad spectrum* penicillinases which hydrolyze benzyl- penicillin and 
cephaloridine at similar rates, ii) the oxacillinases which hydrolyze 
oxacillin rapidly, and iii) the carbenicillinases which destroy 
carbenicillin. Based on amino acid composition and sequence homologies,
Ambler (1980) proposed a classification scheme for p-lactamases, which
included classes A and B, and which has now been extended to C and D.
The nomenclature of different plasmid-mediated p-lactamases is mainly 
attributed to their source or properties. TEM ('Temoniera* , a patient's 
name from whom the g-lactamase-producing E. coli strain was isolated), ROB 
(according to the source strain H. influenzae ROB), SHV (Sulphydryl 
variable), OXA (Oxacillin-hydrolyzing), PSE (Pseudoraonas-specific), and 
CARB (Carbenicillin-hydrolyzing) are several of the common p-lactamase 
enzymes. TEM (TEM-1 or TEM-2) is the most common plasmid-mediated enzyme 
and is found on a wide variety of naturally-occurring plasmids of Gram- 
negative bacteria (Kontomichalou et ai., 1970; Datta et ai., 1971), while 
ROB-1 is a novel enzyme first detected in H. Influenzae type b strain 
isolated from a child with meningitis (Rubin et ai., 1981).
Comparison of some properties of representative plasmid-mediated p- 
lactamases is shown in Table 3, Apart from the MW and pi values as bases of 
distinction, OXA-1 can be distinguished by ready hydrolysis of oxacillin
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TABLE 3. COMPARISON OF PROPERTIES OF PLASMID-MEDIATED BETA-LACTAMASES*
p-lactamase
Relative rate of hydrolysis^ Inhibited by
Mol. wt. 
(kDa) piAp Carb Oxa Clox Cer Cet Clox NaCl
TEM-1 106 10 5 0 76 20 + — 22 5. 4
TEM-2 107 10 5 0 74 20 + - 23. 5 5. 6
ROB-1 186 25 6 <2 24 2 + - . . , 8. 1
SHV-1 212 8 0 <2 56 8 + - 17 7. 6
OXA-1 382 30 197 190 30 15 - + 23. 3 7. 4
PSE-1 90 97 <2 <2 18 <2 — . , . 26. 5 5. 7
CARB-1 88 150 8 <2 40 4 - . , . 32 5. 3
* Adapted from Rubin et al. (1981) and Medeiros (1984).
§ Ap = ampicillin, Carb = carbenicillin, Oxa = oxacillin,
Clox = cloxacillin, Cer = cephaloridine, Cet = cephalothin.
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and cloxacillin, and sensitivity to inhibition by NaCl but not by 
cloxacillin. In contrast, TEM-1, TEM-2, ROB-1, and SHV-1 have low or no 
activities against oxacillin and cloxacillin and are sensitive to 
inhibition by cloxacillin but not by NaCl. PSE-1 and CARB-1 readily 
hydrolyze carbenicillin. Furthermore, TEM- and ROB-type enzymes differ 
mainly in the hydrolysis rates of ampicillin (or carbenicillin) and 
cephaloridine (or cephalothin), ROB-1 has shown higher pi than all other 
enzymes.
1. 4. Plasmids.
A plasmid is an autonomous, self-replicating extrachroraosomal DNA element 
(Lewin, 1987). Following the discovery of conjugation in Escherichia coli, 
Lederberg (1952) first coined the term "plasmid" to refer to all
extrachromosomal genetic elements present in a bacterium. He used to call 
these elements 'symbiotic particles' before the new name was given. Novick 
(1980) considered plasmids as ' subcellular organisms', found in a wide 
variety of bacteria, and not essential to the growth or metabolism of the 
host cell. Plasmids are normally circular molecules (Hardy, 1986), but
linear forms of plasmids have also been reported in Streptomyces rochei
(Hirochika et al,, 1984), Borrelia burgdorferi (Barbour & Garon, 1987), and
Thiobacillus versutus (Wlodarczyk & Nowicka, 1988). They constitute 
between <1 to 3 percent of the host cell's genome and the size of a single 
plasmid may range from 1 to about 300 kilobase pairs (kb).
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1.4.1. Topological forms, functions and types of pi fies.
Plasmids may exist In more than one form in cellular lysates of bacteria, 
but the covalently closed circular (CCC) double-stranded DNA form 
(component I) predominates. The CCC form has no breaks in either strand of 
DNA and is characteristically supercoiled or twisted upon itself (Bauer et 
al, , 1980). Open circular (GO plasmid, resulting from nicks or breaks in
either one or both DNA strands, is a second form (component II) of plasmid 
DNA that may be present in bacterial cell lysates. When both DNA strands 
are broken or nicked at points either exactly opposite or very close to 
each other, a linear form (component III) of plasmid DNA is generated. This 
may occur due to strong shearing stress during plasmid preparation or 
cleavage by endonuclease enzymes.
Various functions have been attributed to plasmids (Broda, 1979; Hardy,
1986); i) resistance to antibiotics and heavy metals, ii) production of 
antibiotics, iii) utilization of complex organic compounds (carbohydrates, 
hydrocarbons) as energy sources, iv) production of bacteriocins and 
haemolysins, v) production of restriction and modification enzymes, vi) 
production of toxins, vii) synthesis of virulence and colonization factors, 
viii) tumorigenicity and nitrogen-fixation in plants and ix) capability to 
mate with a suitable recipient cell (i.e. genetic transfer).
Three main types of plasmids have been characterized most extensively: 
i) F plasmids or fertility factors, ii) drug-resistance (R) plasmids or R 
factors and iii) colicinogenic (Col) plasmids. Plasmids associated with the 
expression of virulence factors in bacteria are often termed 'virulence 
plasmids'. Plasmids with unknown functions are termed 'cryptic plasmids'.
On the basis of replication control systems, plasmids are classified
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into incompatibility (Inc) groups, a group comprising plasmids which cannot 
co-exist together in the same host cell. Incompatibility is a manifestation 
of relatedness; the sharing of common elements involved in plasmid 
replication control or equipartitioning (Novick, 1987). About 30 Inc groups 
have been established for the plasmids found in enterobacteria and 7 for 
the staphylococcal plasmids (Couturier et al, , 1988).
1.4.2. Antibiotic-resistance plasmids (R plafimids).
R plasmids were first discovered in multiple drug-resistant Shigella 
species in Japan during the late 1950s (Ochiai et al, , 1959) and they are
important from the clinical and therapeutic points of view. In Europe, 
plasmids of this type were first reported in Salmonella species (Datta, 
1962).
R plasmids contribute to multiple drug resistance in both Gram-positive 
and Gram-negative bacteria and make their bacterial hosts resistant to
antibiotics by one of four mechanisms (Foster, 1983); i) by altering the
target site of the antibiotic, ii) by modifying the antibiotic so that it 
is no longer active, iii) by preventing the antibiotic from entering the 
cell, and iv) by specifying an enzyme which provides a substitute for a 
host-specified enzyme which is the target of the antibiotic.
Typical R plasmids are large, broad host range, low copy number, self- 
transmissible or conjugative plasmids. They possess two functionally
distinct parts; the resistance transfer factor (RTF), which contains the
genes for replication (rep) and conjugation (tra), and the resistance 
determinant (R-det). R-dets are covalently linked to the tra genes and many 
of them are located on a transposable element (Mitsuhashi, 1977). In some
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instances, the tra genes are clustered in a single region on the plasmid, 
whereas in others, they are scattered in several different regions 
(Willetts & Skurray, 1980). The tra genes determine the production and 
assembly of sex pili (tube-like surface appendages made of protein),
necessary to mediate cell-to-cell contact and DNA transfer (Willetts &
Wilkins, 1984). Non-transmissible or non-conjugative R plasmids are usually 
small, lack the tra genes, but carry the mob (mobility) gene in which the 
origin of transfer replication (orIT) is presumed to be present, A typical 
genetic structure of conjugative and non-conjugative R plasmids is shown in 
Figure 2.
Non-conjugative plasmids can be mobilized into recipients when an 
appropriate conjugation system (i. e, tra) is provided by a co-existing
conjugative plasmid. Mobilization is characterized by lack of covalent
union between the participating conjugative and non-conjugative plasmids. 
Hence the two plasmids are not necessarily co-transferred to recipient 
cells. The non-conjugative plasmid participates actively in the 
mobilization process. It has been shown that the mob genes of ColEl and 
RSFlOlO plasmids encode mobilization proteins (Warren & Sherratt, 1977; 
Derbyshire et al, , 1987) that recognize, and bind to, a specific site on
the plasmid molecule called nic which is probably the orlT of the plasmid. 
In the donor cell, the plasmid DNA to be mobilized is cleaved on one strand 
at the nic or oriT site by the mobilization proteins in order to trigger or 
initiate DNA transfer (Willetts & Wilkins, 1984; Derbyshire & Willetts,
1987). oriT also serves as the site at which recircularization of the 
transferred DNA takes place in the recipient cell. Furthermore, the orlT 
sequence may be required for the formation of primers that initiate 
complementary strand synthesis in the donor and recipient cells (Derbyshire
FIGURE 2. TYPICAL GENETIC ORGANIZATION OF CONJUGATIVE AND NON-CONJUGATIVE 
R PLASMIDS,
The figure was adapted from Saunders (1984).
Key:
oriV = Origin of vegetative replication. 
orlT ~ Origin of transfer replication. 
tra = Transfer genes. 
mob ~ Mobility region.
nic = Nicking site for mobility proteins.
R-det = Resistance determinant.
rep = Replication genes.
inc = Incompatibility determinant.
oriT represents a DNA sequence presumably located at the nic site within, 
or adjacent to, the mob region of both types of plasmid.
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& Willetts, 1987).
The important features identified for the rapid evolution and dispersal 
of R plasmids are their conjugative ability and the presence within their 
sequences of transposable genetic elements known as 'transposons' (Cohen, 
1976). Those plasmids which belong to the IncP group in Gram-negative 
bacteria may be especially important in disseminating drug resistance to a 
wide range of organisms. Multiple drug resistance is thought to arise from 
the accumulation and insertion on a plasmid of individual transposons or 
'jumping genes', derived from another plasmid or from the chromosome of the
same or another bacterium. Transposon-encoded antibiotic resistance was
first observed as a transfer of penicillinase activity between plasmids, 
and between plasmids and chromosomes (Datta et al> , 1971; Richmond à Sykes,
1972). The ampicillin resistance-encoding transposon, TnJ, is one of the 
most extensively studied drug-resistance transposons with regard to the 
mechanisms of transposition (Sherratt, 1989).
It has long been assumed that R plasmid evolution in bacteria is 
promoted by the selection pressure provided by the antibiotics used or 
present in the growth environment (Falkow, 1975).
1.4. 2.1. R plasmids and plasmid-mediated 8-lactamases in Or am-negative
bacteria related to Pasteurella,
Since their discovery in Shigella spp., R plasmids have been found in 
numerous bacterial species pathogenic for man and animals and are 
particularly common in members of the Enterobacteriaceae including E, coli, 
salmonellae and shigellae, and in pseudomonads (Hardy, 1986).
42
Plasmids coding for resistance to a number of antibiotics have been 
demonstrated in the clinically important species of the genus Haemophilus, 
Two types of R plasmids have been found to occur in Haemophilus influenzas'. 
45 to 57-kb plasmids and 3,75 to 6, 6-kb plasmids (De Graaff et al, , 1976;
Elwell et al, , 1977; van Klingeren et al,, 1977; Kaulfers et al, , 1978;
Laufs et al, , 1979). The large Haemophilus R plasmids that have been
described show 65-100% homology in their base sequences independently of 
geographic origin and their antibiotic resistance markers (Elwell et al, , 
1977; Laufs & Kaulfers, 1977), A small plasmid has been shown to be 
closely related to plasmids coding for g-lactamase in gonococci (Laufs et 
al, , 1979). R plasmids encoding multiple resistance to ampicillin,
chloramphenicol and tetracycline have also been reported in H. influenzae 
(Bryan, 1978). Moreover, plasmids coding for 0-lactaraase production and 
sulphonamide resistance have been found in Haemophilus ducreyi (Brunton et 
al. , 1979; Albritton et al, , 1982) and Haemophilus (Actinobacill us> pleura-
pneumoniae (Hirsh et al,, 1982); the latter additionally carried a
streptomycin-resistance plasmid.
In some large surveys, 3-5% of H. influenzae isolates carrying plasmid- 
mediated p-lactamase activity have been detected (Ward et al, , 1978; Green
et al, , 1979). Beta-lactamase-encoding R plasmids are common in H,
influenzae, and the p-lactamase enzymes have been found to be of the TEM- 
type in most cases (Elwell et al, , 1975; Thorne & Farrar, 1975; Laufs & 
Kaulfers, 1977; Gutmann et al, , 1988) and of the more recently described
ROB-1 type in some instances (Rubin et al, , 1981; Medeiros et al. , 1986;
Livrelli et al,, 1988b; Gutmann et al, , 1988). In an epidemiological survey
for the ROB-1 p-lactamase among 161 ampicillin-resistant H. influenzae 
isolates in the United States, 8% of strains produced ROB-1, whereas 92%
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produced TEM-1, as detected by DNA hybridization and p-lactamase 
characterization studies CDaum et al, , 1988). The ROB-1 enzyme has a
substrate profile similar to the TEM-type but with a quite different 
isoelectric point (Table 3), and is more likely to be found in animal 
pathogens (Medeiros et al, , 1986; Gutmann et al, , 1988). The ROB-1 p-
lactamase gene is not structurally related to the genes for the other known 
p-lactamases, including TEM-1 (Medeiros et al, , 1986; Levesque et al, ,
1987; Daum et al, , 1988). The nucleotide sequence of the original
(prototype) ROB-1 p-lactamase gene has been determined by Juteau & Levesque 
(1990),
A ROB-1 p-lactamase-encoding plasmid in association with a TEM-1 p- 
lactaraase plasmid has been recently detected in the same isolate of H. 
ducreyi, and expression of one p-lactamase (TEM-1) appeared to suppress 
expression of the other (ROB-1) (Maclean et al, , 1992).
1.4. 2. 2. R plafiTPids and plasmid-mediated 6-lactamases in P. multocida 
and P. haemolsrtica,
R plasmid-containing Pasteurella strains have emerged in different 
countries, particularly in the USA. Several workers reported the presence 
of R plasmids in antibiotic-resistant strains of P, multocida isolated from 
septicaeraic turkeys (Berman & Hirsh, 1978; Hirsh et al,, 1981; 1985; 1989)
and from pneumonic cattle (Silver et al,, 1979). These plasmids are small
(3.5 to 15 kb in size) and non-conjugative, encoding resistance commonly to 
streptomycin, sulphonamides and tetracycline. Hirsh et al, (1989), in 
addition, isolated a large (105 kb), conjugative R plasmid. Another F-type 
conjugative plasmid was described earlier in P, multocida and shown to be
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responsible for the transfer of a small and non-conjugative R plasmid (11 
kb) from the same strain to E, coli and other strains of P. multocida 
(Hirsh et al. , 1981). A small streptomycin-resistance plasmid (5 kb) has
been detected in P. multocida cultures derived from bovine and swine 
sources (Schwarz et ai,, 1989a). Haghour et al. (1987) found plasmids,
ranging from ~2 to 43 kb, in 35 of 163 isolates of P. multocida from
different animal species, but could not show correlation with antimicrobial 
resistance.
Plasmids associated with antimicrobial resistance phenotypes in bovine 
isolates of P, haemolytica have been reported from the United States
(Zimmerman & Hirsh, 1980; Boyce & Morter, 1986; Chang et al, , 1987),
Germany (Haghour et aJ. , 1987; Schwarz et al, , 1989b), France (Livrelli et
al, , 1988a; 1991) and Britain (Craig et al, , 1989). These plasmids are
small (2 to 8.6 kb), non-conjugative, and associated with resistance 
commonly to p-lactam antibiotics, particularly ampicillin and penicillin, 
and rarely to tetracycline, streptomycin and sulphonamide compounds. Some 
of these reports have correlated particular antibiotic resistances with the 
presence of plasmid (R plasmid) by transfer studies such as transformation 
(Zimmerman & Hirsh, 1980; Livrelli et al, , 1988a; 1991; Schwarz et al, ,
1989b; Craig et al,, 1989) and conjugation (Craig et al, , 1989). R plasmids
in P. haemolytica and their confirmed antibiotic-resistance phenotypes are 
given in Table 4.
Zimmerman & Hirsh (1980) recovered two 8.6- and 8.3-kb plasmids from 
one P, haemolytica strain (T biotype), which were shown to code for 
tetracycline and streptomycin resistance respectively. These authors, in 
addition, noted that ampicillin resistance in the strain was p-lactamase- 
mediated, but this resistance could not be conclusively shown to be
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TABLE 4. R PLASMIDS IN P. HAEMOLYTICA AND THEIR ENCODED PHENOTYPES
Ref erence Country
R plasmid 
(kb)
Encoded
phenotype*
Zimmerman & Hirsh (1980) USA 8. 3 Sm^
8. 6 Tc>=^
Livrelli et al, (1988a) France 4. 4 Ap'^
Livrelli et al, (1991) 4. 1, 4. 4 Ap^
Schwarz et al, (1989b) Germany 4. 3 Ap^
Craig et al, (1989) UK 4. 5 Ap"=^
* For abbreviations of antibiotics, see footnote (*) of Table 2. 
R = resistance.
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plasmid-encoded. The work of Boyce & Morter (1986) demonstrated that only a 
single plasmid (~3 kb) was present in isolates of the A2 serotype, but two 
distinct plasmid profiles (one containing 3 plasmids and the other 
containing 2 plasmids, ranging from 3.9 to 5 kb) were found in isolates of 
the Al serotype of P. haemolytica. It is important to note that only 
strains isolated from sick calves were studied and all were drug resistant 
and contained plasmids. Sulphonamide resistance was presumed to be encoded 
by a 4. 5-kb plasmid, Chang et al. (1987) showed plasmids (2 to 5.4 kb) to 
be present in both typable and untypable strains of P, haemolyt ica and a 
correlation was found between a 5. 2-kb plasmid and resistance to ampicillin 
and penicillin in Al isolates. Several other workers have suggested a 
causal relationship between P. haemolytica plasmids (3.8 to 5, 1 kb) and 
resistance to ampicillin and penicillin (Richards et al. , 1984; Rossmanith
et al, , 1991). Haghour et al, (1987) isolated small plasmids (3,9 to 4.7
kb) exclusively from cattle isolates of P. haemolyt ica and found their 
association with resistance to ampicillin, penicillin, tetracycline, and 
sulphamethoxazole-trimethoprim. R plasmids (4, 1-4. 5 kb) encoding only p- 
lactam resistance (e. g. Ap^) in bovine isolates of P. haemolytica have been 
identified and analyzed in France (Livrelli et al, , 1988a; 1991), Germany
(Schwarz et al, , 1989b) and the UK (Craig et al. , 1989).
Plasmid-mediated p-lactamases have been demonstrated in P. multocida 
(Livrelli et al, , 1988a) and P, haemolytica (Livrelli et al, , 1988a; 1991;
Schwarz et al, , 1989b; Azad et al,, 1992& and were found to be of the ROB-1
type (Livrelli et al, , 1988a; 1991; Azad et al, , 1992^ , The genetic
determinant of this ROB-1 p-lactamase did not show homology with the other 
p-lactamase (TEM-1, OXA-1, SHV-1 or CARB-1)-encoding plasmid genes by 
hybridization experiments (Levesque et al, , 1987; Livrelli et al, , 1991).
47
The nucleotide sequence of the ROB-1 p-lactamase gene from P, haemolytica 
has been recently published CLivrelli et al,, 1991) and shown to be almost
identical to that of the ROB-1 g-lactamase gene from H. Influenzae (Juteau 
& Levesque, 1990). The only contrasting difference in the sequences 
indicated that the ROB-1 p-lactamase genes from Pasteurella and Haemophilus 
species have different promoters. Both types of ROB-1 p-lactaraases were 
found to belong to the class A enzyme (see Section 1.3.2) and share several 
features including amino acid sequence homol^y with Gram-positive bacterial 
p-lactamases (Juteau & Levesque, 1990; Livrelli et al,, 1991).
Several R plasmids from P, multoclda have been tested for Inc grouping 
and it was found that the plasmids did not belong to any of the recognized 
Inc groups, including JncQ (Berman & Hirsh, 1978; Hirsh et al,, 1985). This 
is an unexpected observation, because the moles percent G+C contents of 
these plasmids suggested that they were of enteric origin (Hirsh et al, , 
1985). There has been no report of Inc grouping of R plasmids from P. 
haemolyt lea.
1.4. 2. 3. Homologies and relationships among R plasmi
Relationships among R plasmids, derived from different bacterial hosts, can 
be established by restriction endonuclease analysis, DNA-DNA hybridization 
and electron microscopy of DNA heteroduplexes. DNA-DNA hybridization is an 
efficient and reliable method which is performed by using one plasmid as a 
hybridization probe to seek homology with restriction fragments of other 
plasmids on Southern blots (Southern, 1975).
Several streptomycin and sulphonamide-resistance plasmids of the JncQ 
group, isolated from a wide range of locations and bacterial species
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(.Salmonella, Proteus, Providencia, Pseudomonas and E. coli), were found to 
be closely related (Barth & Grinter, 1974; Grinter & Barth, 1976), By 
employing restriction endonuclease mapping and Southern hybridization 
techniques, homologies were shown between the broad-host-range plasmid 
RSFlOlO (originally obtained from Salmonella panama) and the sulphonamide 
(and/or streptomycin)-resistance plasmids from Bordetella bronchiseptica 
(Lax & Walker, 1986), A. pleuropneumoniae (Wilson et al, , 1989a) and H.
ducreyi (Wilson et al,, 1989b), Laufs & Kaulfers (1977) demonstrated high 
DNA homology of an arapicill|in-resistance plasmid from H, Influenzae with 
various R factors derived from the same species of wide geographic origin.
By DNA-DNA hybridization experiments, the probable origins of R 
plasmids can also be deduced. The sulphonamide-resistance plasmids in H. 
ducreyi were 80% homologous to RSFlOlO, suggesting that they represented an 
extension of the enteric plasmid pool into Haemophilus (Albritton et al, ,
1982). An ampicillin-resistance plasmid from H, Influenzae has been shown 
to contain DNA sequences characteristic of the ampicillin-resistance 
transposon (TnA) found on some R factors of enteric origin (Elwell et al., 
1975; Laufs & Kaulfers, 1977). Several workers hypothesized that the p- 
lactamase-encoding plasmids of Haemophilus spp. and Neisseria gonorrhoeas 
originated by insertion of TnA, possibly derived from an enteric source, 
into phenotypically cryptic indigenous plasmids (Elwell et al. , 1977;
Roberts et al,, 1977; Brunton et al., 1986).
1.4.3. Virulence plasmids in Gram-negative bacteria.
Some plasmids carry genetic determinants which may code for different 
virulence properties characteristic of a number of bacterial pathogens both
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in man and animals (Broda, 1979; Elwell & Shipley, 1980). In many Gram- 
negative bacteria, plasmids contribute to a variety of virulence phenotypes 
including production of enterotoxin, haeraolysin, colicin, and colonization 
or adherence antigen in E. coli\ the invasive ability of E. coli, 
shigellae and salmonellae; and congo-red binding as a virulence marker in 
Yersinia and Shigella species.
Two kinds of E, coll enterotoxin, heat-labile toxin (LT) and heat- 
stable toxin (ST), are plasmid-specified, and have been reviewed in a paper 
on virulence plasmids of animal pathogens (Elwell & Shipley, 1980), That 
haemolysin production, colicin biosynthesis, and elaboration of 
colonization antigen in E, coll are plasmid-mediated, has also been 
reviewed (Novick, 1969; Helinski, 1973). Plasmid-encoded colonization 
antigens are K88 from pig isolates, K99 from calf or lamb isolates, and 
CFAI or CFAII from human isolates of enterotoxigenic E, coll (ETEC). 
Studies with pig and calf isolates of ETEC strains showed that enterotoxin 
production (Smith & Halls, 1968) and expression of both K88 (0rskov & 
0rskov, 1966) and K99 (Smith & Linggood, 1972) adherence proteins were 
encoded by plasmids, which were transmissible. The transmissible nature of 
these virulence plasmids was exploited to assess their role in the 
pathogenesis of porcine diarrhoea by a series of experiments (Smith, 1976). 
This author transferred the plasmids in different combinations into a set 
of non-pathogenic E. coll strains which were then used to infect young 
pigs. The presence of both enterotoxin (Ent) plasmid and K88 plasmid made 
E, coll enteropathogenic, causing diarrhoea in pigs. Further molecular 
studies with the Ent plasmid revealed that there was no transposon for LT, 
but that the ST gene was part of a transposon, TnîSôl (So et ai,, 1979). 
Production of colicin V (ColV) by E. coll is also mediated by a plasmid and
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may enhance virulence by conferring the property of serum resistance upon 
its host (Smith, 1974), Smith & Huggins (1976, 1978) cured human, bovine, 
ovine, and avian B. coli strains of ColV plasmids and showed that loss of 
this virulence plasmid was accompanied by a decrease in pathogenicity. 
Réintroduction of the same plasmid into the cured derivative of E. coli by
conjugation restored pathogenicity to its original level.
Two large virulence plasmids, one (210 kb) associated with invasiveness 
of Shigella flexneri (Sansonetti et al. , 1982) and enteroinvasive E. coli
(Hale et al., 1983), and the other plasmid (180 kb) involved in the 
expression of virulence-related 0-side chains of LPS in the cell wall of
Shigella sonnel (Sansonetti et al,, 1981), have been described. Plasmids of
different sizes were also found to be associated with virulence and 0- 
antigen expression in Shigella dysenterlae (Watanabe & Timmis, 1984; Haider 
et al., 1990). The genetic basis of virulence, including the plasmid-borne 
genes, in Shigella spp. has been recently reviewed (Hale, 1991).
Plasmid-mediated congo-red binding has been shown to be an indicator of 
virulence in Shigella spp. (Maurelli et al. , 1984; Qadri et al, , 1988) and
Yersinia enterocolltlca (Bhaduri et al,, 1987). This dye-binding ability 
was previously shown to be linked to virulence in Pasteurella pestls (now 
called. Yersinia pestls) (Surgalla & Beesley, 1969). Production of two 
virulence factors, coagulase and plasminogen activator, by Y. pestls was 
encoded by a 9. 5-kb plasmid (Sodeinde & Goguen, 1988). A 70-kb virulence 
plasmid has been shown to encode a set of outei— membrane proteins
(called Yops) and surface-associated fibrillar proteins (adhesins) in the 
pathogenic species of Yersinia (Cornelis et al,, 1989). The loss of these 
proteins correlates with loss of pathogenicity.
Large plasmids have been implicated in the virulence of many serotypes
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of Salmonella (Gulig, 1990). The virulence plasmids are primarily 
responsible for spreading infection beyond the host intestines, but the 
exact mechanism is unknown. Initially, Jones et al. (1982) described that 
a 90-kb plasmid was required for the invasive phenotype of Salmonella 
typhimurlum, In different serotypes of non-typhoid Salmonella, Helmuth et 
al. (1985) identified high molecular-weight plasmids which were found to be 
responsible for virulence in animal models. Salmonella plasmids have also 
been reported to be associated with increased serum resistance, a virulence 
phenotype of bacteria, encoded by a number of genes including traT involved 
in conjugative functions (Hackett et al,, 1987; Rhen & Sukupolvi, 1988; 
Sukupolvi et al. , 1992). The virulence genes on Salmonella plasmids have
been identified and analyzed (Williamson et al,, 1988; Lax et al., 1990) 
and found to be distributed among different species of Salmonella (Woodward 
et al, , 1989).
A large virulence plasmid (180 kb) has been isolated from Klebsiella 
pneumoniae (Massif et al,, 1989). This plasmid was shown to code for the 
mucoid phenotype and aerobactin production, both of which contribute to 
virulence properties of this bacterium.
To date, there have been no reports on virulence-related extra-
chromosomal genetic elements (plasmids or bacteriophages) which might play 
a role in the pathogenicity of Pasteurella, Haemolysin production in P. 
haemolytica does not appear to be plasmid-mediated (Chang et al., 1987). 
Production of leukotoxin, the principal virulence factor of this species, 
is not related to the presence of plasmids and has been shown to be
chromosomally-mediated (Richards, 1985; Lo et al. , 1985; Chang et al.,
1987). The chromosomal gene coding for the leukotoxin of P. haemolytica A1
has been cloned (Lo et al,, 1985), sequenced (Lo et al,, 1987) and found to
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have a significant degree of DNA sequence homology with the a-haemolysin 
gene of E. coli (Strathdee & Lo, 1987),
1.4. 3.1. The R factor as a virulence plasmid.
R factors <R plasmids) have been associated with virulence properties of 
bacteria on several occasions (Elwell & Shipley, 1980). The multiple drug- 
resistance plasmids have been shown to increase the virulence of Salmonella 
typhi and S. dysenteriae (Gangarosa et al., 1972). A K99-encoding virulence 
plasmid (78 kb) isolated from a bovine strain of E. coli was found to carry 
the genes for resistance to tetracycline and streptomycin (So et al. ,
1976), Several workers described plasmids which were simultaneously 
associated with the synthesis of enterotoxin of E. coli (LT and/or ST) and 
resistance to tetracycline and streptomycin (Gyles et al. , 1977; Echeverria
& Murphy, 1978). These plasmids were thought to be the result of 
recombination between an Ent plasmid and an R factor. A conjugative R 
plasmid (R6-5) has been shown to increase the pathogenic potential in E. 
coli by endowing the host with the property of high level serum resistance, 
and the traT gene product (a major OMP) has been found to be responsible 
for this phenomenon (Moll et al., 1980). A large, self-transmissible R 
plasmid (117 kb) in an enteropathogenic E. coli has been recently reported 
to play a role in colonization of the rabbit intestinal tract and thus 
contributed to the virulence of this strain (Reynaud et al,, 1991). 
Plasmid-encoded colonization factors were probably fimbrial-like structures 
found on the cell surface.
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1.4.4. Plafimid cloning vectors for E. coli and other Gram-negative 
bacteria.
"Because of their reliability and ease of handling, plasmids have become 
the workhorses of molecular cloning" (Sambrook et al, , 1989), Plasmids are
often used to construct shuttle vectors to transfer foreign genes between 
E. coli and other Gram-negative bacteria in the field of genetic
engineering.
The desirable features of an ideal plasmid cloning vector are: i) small 
size, ii) broad-host-range origin of replication, iii) selectable 
marker(s), iv) wide range of unique restriction sites, v) high copy number, 
vi) capacity for amplification, vii) stability and viii) conjugative or 
mobilization ability.
Plasmid vectors originally designed for use with E, coli employed 
insertional inactivation of one of two antibiotic-resistance genes present 
in the vector for recognition of recombinant clones. Perhaps the best-known 
and widely-used cloning vector of this kind is pBR322 (Bolivar et al. ,
1977), based on the pMBl replicon. This has a size of 4.36 kb, encodes
resistance to ampicillin and tetracycline, and contains unique sites for 20 
different restriction enzymes. Another such cloning vector is pAGYC184
(Chang & Cohen, 1978), constructed from the P15A replicon. This has a size 
of 4.2 kb, and contains tetracycline- and chloramphenicol-resistance genes 
and unique sites for various restriction enzymes. Replication of these 
vectors is restricted to E. coli.
Commonly used E. coli cloning vectors at the present time are those of 
the pUC series constructed by Messing & co-workers (Vieira & Messing, 1982; 
Norrander et al,, 1983; Yanisch-Perron et al,, 1985). The pUC vectors are
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small derivatives of pBR322, 2.69 kb in size. They contain a gene encoding 
resistance to ampicillin. They also carry a segment of DNA derived from the 
lac operon of E, coll that encodes the amino-terminal fragment (a-peptide) 
of p-galactosidase. This fragment, whose synthesis can be induced by 
isopropylthio-p-D-galactoside (IPTG), is capable of intra-allelic (oc) 
complementation with a defective form of p-galactosidase produced by the 
host. Appropriate E. coll strains, transformed with the pUC plasmids and 
then exposed to IPTG, synthesize both fragments of the enzyme and form blue 
colonies when plated on media containing the chromogenic substrate 5-bromo- 
4--chloro-3-indolyl-3~D-galactoside (X-gal). The a-peptide-coding region 
contains a closely arranged series of synthetic cloning sites called a 
polylinker, or polycloning or multiple cloning site. Insertion of foreign 
DNA into one of these sites inactivates the a-peptide resulting in the 
production of white colonies and thus enables immediate visual 
identification of recombinant clones Chistochemical screening).
The pIC plasmid vectors (Marsh et al. , 1984) are derivatives and
improved versions of the pUC plasmids. A greater range of restriction sites 
in the polylinker region have made these improved vectors more versatile. 
However, the vectors of either the pUC or the pIC series appear to lack the 
mob gene and are incapable of transfer by conjugation to another E. coli 
host (Sambrook et al. , 1989; Schweizer, 1991).
A set of broad-host-range cloning vehicles was constructed for Gram- 
negative bacteria based on the pSa origin of replication (Tait et al.,
1983). Concurrently, Simon et al. (1983) developed a mobilization system 
which involved the construction of mobilizing E. coli strains, containing 
RP4 inserted into the chromosome, and mobilizable vectors useful in 
transposon-mutagenesis of other species. Another group of workers described
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several vector derivatives of RK2, including pRK290 and pRK404, which could 
be used as broad-host-range cloning vectors for a wide variety of Gram- 
negative bacteria (Ditta et al,, 1985). Similar vectors based on plasmid 
RSFlOlO have been developed by Labes et al, (1990). These are expression 
and lac fusion vectors, used for the study of function and expression of 
foreign genes in Gram-negative bacteria.
Commonly used broad-host-range vectors (e. g. pRK290, pSa4) could not be 
propagated in P. haemolytica (Craig et al, , 1989). The same was found to be
true for Campylobacter jejuni and a shuttle vector was therefore 
constructed based on a plasmid replicon of C. jejuni origin (Labigne- 
Roussel et al., 1987). Development of shuttle cloning vectors has also been
reported for other Gram-negative bacteria such as Pseudomonas spp. (Nieto 
et al., 1990; Schweizer, 1991), H. influenzae (Trieu & McCarthy, 1990; 
Chandler, 1991), A. pleuropneumoniae (Lalonde & O'Hanley, 1989) and 
Actinobacillus actinomycetemcomitans (Sreenivasan et al,, 1991). Some of 
these vectors were mobilizable by tra functions supplied by another plasmid 
(RP4 or pRK2013), whereas some were not and could only be transferred to 
recipient bacteria by transformation or electroporation (for definition, 
see Section 1.5. 1 ).
Very recently, construction of a broad-host-range shuttle expression 
vector has been described for A. pleuropneumoniae and P. haemolytica (Frey, 
1992). This vector is based on the minimal autonomous replicon of plasmid 
RSFlOlO, and a type II chloramphenicol acetyl transferase gene from plasmid 
pSa for selection purposes.
A detailed review of plasmid cloning vectors for Gram-negative bacteria 
appeared in an article by Schmidhauser et al, (1988).
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1.5. Genetic Transfer Mechanisms.
Three mechanisms exist which allow transfer of genetic information (DNA) 
between bacteria, These mechanisms are; transformation (Griffith, 1928), 
conjugation (Davis, 1950) and transduction (Zinder &- Lederberg, 1952).
1.5.1. Transformation in Pasteurella and related species.
Genetic transformation is a process by which a bacterial cell takes up DNA 
from the surrounding medium. In the case of plasmid DNA this may replicate 
autonomously, whereas chromosomal DNA may be incorporated into the genome 
and bestow an altered genotype that is heritable. Transformation of E. coli 
K-12 by R factor DNA from another bacterium helps to define the antibiotic- 
resistance phenotype encoded by individual plasmids, especially when more 
than one is present.
Numerous reports are now available on the transformation of E. coli by 
R plasmid DNA obtained from P. multocida (Berman & Hirsh, 1978; Silver et 
al. , 1979; Hirsh et al. , 1981; 1989; Schwarz et al. , 1989a) and P.
haemolytica ( Zimmerman & Hirsh, 1980; Livrelli et al, , 1988a; Schwarz et
al,, 1989b; Craig et al,, 1989). Transformation of the P. haemolytica
strains used by Craig et al. (1989) was not possible by the conventional
CaClg-mediated procedure used with E. coli, but was possible by 
electroporation, a method which is based on the pulsing of a suspension of 
recipient bacteria with high voltages that may cause the temporary 
appearance of small holes in the cell envelope allowing entry of DNA 
molecules (Dower et al, , 1988). Electroporation-mediated transformation of
plasmid DNA has also been reported for P. multocida (Jablonski et al.,
1992) and A. pleuropneumoniae (Lalonde et al,, 1989).
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Antibiotic-resistance genes located on the chromosome as well as on 
small plasmids have been transferred between H, influenzae strains by the 
transformation process (Stuy, 1979). Genetic transformation in H,
influenzae is a natural process and occurs more efficiently than in enteric 
bacteria, where it has to be Induced by CaCl^ or other treatments, and has 
been well characterized (Goodgal, 1982). Both intra- and interspecies 
transformation has been shown in Haemophilus (Steinhardt & Harriott, 1968; 
Beattie St Setlow, 1970). An intraspecies DNA transformation has been 
reported in encapsulated isolates of H. influenzae type b by the static- 
aerobic procedure (Rowji et al., 1989), in which the presence of capsule 
did not hinder the transformation process.
1.5.2. Conjugation in Pasteurella and related species.
Conjugation is a process whereby DNA is transferred between bacterial cells 
(donor and recipient) by a mechanism requiring cell-to-cell contact.
The earliest report of R factor transfer from E. coli to Pasteurella 
(Yersinia) pestis by conjugation is that of Ginoza & Matney (1963). 
Although most of the R plasmids identified so far in Pasteurella species 
are small and non-conjugative, both inter- and intraspecies transfer of 
plasmid DNA has been reported for P. multocida and P. haemolytica. Hirsh et 
al. (1989) found that a large conjugal R plasmid (105 kb) from P. multocida 
could be easily transferred to E. coli and P. multocida by conjugation. In 
an earlier study, a 43-kb fertility plasmid in P. multocida was shown to 
transfer an R plasmid (11 kb) present in the same strain to both E, coli 
and other strains of P. multocida (Hirsh et al., 1981). Transfer of several 
natural and suicide plasmids from E. coli to P. multocida has been
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described by Nnalue & Stocker (1989). An attempt to transfer an ampicillin- 
resistance factor from P. haemolyt ica to E. coli by conjugation was
unsuccessful (Wray & Morrison, 1983), but Craig et al. (1989) successfully 
mobilized the same R plasmid from E. coli transformants to P. haemolytica 
and other E. coli strains by conjugation, using the transfer functions of 
the IncP plasmid pRK2013 (Figurski & Helinski, 1979).
Large plasmids coding for resistance to one or more antibiotics have 
been shown to be transferable between strains of H. influenzae and between
H. influenzae and E. coli (Thorne & Farrar, 1975; van Klingeren et al. , 
1977; Stuy, 1979). The genetic transfer is likely to be mediated by 
conjugation although sex pili have not been described in haemophili. The 
same transfer mechanism has been reported in H. ducreyi (Brunton et al, , 
1979; Deneer et al. , 1982).
I.5.3. Transduction in Pasteurella and related species.
Transduction involves the transfer of bacterial DNA from one bacterium to 
another by the agency of a virus particle (temperate or defective virus).
Four different transducing bacteriophages of H. influenzae have been 
reported: HPl, HP3, S2, and N3 (Stuy, 1978). Differences in phage
sensitivity and lysogeny have been demonstrated among H. influenzae 
serotypes and a number of Haemophilus species (Stuy, 1978),
Nothing has been reported on bacteriophage-mediated transduction in 
Pasteurella spp. A common group of bacteriophage (group 5 phage) has been 
reported to be induced from all isolates of P. haemolytica tested (Richards 
et al., 1984), and the kinetics of induction of the bacteriophages and 
their morphology have been determined (Richards, 1985).
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OBJECTIVES OF THE RESEARCH
Currently, very little is known about the genetics of P. haemolytica.
Because of the use of antibiotics in the control of disease caused by P. 
haemolytica, a knowledge of the genetic basis of antibiotic resistance in 
this bacterium is important. The initial aim of the project was to 
correlate the presence of plasmids in P. haemolytica isolates with the
source and health status of the host animal, and with resistance to 
antibiotics exhibited by the isolates. The project also had the objective 
of determining whether different serotypes and untypable isolates of P, 
haemolytica had their own distinct plasmid profiles and then to 
characterize any R plasmids by transfer studies between E. coli and P. 
haemolytica, by examining their stability in E. coli, by seeking homology 
to other known drug-resistance plasmid(s), and by analyzing the plasmid- 
encoded enzymes.
Previous reports had indicated that plasmid DNA of P, haemolyt ica
origin was difficult to reisolate ■ or recover from E. coli after
transformation and, therefore, another aim of the investigation was to 
devise procedures to amplify plasmid DNA in E, coli to obtain a good yield 
useful for characterization and cloning purposes.
An understanding of the role of virulence factors of P. haemolytica in 
the disease process has been hampered by a lack of vectors for transfer of 
cloned genes between E, coli and P, haemolytica and vectors to mediate 
transposon mutagenesis. The ultimate aim of this project was to identify a 
suitable plasmid which would provide the basis for construction of a 
shuttle vector for manipulation of Pasteurella genes to facilitate 
virulence studies and vaccine development.
2. MATERIALS AND METHODS
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2. 1. Bacterial Strains.
2.1.1. P. haemolytica strains.
Thirty five isolates of P. haemolytica from cattle or sheep were used in 
this study. These strains and their sources are listed in Table 5. Eighteen 
were serotype Al, 7 were A2, 1 each was T4 and TIO, and 8 were untypable
strains. Twenty three were bovine and 12 were ovine isolates. The majority 
of the isolates (30) were from pneumonic cases, only 3 were from healthy 
animals and 2 were from animals in contact with pneumonic cases. Nineteen 
P. haemolytica isolates of both ovine and bovine origin were kindly 
provided by Dr. W. Donachie of the Moredun Research Institute, Edinburgh; 
15 bovine isolates were kindly supplied by Dr. H. A. Gibbs of the Glasgow 
University Veterinary School; and 1 bovine isolate (CVL33) was a gift from 
Dr. C. Wray of the Central Veterinary Laboratory, Surrey, UK. Apart from 
the source and the health status of the host animal (Table 5), details such 
as the source case (experimental or field case), antibiotic therapy of the 
animal (treated or untreated) and the site of isolation (nasopharynx or 
lungs) for several isolates were also known. In addition, strains A2S and 
A2N were used in this study. These were spontaneously-derived streptomycin 
(Sm) and nalidixic acid (Nal) resistant mutants, respectively, of P. 
haemolytica strain FA2 (serotype A2), isolated by Dr. F. F. Craig in our 
laboratory. Similarly, strains AIS and AIN were isolated in the present 
study (see following section).
All isolates were further characterized by the API 20NE system and 
serotyped by the indirect haemagglutination test (Q. Ali, personal 
communication).
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TABLE 5. P. HAEMOLYTICA STRAINS USED IN THIS STUDY
Source
Strain Animal
Health status 
of animal Organizat ion#
Serotype A1
FAl Ovine Pneumonic MRI
B2070 Bovine Pneumonic » 1
B2086 Bovine Pneumonic % »
V965B Ovine Pneumonic f »
W629 Ovine Pneumonic » >
CVL33 Bovine Pneumonic CVL
S/B 82/1 Bovine Pneumonic GUVS
S/C 82/1 Bovine Pneumonic i 1
S/L 82/1 Bovine Pneumonic » 1
G/A 83/5 Bovine Pneumonic » *
H/L 82/1 Bovine Pneumonic * >
W/S 82/1 Bovine Pneumonic » 1
H/D 84/1 Bovine Pneumonic > >
M/F 83/1 Bovine Pneumonic > t
D/C 83/6 Bovine In-contact with pneumonic * 1
S/C 84/3 Bovine In-contact with pneumonic » >
G/A 83/1 Bovine Healthy » >
W/D 83/4 Bovine Healthy > »
Serotype A2
FA2 Ovine Pneumonic MRI
B664 Ovine Pneumonic
Continued on next page
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TABLE 5 (Continued)
Source
Strain Animal
Health status 
of animal Organization#
T884 Ovine Pneumonic MRI
Y510 Ovine Pneumonic t f
C/P 84/2 Bovine Pneumonic GUVS
D/I 85/1 Bovine Pneumonic > >
G/T 85/15 Bovine Healthy y »
Serotype T4
FT4 Ovine Pneumonic MRI
Serotype TIO
FTIO Ovine Pneumonic » »
Untypable
T1262A Ovine Pneumonic » t
T1368 Ovine Pneumonic > »
P709C Bovine Pneumonic ) t
U133 Bovine Pneumonic > »
B1031 Bovine Pneumonic * 1
U300 Bovine Pneumonic » )
U1284 Bovine Pneumonic » t
U1447 Ovine Pneumonic
# MRI: Moredun Research Institute, Edinburgh EH17 7JH, U. K.
CVL; Central Veterinary Laboratory, Surrey KT15 3NB, U. K.
GUVS: Glasgow University Veterinary School, Glasgow G61 IQH, U. K.
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2.1,1.1. Isolation of spontaneous antibiotic-resistant mutant strains 
of P. haemolytica Al.
P, haemolytica strain FAl (serotype Al) was grown overnight ("10^ cells ml”
■') in brain heart infusion broth (see Section 2.2) with shaking at 37'^ C, A 
100 pi portion of the culture was spread on brain heart infusion agar 
containing either Sm (200 pg ml”'') or Nal (20 pg ml”’). The seeded plate 
was allowed to dry and then incubated at 37°C for 2-3 days. Antibiotic- 
resistant colonies (one or two) grown on the plate were picked, and their 
phenotype was confirmed by subculture on agar medium containing the same 
concentrations of antibiotics. The Sm- and Nal-resistant mutants were 
designated AIS and AIN respectively.
2.1.2. E. coli strains.
E. coli strains used in this study are given in Table 6. All strains were 
available from the departmental culture collection, except J53 which was 
kindly provided by Dr. D. J. Platt of the University Department of 
Bacteriology, Glasgow Royal Infirmary, Glasgow, UK. Competent cells of E. 
coli XL-1 Blue were obtained from Dr. G. Westrop of our laboratory.
2. 2. Media and Growth of Bacterial Strains.
For composition and preparation of bacterial growth media, see Appendix 1.
All strains were stored frozen in 50% (v/v) glycerol in brain heart 
infusion (BHD broth (Oxoid, Basingstoke, UK) at-70^C. P. haemolytica 
strains from the frozen glycerol stocks were subcultured routinely on BHI 
agar medium with or without the supplementation of 5% (v/v) defibrinated
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TABLE 6. E, COLI STRAINS USED IN THIS STUDY
Strain Genotype/Phenotype Ref erence
C600 sup£44 hsdR thi~l thr-1 leuB6 
JacTl tonA21
Appleyard (1954)
DHl sup£44 hsdRl? recAl endAl gyrAB6 
thi-l relAl
Hanahan (1983)
DH5 supE44 hsdRll recAl endAl gyrA96 
thi-l relAl
Hanahan (1983)
HBlOl supE44 h s d £ 2 0 r e c A 1 3  ara-14 
proA2 lacYl galK2 rpsL20 xyl~5 mtl-1
Boyer & Roulland- 
Dussoix (1969)
JM83 ara Eilac-proAB) rpsL (p80dJacEAMlS Vieira & Messing (1982)
JC3272 His”Lys”Trp”Sm^ Achtman et al, (1971)
J53 Pro”Met“ Meynell & Datta (1966)
XLl-Blue 5upE44 hsdR17 recAl endAl gyrAAQ 
thi relAl lacr F' C proAB*' lacl'^  
iac2AM15 TnjO(tefr)]
Bullock et al, (1987)
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sheep blood (Becton Dickinson, UK), Blood agar was occasionally used for 
enrichment purposes for rapid growth, and for periodical confirmation of P, 
haemolytlea strains by virtue of their characteristic haemolytic activity. 
E. coli strains were subcultured on either BHI agar or nutrient agar 
(Oxoid) or Luria-Bertani (LB) agar medium. All plates were incubated at 
37°Q overnight. Liquid cultures of the strains were grown in the 
corresponding broth media in dimpled or plain conical flasks with shaking 
overnight on an orbital shaker at 37^ 0. Where necessary, antibiotic- 
resistant strains were grown on agar or in liquid media containing 
appropriate antibiotics (concentrations of antibiotics are given in the 
following section).
2.3. Antibiotics.
Beta-lactam antibiotics used in this study were: penicillin G or benzyl-
penicillin (Pe), ampicillin (Ap), carbenicillin (Garb), ticarcillin (Tic), 
oxacillin (Oxa), cloxacillin (Clox), cephaloridine (Cer), cephalothin (Get) 
and cephalexin (Gex). Other antibiotics used were; chloramphenicol (Cm), 
tetracycline (Tc), kanamycin (Km), trimethoprim (Tp), Sm and Nal, All 
antibiotics were obtained from Sigma, St. Louis, MO., except Garb which was 
from Beecham, Brentford, UK. Preparations of stock solutions of antibiotics 
are described in Appendix 2. The sterile antibiotic solution was added to 
broth or agar media, after they had been autoclaved and then cooled to 
50°G. The concentrations of the antibiotics used in selective media were 
(pg ml-T): Ap (50 or 100), carb (100), Tc (10), Gm (25), Km (50), Tp (100), 
Sm (200) and Nal (20),
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2. 4. pi maml dp;.
The following plasmids were used in this study;-
pRK2013: A broad-host-range helper plasmid (48,0 kb) of the IncP group
(Figurski & Helinski, 1979), used in mobilizing the non-conjugative 
plasmids. This plasmid carries the transfer gene functions (tra) from RK2, 
the Km*^  gene and a ColEl replication origin. This was obtained from Dr. S. 
Long, Stanford University, California, USA.
pRM3022: A prototype ROB-1 p-lactamase-encoding plasmid (4. 4 kb),
originally isolated from H, influenzae strain F990 and designated Rrob 
(Rubin et al, , 1981). This plasmid in E. coli HBlOl was a generous gift
from Professor E. R. Moxon, Institute of Molecular Medicine, Oxford 
University, Oxford, UK.
RP4: A broad-host-range conjugative (tra*) plasmid (54.0 kb), encoding
resistance to Ap, Km and Tc, and producing the prototype TEM-2 3-lactamase 
(Datta et al, , 1971). This plasmid is a member of the IncP group and
indistinguishable morphologically and biochemically from RPl, RK2, and R58
(Burkardt et ai., 1979), It carries transposon Tni. This plasmid in E, coli
J53 was kindly provided by Dr. D. J. Platt, University Department of 
Bacteriology, Royal Infirmary, Glasgow, UK.
R6K: A prototype TEM-1 3”lactamase-encoding plasmid (40.0 kb), which
is conjugative (tra*) and also encodes Sm^ (Kontomichalou et ai., 1970). 
This plasmid belongs to the IncX group and carries a Tn3-like transposon 
Tn2660, It was also kindly supplied in E, coli J53 by Dr. D. J, Platt of 
Glasgow Royal Infirmary.
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pUW964: A chimeric plasmid (73.0 kb) constructed from pRKTVS, a
derivative of pRK2013, in which the pre-existing kanamycin resistance 
determinant had been inactivated by a Tn7 (Tp^ , Sm*^  and spectinomycin^) 
insertion, followed by a transposition of Tn5 (Km*^ ) onto the plasmid (Weiss 
et ai., 1983). This plasmid was obtained from Dr. A. A. Weiss, University 
of Virginia Medical School, USA,
pBR322: : TnSCm”; A suicide transposon vector, obtained by insertion of 
Tn5Cm*^  (Sasakawa & Yoshikawa, 1987) into the Tc*^  gene of plasmid pBR322 
(Bolivar et ai. , 1977). This was constructed by Dr. F. F. Craig in the
Microbiology Department, Glasgow University.
pRK404; : Tn5Cnf*: A transposon-carrying plasmid vector, obtained by
insertion of Tn5Cm'^  onto the Tc*^  broad-host-range plasmid pRK404 (Ditta et 
ai., 1985). This was constructed by Dr. J. G. Coote in the Microbiology 
Department, Glasgow University.
pIC20H: An improved version of the E, coli cloning vector pUClS and
one of the vectors of the pIC series (Marsh et ai., 1984). This vector
contains a p-lactamase Ap*^  gene, an origin of replication and a portion of 
the p-galactosidase iacZ gene. It has a multiple cloning site (MCS) or
polylinker within the iacZ region and DNA fragment insertion into the MCS 
results in loss of p-galactosidase activity, producing white colonies on X- 
gal media (Appendix 25). For more information on this plasmid vector, see
Results (Section 3. 15). It was obtained from Dr. J. Marsh, University of
California, USA.
pILL514: A shuttle cloning vector for Campylobacter jejuni (Labigne-
Roussel et al, , 1987). It contains a Km'^  gene and a 760-bp fragment
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containing oriT (mob functions) of RK2. This vector in E. coll DHl was 
obtained from Dr. A, Labigne-Roussel, Pasteur Institute, Paris, France.
2.5. Antimicrobial Sensitivity Tests.
An antimicrobial sensitivity test or antibiogram for P, haemolytica strains 
was carried out by the disk-diffusion method (Barry & Thornsberry, 1980) 
using cartridge-borne antibiotic disks and a multiple disk dispenser
(Oxoid). Sixteen antimicrobial agents were tested at the following
concentrations per disk (pg): Ap (10), Cm (30), colistin sulphate (10),
erythromycin (15), gentamicin (10), Km (30), lincomycin (2), Nal (30),
neomycin (30), nitrofurantoin (300), polymyxin B (300 I.U.), Sm (10), 
sulphonamide compound (3300), sulphamethoxazole-trimethoprim (25), Tc (30) 
and Tp (1.25).
Two or three isolated colonies of P, haemolytica from an overnight 
culture plate were inoculated into a 50-ml flask containing 5 ml BHI broth 
and grown for 3 to 4 h with shaking on an orbital incubator at 37*C. The 
turbidity of the broth culture was adjusted, if necessary, with sterile 
normal saline (0. 85% NaCl) to match that of the McFarland 0. 5 standard (API 
system, France). Using a sterile bent glass rod, 100 pi of the culture 
suspension was spread over the entire surface of a pre-dried Muellei— Hinton 
agar medium (Difco, Detroit, MI) (Appendix 1) supplemented with 5% 
defibrinated sheep blood (Beckton Dickinson). The seeded plate was allowed 
to dry for 5 min and the antibiotic-impregnated disks were then applied to 
the surface of the plate by means of a multiple disk dispenser. A 'pre- 
diffusion* period of 15 to 20 min for the antibiotics was allowed before 
the plates were inverted and incubated at 37*^ 0 for 18 to 24 h. The
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diameters of the zones of inhibition of bacterial growth were measured in 
millimetres (mm) and compared with ‘zone diameter interpretive standards' 
(Barry & Thornsberry, 1980). The test strains were thus determined to be 
resistant (R) or sensitive (S) to each antibiotic.
2.6. Plasmid DNA Preparation. Purification and Analysis.
2.6.1. Small-scale preparation (miniprep) of plasmid DNA.
Miniprep plasmid DNA was isolated according to the modified alkaline-lysis 
method of Birnboim & Doly (1979) as described by Sambrook et al. (1989). A 
single colony of P, haemolytica or E. coli from a fresh overnight culture 
plate was inoculated into 10 ml BHI broth and incubated at 37°C on a rotary
shaker for 18 h. Cells from 1 ml of this culture were harvested by
centrifugation at 15, OOOxg in a bench-top microcentrifuge (Biofuge A, 
Heraeus Sepatech, FRG). The pellet was drained on tissue paper after 
removing the supernate and resuspended in 100 pi of ice-cold lysis buffer 
(TEG buffer with lysozyme) (Appendix 3) and then left for 5 min at room 
temperature. To each microfuge tube, 200 pi of freshly prepared alkaline- 
sodium dodecyl sulphate (SDS) solution (Appendix 4) was added and the
contents were mixed by inverting the tube several times followed by
incubation on ice for 5 min. Then 150 pi of freshly prepared ice-cold 
acidified potassium acetate solution (Appendix 5) was added to the tube 
which was vortexed in an inverted position for 10 sec and left on ice for 5 
min. After centrifugation at 15, OOOxg for 5 min at 4'^‘C, the supernate was 
removed to a fresh tube to which 400 pi of buffet— saturated 
phenol:chloroform (1:1) (Appendix 6) was added. The contents were mixed by 
vortexing, centrifuged at 15,OOOxg for 5 min and the supernate was removed
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to a fresh tube, avoiding the material at the interface. Chloroform (400 
pi) was then added. The two phases were mixed by brief vortexing, 
centrifuged for 2 min at 15, OOOxg and the upper phase was removed to a 
fresh tube to which 800 pi of ethanol (Hayman, Witham, UK) was added. The 
mixture was gently vortexed, left for 2 to 5 rain at room temperature and 
the plasmid DNA was pelleted by centrifugation for 10 min at 15,OOOxg in a 
microfuge. The DNA pellet was saved by carefully pouring off the supernate, 
rinsed with 70% (v/v in H^O) alcohol and then freeze-dried (5 min) or aii—  
dried (20 min). The dried pellet was redissolved in a small volume of Tris- 
EDTA (TE) buffer, pH 8.0 (Appendix 7) and treated with 20 pg ml”’ 
pancreatic ribonuclease (RNase) A (Sigma) (Appendix 8) at 37°C for 30 min 
before use.
2.6.2. Large-scale preparation of plasmid DNA.
Plasmid DNA on a large scale was extracted from 500 to 1000 ml cultures by 
the modified alkaline-lysis method (Sambrook et al. , 1989) with further
modifications. Cells were harvested by centrifugation at 10,OOOxg for 10 
min at 4‘=*C in a Sorvall GS3 rotor. The pellet was drained on a paper towel 
and resuspended by vortexing in 10 ml of ice-cold lysis buffer (Appendix 3) 
and then left for 10 min at room temperature. To each bottle containing the 
lysate, 20 ml of freshly prepared alkaline-SDS solution (Appendix 4) was 
added and the contents were mixed by gently inverting the bottle several 
times and left on ice for 10 min. Then 15 ml of freshly prepared ice-cold 
acidified potassium acetate solution (Appendix 5) was added. The contents 
were mixed by shaking or gently vortexing the bottle several times and left 
for a further 10 min on ice. The suspension was centrifuged at 12, OOOxg for
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10 min at 4°C in a Sorvall SS-34 rotor, The supernate was filtered through 
tissue paper to remove suspended particles. Approximately 0,6 volume (~27 
ml) of isopropanol (BDH, Poole, UK) was added and the mixture was left for 
15 min at room temperature. The precipitated DNA was pelleted by 
centrifugation for 10 min at 15,OOOxg at room temperature in a Sorvall SS- 
34 rotor. The pellet was gently washed with 70% alcohol, freeze-dried for 
10 rain and resuspended in 10 ral of TE buffer (pH 8.0), An equal volume of 
polyethylene glycol (PEG 8000; Sigma)-NaCl solution (Appendix 9) was added 
and the mixture was centrifuged for 10 min at 12, OOOxg in an SS-34 rotor. 
The DNA pellet was redissolved in 10 ml of TE (pH 8.0) in a glass universal 
to which an equal volume of buffered-phenol;chloroform (1:1) (Appendix 6) 
was added and the mixture was centrifuged for 10 min at 2300xg in a bench 
centrifuge (MSE minor, UK). The supernate was removed to a fresh universal, 
avoiding debris at the interface. The extraction was repeated with 10 ml of 
chloroform only and the supernate was removed to a 50-ml tube to which 10 
ml of 5M ammonium acetate was added and the mixture was incubated on ice 
for 15 min to precipitate the majority of RNA and chromosomal DNA, This was 
then centrifuged at 12, OOOxg for 10 min in an SS-34 rotor. The supernate 
was decanted into a clean glass beaker to which 2 volumes (~40 ml) of 
isopropanol were added and the mixture was left at room temperature for 10 
min. The plasmid DNA was pelleted by centrifuging at 15,OOOxg for 10 min in 
an SS-34 rotor. The pellet was drained well, rinsed with 70% alcohol and 
freeze-dried for 15 min. The dried preparation was taken up in 500 pi of TE 
(pH 8,0) and treated with RNase A (20 pg ml~^  final concentration) at 37^0 
for 30 min to remove residual RNA. The plasmid DNA preparation was stored 
at -20°C until use.
Large-scale preparation of plasmid DNA was also carried out by using
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QIAGEN-tip 500 of the plasmid maxi kit (DIAGEN GmbH, FRG), according to the 
manufacturer's instructions, starting from 500 ml broth cultures grown 
overnight.
2.6.3. Large-scale purification of COG plasmid DNA
Plasmid DNA extracted on a large-scale, by the method described in the 
preceeding section, contained chromosomal DNA and/or different topological 
forms of plasmid DNA. These crude plasmid DNAs were purified to CGC forms 
by an improved and modified acid-phenol extraction method CAzad et ai., 
1992a), based on method described by Zasloff et al. (1978).
To a 1.5 ml microcentrifuge tube containing a maximum of 300 pi crude 
plasmid DNA in TE buffer (pH8.0) was added 30 pi of 500mM sodium acetate 
(pH 4.0) and 33 pi of 15mM MgCl^ (AnalaR®; BDH) instead of 750mM NaCl, as 
used by Zasloff et al. (1978). An equal volume of phenol (Formachem) 
equilibrated with 50raM sodium acetate (pH 4.0) <1:1 w/v) was added and the 
mixture was vortexed vigorously for 60 sec. The mixture was centrifuged at 
15, OOOxg in a microcentrifuge (Biofuge A) for 5 min. The supernate was 
removed to a fresh tube and neutralized by adding 36 pi of 500mM Tris. HCl 
(pH 8,0) and mixed by gentle agitation. Then 396 pi of chloroform mixture 
(Appendix 6) was added and, after brief vortexing, the mixture was 
centrifuged at 15, OOOxg for 3 min. The supernate was removed to a fresh 
tube to which 39 pi of 3M sodium acetate (pH 6, 0) and 860 pi of ethanol 
were added. The contents were mixed by gentle inversion of the tubes and 
then left at room temperature for 10 min. The purified CGC plasmid DNA was 
recovered by centrifugation at 15,OOOxg for 10 min, rinsed with 70% ethanol 
and air-dried. The dried pellet was redissolved in TE buffer (pH 8,0) or
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distilled H^ O, All manipulations in the purification procedure were carried 
out at room temperature.
2, 6. 4. Electrophoresis, staining and photography of agarose gels containing 
plasmid DNA.
Agarose gel electrophoresis was carried out in a horizontal submarine 
electrophoresis apparatus (GNA-100 or 200; Pharmacia, Uppsala, Sweden), 
Type II-A medium EEC agarose (Sigma) was used in analytical gels, while low 
melting point (LMP) agarose (uiiraPure™; BRL, Gaithersburg, MD) was used in 
preparative gels. LMP agarose was also used in some analytical gels to 
separate and clearly visualize the smaller DNA fragments. Gels were 
prepared and run in either 0, 5X TBE buffer (Appendix 10) (for analytical
gels) or IX TAE buffer (Appendix 11) (for preparative gels).
Gel-loading buffer (Appendix 12) was mixed with DNA samples in a ratio 
of 1:5 (i.e., 1 pi per 5 pi sample). Then 10 to 12 pi of the sample mix was
loaded into each of 11 wells of the minigel system and 18 to 20 pi into 
each of 22 wells of the maxigel system. To create a bigger well, when 
required, teeth of the minigel comb were paired with sellotape and this 
allowed 40 to 50 pi DNA samples to be easily applied for both analytical 
and preparative purposes.
Plasmid DNA was routinely electrophoresed in 0. 8% (w/v) agarose using a
minigel (10.6 cm x 7,8 cm) at lOOV ("6, 6V/cm) for about 2 h or using a
maxigel (20 cm x 20 cm) at lOOV (~3,3V/cm) for about 4 h. Electrophoresis
of the smaller DNA fragments up to 50 bp was carried out in agarose gels of 
high concentration (up to 2%) at high voltage (lOV/cm) for a short time 
("80 min).
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Following electrophoresis, gels were stained in distilled water 
containing ethidium bromide (1 pg ml"'' final concentration) for 20 min and 
then rinsed with plain distilled water for at least an equal length of 
time. In the case of preparative gels, ethidium bromide (0,5 pg ml"' final 
concentration) was added to the melted agarose, before pouring on to the 
gel-former, and also to the running buffer. However, for analytical 
purposes, post-electrophoresis staining was preferred to prior addition of 
ethidium bromide as it gave a clearer background to the agarose gel,
DNA fragments were visualized under ultraviolet illumination, using a 
short wave transilluminator (UVP Inc,, San Gabriel, GA). Gels were 
photographed through an orange filter, using a Polaroid MP-4 Land camera 
with Polaroid 667-type Land film,
2.6.5. Standardization of p1a«m1d DNA (size and concentration).
Sizes of the plasmid DNA fragments were estimated from a standard
calibration curve obtained by plotting the relative mobility of the 
reference or marker DNA fragments against their logarithmic size in base 
pairs. Different types of DNA size markers were used, depending on the
topological forms and the fragment sizes of plasmid DNA, For calculating 
the sizes of uncut or GCG plasmids, a supercoiled DNA ladder (11 fragments) 
(Gibco-BRL, Paisley, UK) was used. For sizing the digested or linear
plasmid DNA fragments, either //incŒ II-digested X DNA (8 fragments) or 
//aelll-digest ed #X174 RF DNA (11 fragments) or 1 kb DNA ladder (23
fragments) (all from Gibco-BRL) was used. When the linear double-stranded 
fragments (e.g., X DNA/HinolII) were used as size markers, the supercoiled 
equivalent plasmid DNA size was determined by the method of Platt & Taggart
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(1987), The fragment sizes of different DNA markers used in this study are 
given in Appendix 13.
The approximate concentration of plasmid DNA fragments was determined 
visually on agarose gels, by comparison of their staining intensities with 
those of known quantities of marker DNA of a similar size (e.g., X DNA/ 
Hindlll fragments).
2.7. Transformation.
Transformation of E. coli was carried out by the standard CaCl^-procedure 
(Hanahan, 1983) and that of P, haemolytica by the static aerobic procedure, 
originally employed for encapsulated H. Influenzae (Rowji et al., 1989).
2.7.1. CaCl^-medlated transformation.
A 0,2 ral portion of a fresh overnight E. coli culture was inoculated into 
50 ml of prewarmed SOC medium (Appendix 14) in a 250-ml dimpled flask and 
shaken at 37^0 until the culture reached an optical density (OD)eso of 0, 2 
("5x10^ cells ml"'). The culture was then chilled on ice for 10 min and the 
cells were harvested by centrifugation in sterile glass universels with a 
bench centrifuge (MSE) at 2000xg for 10 min (4^ 0). The cell pellet was 
resuspended in 20 ml of ice-cold lOOmM CaCl^, incubated on ice for 25 min 
and repelleted by centrifugation as before. The cells were then gently 
resuspended in 0,5 ml of ice-cold lOOmM CaCl-., transferred to a prechilled 
microfuge tube and left on ice overnight before use or stored at -70^C in 
15% sterile glycerol.
Routinely, 1 to 2 pi of miniprep plasmid DNA (approximately 1 to 10 ng 
of DNA) was added to 20 pi of competent cells in a prechilled sterile
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microfuge tube, which was placed on ice for 30 min. The cells were then 
heat-pulsed at 42°C in a water bath for 90 sec and immediately returned to 
ice for a further 2 min. About 80 pi of SOC medium was added to the cell 
suspension which was then incubated with gentle shaking (225 rpm) at 37°C 
for 1 h to allow expression of plasmid-encoded antibiotic resistance. The 
whole of the transformation culture (~100 pi) was then spread onto a pre­
dried selective plate containing appropriate antibiotic(s) and the plate
was incubated at 37°C overnight or longer to obtain transformant colonies.
The amounts of plasmid DNA, competent cells and SOC medium, used in the 
transformation process, could be scaled up, if required. In that case, the 
cell suspension after 1 h incubation at 37°C was centrifuged and the pellet 
resuspended in 100 pi of SOC medium before plating.
2.7.2. Transformation by static aerobic procedure.
A fresh overnight culture of P. haemolytica was diluted into BHI broth
supplemented with ImM MgSO* (1:25 dilution i, e. , 0.4 ml culture into 10 ml 
fresh broth) and incubated in a sterile plastic petri dish (90 mm diameter) 
at 37®C without shaking for 6 to 8 h to allow growth to the early
stationary phase (ODsso 0,6). Then 10 pi each of plasmid DNA preparation 
and of statically-grown P. haemolytica cells were added to a tube
containing 80 pi of BHI broth plus ImM MgSO* and the suspension was
incubated for 30 min at 35°C without shaking. Pancreatic DNase was added at 
the concentration of 10 pg ml"' to the suspension which was then incubated 
for a further 10 min at 35*C without shaking. The whole of the 
transformation culture ("100 pi) was spread onto a selective plate which 
was incubated at 37*C for 24 to 48 h.
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2. 8. Plasmid Curing.
Curing studies were performed according to Hafiz et al. (1979), in 
conjunction with the procedures of Tomas & Kay (1984).
Different concentrations of ethidium bromide (pg ml”': 0.25, 0.5, 1.0,
1.5, 2.0, 2.5, 5.0 and 50) and acrldine orange (pg ml”': 75 and 100) were 
prepared in 10 ml of BHI broth in conical flasks and the media were 
autoclaved. A suspension of the P. haemolytica strain (to be cured) from a 
fresh 18-h culture on BHI agar was made in phosphate-buffered saline (PBS), 
the turbidity was matched with McFarland 0. 5 standard ("10^ cells ml”') and 
100 pi of this suspension was inoculated into each dilution of ethidium 
bromide and acridine orange and into the control (BHI broth alone). The 
flasks were incubated at 37°C on a rotary shaker and the organism was 
subcultured by streaking onto a BHI agar plate every 20 h. The antibiotic 
sensitivity of representative colonies of each subculture was tested by the 
disk-diffusion method, using the antibiotic disks to which the organism was 
resistant. The effects of ethidium bromide and acridine orange on the 
growth and drug-sensitivity of the P. haemolytica strain was noted.
2.9. Conjugation.
2.9.1. Plate mating of cultures by a two- or three-way cross.
Fresh 18-h cultures of donor, recipient (P. haemolyt ica or E. coii) and/or 
helper (E. coli HBlOl or DH5 containing plasmid pRK2013) strains, grown on 
selective agar, were streaked (a single stroke) individually onto a fresh 
BHI agar plate from different directions converging to a single point. 
Following overnight incubation of the plate with surface uppermost at 37°C,
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a loopful of growth from the meeting-point of the streaks was suspended in
2.0 ml of sterile saline or BHI broth. Then 100 pi amounts of the resulting
suspension or its dilutions were spread onto transconjugant-selection 
plates containing antibiotics to counter— select donor and helper strains. 
A control was set up by streaking separately the growth from the top of the 
streak of each participating strain onto a transconjugant-selection plate. 
All plates were incubated at 37®C for 18 to 48 h.
2.9.2. Plate mating of overnight broth cultures.
This type of plate mating was carried out by the method of Bradley et al.
(1980), with the exception that overnight cultures instead of exponential- 
phase cultures of donor, recipient and/or helper strains were used and with 
mating for 6 h (E. coll recipient) or 16 h (P. haemolytica recipient) 
instead of 1 h.
Each strain was grown overnight at 37°C on a shaker, in 10 ral BHI broth 
containing the appropriate antibiotic. Equal volumes (50 pi, except a 
double volume for the P. haemolytica recipient only) of the cultures of 
donor, recipient and/or helper strains were mixed in a microfuge tube by 
gentle vortexing and spread over the surface of a prewarmed BHI agar plate, 
which was then incubated with surface uppermost at 37^c for mating. Growth 
from the mating plate was harvested by washing the plate three times each 
with 1 ral sterile saline and appropriate dilutions were made. Then 100 pi 
aliquots of a neat sample or the dilutions were spread onto transconjugant- 
selection plates which were incubated for 18 h (E. coli recipient) or 48 h 
(P. haemolytica recipient).
In a further conjugation experiment, P. haemolytica recipient cells
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were subjected to heat treatment at 42.5*0 for 9 min before mating, a 
device adopted for plasmid transfer to coryneform bacteria (Schëfer et al, , 
1990).
Plasmid transfer frequencies by conjugation were obtained by dividing 
the total number of transconjugants by the original number of recipient 
bacteria in the conjugation mixture,
2. 10. Determination of Minimnm Inhibitory Concentrations (MICs) of Beta-
Lactam Antibiotics for Ap*^  Strains.
MICs of p-lactam antibiotics were determined by the agar-dilution method 
(Washington & Sutter, 1980). The 3-lactam antibiotics used were; Pe, Ap, 
Garb, Tic, Cex, Get and Ger (see Section 2.3).
A MIG plate was prepared as follows; dehydrated Iso-sensitest agar 
medium (Oxoid) was reconstituted with 900 ml (instead of 1 litre) of 
distilled H^ O, dispensed in 18 ml aliquots in screw-capped universels and 
then autoclaved. Serial double dilutions of g-lactam antibiotics were 
prepared (Appendix 15), and 2 ml of the antibiotic solution of appropriate 
concentration was added to 18 ml melted agar (~50*G), mixed thoroughly and 
poured into a petri dish. Plates were allowed to dry before use.
Four to five discrete colonies of the test bacterium from a fresh 
overnight culture plate were suspended in 4 to 5 ml of sterile normal 
saline and the turbidity of the culture suspension was adjusted to that of 
McFarland 0.5 standard. Then 50 pi of the suspension was added to 950 pi of 
BHI broth (1:20 dilution) in a sterile microfuge tube, mixed by gentle 
vortexing and the agar surface was spot-inoculated (without spreading) with 
this suspension, using a wire loop calibrated to deliver 1 to 2 pi. The
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plates were allowed to stand undisturbed with surface uppermost until the 
inoculum spots were completely absorbed and then incubated at 37*C 
overnight, The MIC value represented the lowest concentration of antibiotic 
at which complete inhibition of bacterial growth occurred. A very fine, 
barely visible haze or a single colony was disregarded.
2.11. Beta-Lactamase Test with Beta-Lactamase Detection Papers.
The production of 3-lactamase by Ap"^  strains was tested by 3”lactamase 
detection papers (Oxoid), according to the manufacturer's instructions.
One drop of distilled water was placed on a clean microscope slide and 
covered with a 3”lactamase test strip so that the strip was moistened but 
not oversaturated, Several colonies of the test organism were scrapped from 
a fresh overnight culture plate, using a wire loop and and streaked onto 
the dampened strip. The 3”lactamase production by the culture was indicated 
by the streaked portion of the strip changing colour from violet to yellow 
instantly or after approximately 5 min, depending on the activity of the 
enzyme.
2.12. Beta-Lactamase Assay.
2. 12. 1. Preparation of crude extracts of E. coli containing B-lactamase.
Three to four colonies of a 3”lactamase-containing E. coli strain from a 
fresh 18-h culture plate were inoculated into a 250-ml dimpled flask 
containing 50 ml BHI broth supplemented with Ap (50 pg ml”') and grown with 
shaking at 37*0 for 7 to 8 h. This starter culture was then added to 1 
litre of fresh Ap-supplemented BHI broth and incubated overnight at 37*0 on
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a shaker.
Cells were harvested by centrifugation at 12, OOOxg for 10 min at 4*0 in 
a Sorvall GS3 rotor and washed once with 0. IM potassium phosphate buffer, 
pH 7.0 (Appendix 16). The pellet was resuspended in a minimal volume of 
buffer (10-20 ml) and the cells were disrupted for 3 to 4 min (4 x 30 sec 
with 30 sec intervals on ice) with an ultrasonic disintegrator (MSE; 
maximum peak setting). Supernates were collected after centrifugation at 
140, OOOxg for 1 h at 4*0 in an ultracentrifuge (Sorvall® OTD-OOMBI, Dupont 
Oo, , CT), dialyzed overnight at 4*0 against deionized distilled water, and 
concentrated by freeze-drying. Freeze-dried samples were reconstituted with 
0. IM phosphate buffer (pH 7.0) and used as sources of g-lactamase enzymes.
2.12.2. Determination and inhibition of beta-lactamase activity.
Beta-lactamase activity was assayed by the raacroiodometric method of Ross & 
O'Callaghan (1975) on crude sonic extracts of E. coli cells. The method was 
scaled down 5-fold, using a 5-ml burette graduated to 0.02 ml. Penicillin 
G, Ap, Garb, Oxa, Clox, Oer, Cet and Cex (see Section 2. 3) were used as 
substrates to measure the rate of g-lactam hydrolysis.
One millilitre of p-lactam antibiotic solution (5mM in 0. IM potassium 
phosphate buffer), prewarmed to 37*0, was dispensed into each of two 
universels, followed by addition of 0.2 ml of enzyme solution (prewarmed 
to 37*0) to one bottle. The other bottle without enzyme was used as a 
control. Both test and control universels were incubated at 37*0 for 30 min 
in a shaking waterbath, before addition of 2 ml of prewarmed iodine reagent 
(Appendix 17) to each container. Enzyme solution (0.2 ml) was added at this 
time to the control only. The reaction mixtures were left in the shaking
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water bath <37*0 for a further 10 rain (penicillins) or 20 min 
(cephalosporins) and then titrated with 0,0166N sodium thiosulphate, using 
one drop of 2% hydrolyzed starch as indicator. If the titration was less 
than 0. 9 ml, the assay was repeated with diluted enzyme. Under these 
conditions, 1 ml of 0.0166N iodine consumed was equivalent to 2 pmoles of a 
penicillin or 4 pmoles of a cephalosporin destroyed. The specific activity 
of p-lactamases was expressed as pmol min”' (mg protein)”' (see following 
section for protein estimation).
Inhibition of p-lactamase activity, either by lOOmM NaCl or 0. ImM Clox, 
was carried out by the same method with Pe as substrate. To 0. 2 ml of 
enzyme suspension, 0.02 ml of either 5M NaCl or 5mM Clox was added before 
addition of Pe.
2.12.3. Estimation of protein.
Protein content of enzyme preparations was estimated by the Bradford method 
(Bradford, 1976), using bovine serum albumin (BSA) (Sigma; Fraction V) as 
standard.
Five millilitres of Bradford reagent (Appendix 18) were added to 100 pi 
of standard solution of BSA containing 10 to 50 pg of protein (100 to 500 
pg protein ml”'), mixed well and allowed to stand for 5 to 30 rain. 
Absorbance was then measured at 595 nm against a blank prepared from 100 pi 
of sample buffer and 5 ml of Bradford reagent, using a UV-240 
spectrophotometer (Shimadzu Corp. , Kyoto, Japan) and visible range 
cuvettes. Unknown protein samples were assayed by the same procedure, on 
100 pi volumes of different dilutions. A standard calibration curve was
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plotted and the protein concentrations (pg ml"') of unknown samples were 
worked out from the curve.
2. 12.4. Analytical isoelectric focusing.
Analytical isoelectric focusing was done using an LKB 2117 Multiphor 
apparatus and Ampholine® PAG plates (pH 3.5-9. 5) (Pharmacia LKB, Uppsala, 
Sweden), according to the manufacturer's instructions. The test samples 
were sonic extracts of E. coli containing either the p-lactamase-encoding 
plasmids from P. haemolytica or the known TEM- and ROB-type 3-lactamase- 
encoding plasmids. Staining and photography of the gel were performed as 
described by Matthew et ai. (1975).
The gel was placed on a sample application template supported on a 
cooling plate maintained at 4-10*0 by circulating cold water. Paraffin oil 
was spread uniformly over the cooling plate and the sample application 
template to ensure complete contact between the plate, the template and the 
gel respectively. The electric field was applied via two strips of paper, 
soaked in the appropriate anode (IM H^PO^) and cathode (IM NaOH) buffers 
and placed on two opposite edges of the gel marked by the respective 
electrode signs. The sample application strips (10 x 5 mm) were placed on 
the gel surface towards the anodic side upon which the test samples (15 to 
20 p.1) were applied by means of a micropipette. Isoelectric focusing was 
run at a constant power of 1 W with a maximum of 400 V for 3 to 4 h. The 
sample application strips were removed after approximately half the 
focusing time and the experiment was continued. The run was terminated and 
the gel was placed on a large glass petri dish for staining.
A sheet of Whatman no. 50 paper was soaked in a solution of a
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chroraogenic cephalosporin called "nitrocefin" <0.5 mg ml"') (Oxoid), laid 
over the surface of the gel and then removed, in one continuous rotary 
motion. Pink bands appeared on a yellow background, representing g- 
lactamase activity. Either the gel or the filter-paper blot from the gel 
was immediately photographed with a Polariod MP-4 camera using 665 film.
Isoelectric points (pis) of unknown p-lactamases were determined by 
reference to those of known g-lactamases.
2. 13. Plasmid Stability Test in E. coli.
An E. coli strain harbouring a P. haemolytica Ap^ plasmid was grown from a 
glycerol stock on LB agar containing Ap. One colony was streaked onto an 
antibiotic-free LB agar and grown for 16 h to single discrete colonies. 
Four colonies were picked, streaked separately onto LB agar plates and 
grown for 18 h to single discrete colonies. Sixteen colonies, four from 
each plate, were randomly selected and tested for the Ap*^  phenotype by 
streaking them separately onto LB agar plates containing Ap. The p- 
lactamase phenotype of these colonies was concurrently tested by using the 
p-lactamase strips. Serial passages of the plasmid-containing E. coli 
strains could be continued in this way in the absence of antibiotic 
selection and the stability of plasmids monitored by the demonstrated 
phenotypes of the bacteria.
2. 14. Amplification of Plasmid DNA in E. coli.
A single colony of an E. coli transformant, containing an Ap*^  plasmid from 
P, haemolyt ica, from a fresh overnight culture plate was inoculated into 
either BHI broth, nutrient broth, LB broth (Appendix 1), Terrific broth
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(Tartof & Hobbs, 1987) (Appendix 19) or 1% yeast nitrogen base (YNB)
(Difg o )-supplemented Terrific broth (Azad et al,, 1992b) and grown for 6 to 
7 h to late exponential phase (OD^oo ~0.6), A 0.05 to 0, 1 volume from these 
cultures was inoculated into corresponding fresh broth (prewarmed) and 
incubated with vigorous shaking (300 rpm) at 37*0 for 2. 5-3. 0 h (ODsoo
"0.4). At this stage, Cm (170 pg ml"' final concentration) (Clewell, 1972) 
or Tc (15 pg ml”' final concentration) was added and incubation continued 
for a further 14-15 h. Ampicillin selection was maintained throughout 
growth and the OD^oo was noted before the cells were used for preparation 
of plasmid DNA.
The same procedure was also applied for amplification in E. coll of the 
vector constructs, derived from a P. haemolyt ica plasmid.
2. 15. Restriction Endonuclease Digestion of Plasmid DNA.
Restriction endonuclease enzymes were purchased from different 
manufacturers and used according to the suppliers' instructions. The
suppliers' names, reaction buffers and recognition sequences of 42
restriction enzymes used in this study are given in Table 7.
Restriction enzyme digestion was routinely performed in a 40 pi volume 
containing approximately 2 pg of DNA, 4 to 20 units of enzyme (2 pi) and 
reaction buffer diluted to IX. Sterile distilled H^ O, reaction buffer 
(lOX), plasmid DNA solution and restriction enzyme were sequentially added 
to a sterile microfuge tube placed on ice and mixed gently by tapping the 
tube. The reaction mixtures were incubated overnight at the appropriate 
temperatures (generally 37*0, unless otherwise specified) and analyzed by 
gel electrophoresis in 1 to 2% agarose. About 7 pi of gel-loading buffer
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TABLE 7. RESTRICTION ENDONUCLEASES USED IN THIS STUDY
Restriction
enzyme
Recognition
sequence*
Reaction 
buf f erf Suppliers
Acyl 5'-GRiCGYC-3' Universal buffer Stratagene
Alul 5' -AG4.CT-3' REact*! Gibco-BRL
Apal 5'-GGGCCiC-3' REact™4 Gibco-BRL
ApaLl 5'-GiTGCAC-3' Assay buf f er 1 Stratagene
Aval 5'-C4YCGRG-3* REact™2 Gibco-BRL
Avail 5'-GiGWCC-3' REact™2 Gibco-BRL
Baaia 5'-GiGATCC-3' REact™3 Gibco-BRL
Bgll 5'-GGCNaiNGGC-3' REact™2 Gibco-BRL
Bglll 5’-AiGATCT-3' REact™3 Gibco-BRL
Bscl 5'-ATiCGAT-3' Bscl buffer NBL
Bspl2661 5*-GDGCHiC-3’ Assay buffer 1 Stratagene
BssHII 5'-GlCGCGC-3' Buffer A BM
Cfol 5'-GCGC-3' REact™! Gibco-BRL
CJal 5'-ATiCGAT-3' REact™! Gibco-BRL
Dpnl 5'-GmAiTC-3' REact™4 Gibco-BRL
Dral 5»-TTTlAAA-3' REact"! Gibco-BRL
EcoRX 5'-GiAATTC-3' REact"3 Gibco-BRL
EcoRV 5'-GATiATC-3' REact™2 Gibco-BRL
Cont inued on next page
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TABLE 7 (Continued)
Restriction
enzyme
Récognition
sequence*
Reaction 
buf f ert Suppliers
H a ell 5'-RGCGCiY~3' Buffer A BM
Hindi 5'-GTYiRAC-3' REact"4 Gibco-BRL
Hindlll 5' -A4.AGCTT-3' REact™2 Gibco-BRL
Hinfl 5'-GlANTC-3' REact™2 Gibco-BRL
Hpal 5« -GTT4-AAC-3' REact"4 Gibco-BRL
Hpall 5'-CiCGG-3' REact™8 Gibco-BRL
Kpnl 5*-GGTACiC-3' REact™4 Gibco-BRL
Mbol 5'-iGATC-3' REact™2 Gibco-BRL
Mspl 5'-CiCGG-3' REact"! Gibco-BRL
Narl 5'-GGiCGCC-3' Assay buffer ! Stratagene
Pstl 5' -CTGCA4-G-3* REact"2 Gibco-BRL
Pvull 5'-CAGiCTG-3' REact™6 Gibco-BRL
Sad 5'-GAGCTiC-3' Buffer A BM
Sali 5' -G4-TCGAC-3' REact"!0 Gibco-BRL
Sau5Kl 5'-iGATC-3' REact"4 Gibco-BRL
Seal 5’-AGTiACT-3' REact™6 Gibco-BRL
Cont inued on next page
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TABLE 7 (Continued)
Restrct ion 
enzyme
Recognition
sequence*
Reaction 
buf fert Suppliers
Smal 5' -CCC4.GGG-3' REact™4 Gibco-BRL
Sphl 5'"GCATGiC-3' REact"6 Gibco-BRL
St uL 5'-AGGlCCT-3' REact™2 Gibco-BRL
Taql 5‘-T4CGA-3' REact™2 Gibco-BRL
Thai 5' -CGiCG-3* REact"! Gibco-BRL
Xbal 5'-TiCTAGA-3' REact™2 Gibco-BRL
Xhol 5*-CiTCGAG-3* REact"2 Gibco-BRL
Xholl 5'-RiGATCY-3' Xholl buffer ABL
* R = A or G, Y = C or T, W = A or T, N = A or C or G or T, D = A or G
or T, H = A or C or T; 4- indicates the cleavage site within a 
recognition sequence, 
t Reaction buffers were supplied as lOX concentrates; composition of 
buffers is given in Appendix 20.
§ BRL, Bethesda Research Laboratories;
NBL, Northumbria Biologies Limited;
BM, Boehringer Mannheim;
ABL, Anglian Biotec Limited,
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(Appendix 12) was mixed with each restriction digest and the mixture was 
centrifuged briefly to remove bubbles before loading onto the gel.
2.15.1. Restriction mapping of plasmid DNA.
Restriction mapping was done by a combination of single and double 
digestion of DNA, Double digestion was carried out by using the combination 
of two enzymes and a single buffer system in either a one- or a two-step 
incubation, depending on the incubation temperature(s) required by the 
enzymes. The reaction conditions for double digestion of plasmid DNA are 
detailed in Table 8. A restriction map of circular plasmid was constructed, 
by trial-and-error search, using the relative cleavage positions of the 
enzymes as determined from the estimated sizes of different restriction 
f ragraents,
2.16. Southern Blotting and Hybridization.
In this study, a EauSAI or an Aiul digest of plasmid pPH843 was used as a 
probe for hybridization to Sau3AI- or AJuI-digested fragments, 
respectively, of the prototype ROB-1 plasmid pRM3022. The transfer and
hybridization of DNA fragments were essentially carried out according to
Southern (1975), as described either by Sambrook et aJ, (1989) or by
Ausubel et ai, (1987).
DNA fragments generated by restriction enzyme digestion were separated 
by gel electrophoresis, stained in 1 pg ml"' ethidium bromide and 
photographed under UV light. The gel was then submerged in dénaturation 
solution (1.5M NaCl, 0. 5M NaOH) and left for 15 min with constant, gentle 
agitation. After that the gel was rinsed in distilled water, placed in
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TABLE 8. REACTION CONDITIONS FOR DOUBLE DIGESTION OF PLASMID DNA
WITH RESTRICTION ENZYMES
Restriction
enzymes
React ion 
buf f er*
First- step digestion
Single- or second-step 
digestiont
enzyme: temperature; time temperature:time
PstI+Bspl286I REact"2 1 . 1 37*C ; overnight
Pstl+Dral REact™2 . . , 37*C : overnight
Bspl2Q61+Dral REact™1 , . , 37*C ; overnight
ThaïPstl REact™! Thai : 60*C : 10 h§ 37*C ; overnight
Thal+Bspl2&61 REact™! Thai ; 60*C ; 10 h 37*C : overnight
Thaï + Dral REact™! Thai ; 60*C : 10 h 37*C ; overnight
Taql + Pstl REact™2 Taql : 65*C : 10 h 37*C ; overnight
Taql+Bspl2Q61 REact™2 Taql : 55*C ; 10 h 37*C : overnight
Taql+Dral REact™2 Taql ; 65*C : 10 h 37*C : overnight
Thal + Taql REact™! Thai ; 60*C : 10 h§ 65°C : overnight
ApaLl+Pstl REact™2 * ’ • 37*C ; overnight
ApaLl-i-Bspl2d61 REact™! ' ' ' 37*0 : overnight
ApaLl+Dral REact™! ’ ' ’ 37*C : overnight
A val+Pstl REact™2 37*C : overnight
Continued on next page
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TABLE 8 (Continued)
Restriction
enzymes
Reaction 
buf f er*
First-step digestion
Single- or second-step 
digestiont
enzyme; temperature; time temperature; time
Aval + Bspl2Q61 React™2 37*C : overnight
Aval+Pral REact™2 37*C ; overnight
HinfL-i-Pstl REact™2 37*C ; overnight
Hlnfl+Bspl2Q61 REact™2 37*C : overnight
Hlnfl+Dral REact™2 37*C ; overnight
Scal+Pstl React™6 37*C ; overnight
Seal+Bspl2861 REact™6 37*C ; overnight
Scal+Z>ral REact™6 37*C : overnight
* Supplier: Gibco-BRL.
t In the case of a single-step digestion, both restriction enzymes were
used at the same time in the same REact™ buffer and incubated overnight 
at 37*C. In the case of a second-step digestion, the second restriction 
enzyme was added after the first-step digestion and incubated overnight 
at the appropriate temperature.
§ The appropriate salt concentration in the pre-existing REact™ buffer was 
adjusted by adding 2 pi of IM NaCl per 40 pi reaction volume after the 
first-step digestion.
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neutralization solution (2M NaCl, IM Tris, HCl, pH 7.4) and left for 15 min 
with gentle agitation.
A DNA transfer pyramid was set up by filling a tray with 20X SSC (3M 
NaCl, 0. 3M tri-sodium citrate, pH 7.0) and placing a wick, made from 
Whatman 3MM paper and soaked in 20X SSC, on a glass plate platform over the 
tray with both ends of the wet wick hanging over the glass plate into 20X 
SSC. The gel was removed from the neutralization solution and placed over 
the Whatman 3MM wick, avoiding trapped air bubbles beneath the gel. A sheet 
of Hybond”N+ membrane (Amersham, England) was cut to the exact size of the 
gel and soaked on one edge in distilled water followed by complete 
immersion in 2X SSC for at least 5 min. The wet nylon filter was then 
placed on top of the gel and air bubbles trapped between the filter and gel 
were removed by gently rolling a 10-ml pipette back and forth over the 
filter. Two pieces of 3MM paper, cut to exactly the same size as the filter 
and soaked in 2X SSC, were placed on top of the gel and wet filter, and air 
bubbles were smoothed out. A stack of absorbent paper towels <5-8 cm high), 
just smaller than the pieces of 3MM paper, was made and placed on top. A 
glass plate was then placed on the paper towels and a 0. 75 to 1 kg weight 
(e.g., a bottle) was put on the glass plate. The transfer of DNA was 
allowed to proceed for 16 to 20 h.
After the transfer was complete, the filter was rinsed in 2X SSC for 5 
rain, blotted dry on a paper towel and left at room temperature for 30 min 
before wrapping in Saran wrap (Dow Chemical Co.). The side of the Hybond 
membrane with the bound DNA was exposed to a source of UV light (254 nm) 
for 2 min to fix the DNA.
The membrane was placed in a heat-sealable polythene bag. One hundred 
microlitres of denatured salmon sperm DNA (10 rag ml”') (Appendix 21) were
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mixed with 10 ml of prehybridization solution (Appendix 22) and added to
the bag. As many air bubbles as possible were squeezed out of the bag 
before sealing the open end with a heat sealer and the filter was 
prehybridized in a shaking water bath at 42*C overnight with gentle
agitation.
Fifty microlitre volume of DNA probe was prepared by labelling the DNA 
fragments to high specific activity with [ a-^ =^ P] dATF (Amersham) by the 
random priming technique (Feinberg & Vogelstein, 1984) (Appendix 23), The 
probe was denatured by heating to 100*C in a boiling water bath for 5 min, 
chilled quickly in ice-water and then added to 10 ml of hybridization 
solution (Appendix 22). The prehybridization solution was removed from the 
bag and replaced by the hybridization mixture. Air bubbles were removed,
the bag was re-sealed and incubated overnight at 42*C with gentle
agitation.
The filter was removed from the bag and immediately washed twice in 2X
SSC, 0. l%(w/v) SDS at room temperature for 1 h and twice in IX SSC, 0. 1%
(w/v) SDS at 60*C for 2 h with agitation.
After the washing steps, the filter was blotted dry, wrapped in Saran
wrap and then exposed to X-ray film (Kodak X-OMAT S, France) against an
intensifying screen, to obtain an autoradiographic image. Autoradiographs 
were incubated at -70*C for varying periods of time, developed in Kodak 
LX24 developer and fixed in Kodak Unifix solution for 5 min each before 
rinsing under running tap water and then drying at room temperature.
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2. 17. Cloning.
2. 17. 1. Partial digestion of plasmid DNA.
For cloning purposes, plasmid pPH843 was subjected to partial digestion 
with TaqL restriction enzyme, according to the protocol of Ausubel et al, 
(1987).
A lOO-jil reaction mixture containing DNA in IX restriction enzyme 
buffer was made up and divided into 5 microfuge tubes such that tube 1 
contained 30 pi, tubes 2 to 4 contained 20 pi each, and tube 5 contained 10 
pi. All tubes were placed on ice. One microlitre of Taql enzyme was added 
to tube 1 (i. e. , 10 units of enzyme per 30 pi reaction volume), mixed
quickly by flicking the tube, and placed back on ice. Then 10 pi portions 
were dispensed from tube 1 into tube 2 by using a fresh pipette tip, mixed 
quickly and placed back on ice. The serial dilution process was continued 
by successively pipetting 10 pi from tube 2 to 3, 3 to 4, and 4 to 5, such 
that each tube contained 20 pi and was on ice. All five tubes were then 
incubated for 15 min at 65*C in a water bath. The reactions were stopped by 
adding 0. 5M EDTA, pH 8.0 (lOmM final concentration) and analyzed by agarose 
(LMP) gel electrophoresis.
2.17.2. Dephosphorylation of linearized DNA fragments.
In order to prevent linearized vectors from self-ligation or 
recircularization during cloning, the 5'-phosphate groups of double­
stranded DNA fragments were removed by treatment with calf intestinal 
phosphatase (CIP) (Pharmacia), according to the protocol of Sambrook et al, 
(1989).
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Plasmid DNA (2-4 pg) was digested to completion with the appropriate 
restriction enzyme in a 40 pi volume. In the case of DNA fragments having 
protruding 5' termini, 1 pi (6.7 units) of CIP was added to the digestion 
mix and incubated at 37*0 for 30 min. In the case of either blunt or 
recessed termini, 2 pi of CIP was added and incubated at 37*C for 15 min, 
followed by addition of another aliquot of CIP and incubation for a further 
45 min at 55*C. Dephosphorylated DNA fragments were purified by LMP-agarose 
gel electrophoresis in TAE buffer, followed by the GENECLEAN procedure (see 
following section).
2.17.3. Elution and purification of DNA fragments from agarose gels.
Before proceeding to the cloning protocol, DNA fragments were eluted and 
purified from LMP-agarose gels (in TAE buffer) by the GENECLEAN procedure, 
using the GENECLEAN II® Kit (BIO 101 Inc., LaJolla, CA),
The DNA band of interest was excised from an ethidium bromide-stained 
agarose gel with a sharp scalpel under long wave UV light, and the gel 
slice was put in a pre-weighed microfuge tube. About 3 volumes of Nal stock 
solution were added to the gel slice in the tube and incubated at 55*C in a 
water bath for 5 min or more with occasional vortexing until the agarose 
was dissolved. GLASSMILK® tube was vortexed vertically and horizontally for 
"1 min and 5 pi of the GLASSMILK suspension was added to the melted 
agarose, mixed well and incubated on ice for 5 min or more with occasional 
mixing. The GLASSMILK/DNA complex was pelleted at top speed for 5 sec in a 
Sarstedt microcentrifuge (NUmbrecht, FRG). The supernate was discarded by 
using a 1-ml micropipette and the white pellet was washed three times with 
ice-cold NEW (NaCl: Ethanol: Water) WASH, by adding 400 pi of NEW WASH,
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resuspending the pellet by repeated pipetting, centrifuging for 5 sec and 
then discarding the supernate. The pellet was freeze-dried briefly, 
resuspended in 5 to 10 pi distilled water and then incubated at 55°C for 3 
to 5 min with occasional gentle mixing. GLASSMILK was repelleted by 
centrifuging the suspension at top speed for 30 sec in a Sarstedt 
microcentrifuge and the supernate containing the purified DMA was recovered 
for immediate use or storage at -20‘^C.
2.17.4. "Filling in" or “trimming* reactions for converting incompatible 
DWA ends into blunt ends.
For ease of cloning, incompatible DNA ends were converted into blunt ends. 
This was carried out by "filling in" of 3* recessed ends (e.g. produced by 
or "trimming" of 3' protruding ends of DNA (e.g. produced by Pstl).
Plasmid DNA was digested to completion with the appropriate restriction 
enzyme in a 40 pi volume and fragments were separated by LMP-agarose gel 
electrophoresis, DNA fragments of interest were purified by the GENECLEAN 
procedure and taken up in distilled water in a fresh microfuge tube to 
which REact™4 was added as a substitute for DNA polymerase buffer. dNTP mix 
(a mixture of 25mM dATP, dCTP, dGTP, and dTTP; obtained from Boehringer 
Mannheim) was added to the tube at a final concentration of ImM (filling 
reaction) or 2mM (trimming rection). To this was added 1-2 pi of Klenow 
fragment of F. coli DNA polymerase I for the filling reaction and 
bacteriophage T4 DNA polymerase for the trimming reaction. The reactions 
were incubated for 15 min at room temperature (filling) or for the same 
period at 12‘^C (trimming).
DNA polymerase enzyme or fragment of enzyme was inactivated by heating
97
the reaction mixture to 75°C for 10 min before proceeding with the ligation 
or cloning protocol.
2.17.5. Ligation, transformation, and selection of recombinant clones.
Ligation reactions were routinely performed in a 20 pi volume. Aliquots of 
purified 'vector' and 'insert' DNAs were combined in proportions to make up 
a 10 pi volume in a pre-chilled tube and stored on ice, A 2X T4- DNA ligase 
mixture was made up in another tube as follows:-
Blunt-end Cohesive-end
Content ligation* ligation*
Sterile distilled
T4 DNA ligase buffer, 5X (Gibco-BRL) 
(Appendix 24)
lOmM ATP
T4 DNA ligase (Gibco-BRL)
4 pi
4 pi 
0 pi 
2 pi
4 pi
4 pi 
1 pi 
1 pi
* Values shown are for one ligation reaction.
The mixture was stored on ice. Then 10 pi of the ice-cold 2X ligase 
mixture was added to 10 pi of combined DNAs, mixed by flicking the tube and 
incubated at 16-18*^ 0 for 12-16 h.
After the ligation reaction was over, 5 to 10 pi of the ligated 
products were added to 100 to 200 pi of E. coll competent cells for 
transformation (see Section 2.7.1). The remaining portions of the ligated 
products were analyzed by gel electrophoresis.
Recombinant clones were selected on LB+X-gal media (Appendix 25)
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containing Ap and identified by their blue colour on these media. Plasmid 
DNA was prepared from blue clones by the miniprep procedure and analyzed by 
restriction enzyme digestion.
3. RESULTS
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3. 1. Antibiotic Resistance Profiles of P. haemolyilca Isolates.
Sixteen antibiotics were evaluated by the disk-diffusion method to 
determine the antibiotic resistance patterns of P. haemolytica isolates 
(Table 9), All 35 isolates belonging to serotypes Al, A2, T4, TIO, and
untypable group were found to be multiply-resistant to at least 3 
antibiotics. Serotype Al isolate S/C 84/3 exhibited the widest range; being 
resistant to 8 of 16 antibiotics tested, All strains (100%) were resistant 
to Lm, Sra and Su, and sensitive to Ct, Er, Fu, Gm, Km, Neo and PB. Twenty 
five (71,4%) strains showed resistance to Tp, 23 (65,7%) to SxT, 6 (17.1%)
to Tc, 4 (11,4%) to Ap, 2 (5.7%) to Nal, and only 1 (2.9%) strain to Cm, in
combination with other antibiotics. It should be noted that the
concentrations of Lm and Sm in the disks were low (Section 2.5) and
resistance may thus have represented only a natural resistance of P,
haemolytica to these antibiotics. Resistances to Tc, Ap, and Cm were only
found in isolates of Al serotype. Strain S/C 84/3 was partially resistant
to Ap, as determined by an obviously poorer zone of inhibition of bacterial 
growth. The prevalence of individual antibiotic resistances shown by the P. 
haemolytica isolates is depicted in Figure 3,
3.2. Plasmid DNA Profiles of P. haemolytica Isolates and Their Relation­
ships to Antibiotic Resistance Phenotypes,
All 35 isolates were analyzed for the presence of plasmid DNA. Plasmids 
were detected in 8 (22,9%) of the isolates (Figure 4). The plasmid profiles 
and the plasmid-associated antibiotic resistance phenotypes of these 8 
strains are given in Table 10, A 4. 3-kb plasmid was present in each of the
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TABLE 9. ANTIBIOTIC RESISTANCE PATTERNS OF P. HAEMOLYTICA ISOLATES
Antibiotics used*
tica strain Ap Cm ct Er Fu Gm Km Lm Neo Nal PB Sm Su SxT Tc Tp
Serotype Al
FAl S S s S s S S R S s S R R R S R
B2070 R S s s s S S R S 5 S R R R R R
B2086 S S s s s S S R S S s R R R R R
V965B S S s s s S S R S S s R R R S R
W629 S S s s s s S R S S s R R R S S
CVL33 R S s s s s S R S S s R R R R R
S/B 82/1 S s s s s s S R S S s R R S S R
S/C 82/1 R s s s s s S R S S s R R R R R
S/L 82/1 S s s s s s S R s S s R R S S S
G/A 83/5 S s s s s 5 S R s s s R R R S R
H/L 82/1 S s s s s S s R s s s R R S S S
W/S 82/1 S s s s s S s R s R s R R R s R
H/D 84/1 S s s s s s s R s S s R R S s R
M/F 83/1 S s s s s s s R s s s R R S R S
D/C 83/6 S s s s s s s R s s s R R R s R
S/C 84/3 pR R s s 5 s s R s s s R R R R R
G/A 83/1 S s s s s s s R s s s R R S S R
W/D 83/4 S s s s s s s R s s s R R R S R
Serotype A2
FA2 S s s s s s s R s s s R R R S R
B664 S s s s s s s R s s s R R R S R
Continued on next page
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TABLE 9 (Continued)
P. haemoly­
tica strain
Ant ibiot ics; used*
Ap Cm ct Er Fu Gm Km Lm Neo Nal PB Sra Su SxT Tc Tp
T844 S S s s S S S R S S s R R R S R
Y510 S S s s S S S R S S s R R S s R
C/P 84/2 S S s s S S S R S S s R R R s R
D/I 85/1 S S s s S S s R S s s R R R s S
G/T 85/15 S s s s S S s R S s s R R R s R
Serotype T4
FT4 S s s s S S s R S s s R R R s R
Serotype TIO
FTIO S s s s s S s R S s s R R R s R
Untypable
T1262A S s s s s S s R s s s R R S s S
T1368 S s s s s S s R s s s R R S s S
P709C S s s s s s s R s s s R R S s S
U133 S s s s s s s R s s s R R R s R
B1031 S s s s s s s R s R s R R R s R
U300 s s s s s s s R s s s R R S s S
U1284 s s s s s s s R s s s R R S s S
U1447 s s s s s s s R s s s R R R s R
KEY: S = Sensitive, R = Resistant, pR = Partially Resistant.
* Ap, ampicillin; Cm, chloramphenicol; Ct, colistin sulphate; Er, erythro­
mycin; Fu, nitrofurantoin, Gm, gentamicin; Km, kanamycin; Lm, lincomycin; 
Neo, neomycin, Nal, nalidixic acid; PB, polymyxin B; Sm, streptomycin; Su, 
sulphonaraide compound; SxT, sulphamethoxazole-trimethoprim; Tc, tetracyc­
line; and Tp, trimethoprim.
FIGURE 3. HISTOGRAM SHOWING THE PREVALENCE OF INDIVIDUAL ANTIBIOTIC 
RESISTANCES EXHIBITED BY P. HAEMOLYTICA ISOLATES.
Lm = Lincomycin (2)
Sm = Streptomycin (10)
Su = Sulphonamide compound (3300)
Tp = Trimethoprim (1.25)
SxT = Sulphamethoxazole-trimethoprim (25)
Tc = Tetracycline (30)
Ap = Ampicillin (10)
Nal = Nalidixic acid (30)
Cm = Chloramphenicol (30).
Values in parentheses indicate the concentrations of antibiotics in pg per 
disk.
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FIGURE 4. AGAROSE GEL ELECTROPHORESIS OF PLASMID DNA PREPARATIONS FROM 
P. HAEMOLYTICA SEROTYPES Al, A2 AND UNTYPABLE ISOLATES.
Key to figure:
M = A supercoiled DNA ladder used as the marker DNA.
1 = Plasmid DNA from strain B2070 (serotype Al
2 = Plasmid DNA from strain CVL33 ( ,,
3 = Plasmid DNA from strain S/C 82/1 ( ,,
4 = Plasmid DNA from strain S/C 84/3 ( ,,
5 = Plasmid DNA from strain B664 (serotype A2
6 = Plasmid DNA from strain D/I 85/1 ( ,,
7 = plasmid DNA from strain G/T 85/15 ( ,,
8 = Plasmid DNA from strain T1368 (untypable).
The figure is a composite of three separate 0.8% (w/v) agarose gels run 
under identical conditions with the marker DNA in each. The two smaller 
plasmids of strain T1368 (lane 8) are not clearly separated in this figure. 
The diffuse staining regions in lanes 4, 5, 7 and 8 are assumed to 
represent chromosomal DNA.
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TABLE 10. PLASMID PROFILES OF P, HAEMOLYTICA STRAINS AND THEIR
ANTIBIOTIC RESISTANCE PHENOTYPES
Serotype 
(n = no, of strains 
tested)
Strain no. 
(positive for 
plasmid)
Antibiotic
resistance
phenotype*
Plasmid
(kb)
Al (n = 18) B2070 Ap, Tc 4, 3
CVL33 Ap, Tc 4. 3
S/C 82/1 Ap, Tc 4. 3
S/C 84/3 Apt, Tc, Cm ~20, 4, 3, 2. 8
A2 (n = 7) B664 None 7, 6, 4. 0
D/I 85/1 None 3. 9, 2. 7
G/T 85/15 None 3. 9, 2. 7
Untypable (n = 8) T1368 None 5. 9, 3. 1, 2, 9
* Refers only to plasmid-associated antibiotic resistance; all 35 
strains (including the two T4 and TIO strains) tested by the disk- 
diffusion method were resistant to Lm, Sm and Su, and most of the 
strains were resistant to SxT and Tp. 
t Partially resistant, as observed by partial inhibition of growth.
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four serotype Al strains B2070, CVL33, S/C 82/1 and S/C 84/3. Strain S/C 
84/3 additionally contained two other plasmids of approximately 20 kb and 
2.8 kb. The three serotype A2 strains each appeared to contain two 
plasmids; two strains CD/I 85/1 and G/T 85/15) had similar plasmid profiles 
(~4.0 and 2.7 kb) whilst in the third strain (B664) a 2. 7-kb plasmid was 
replaced by a 7. 6-kb plasmid. The untypable strain T1368 had three 
plasmids, all apparently different from those of the Al and A2 strains. No 
plasmid DNA was detected in either the serotype T4 strain FT4 or the 
serotype TIO strain FTIO.
Resistance to Ap, Tc and/or Cm was only found in the plasmid-bearing 
bovine Al isolates. Since the Lm, Sm and Su resistances were common to all 
the strains and the SxT and Tp resistances were found in a majority of the 
strains of P. haemolytica irrespective of plasmid presence or absence, it 
was considered unlikely that these resistances were plasmid-mediated. 
Since these were the only resistances exhibited by the plasmid-carrying A2 
and untypable strains, no resistance phenotype could be ascribed to their 
plasmids. Such plasmids may be of the cryptic type. The plasmid-carrying Al 
strains were Ap^ and Tc^ , and also Cm'^  in the case of strain S/C 84/3, and 
these were candidate resistances for carriage by these plasmids. However, 
Tc'^  was also exhibited by two plasmid-less Al isolates. The resistance 
phenotypes of plasmid-harbouring P. haemolytica isolates and the possible 
location of the genetic determinants (chromosome or plasmid) are 
illustrated in Figure 5.
FIGURE 5. HISTOGRAM SHOWING INDIVIDUAL ANTIBIOTIC RESISTANCE PHENOTYPES 
OF PLASMID-CONTAINING P, HAEMOLYTICA ISOLATES AND THEIR 
POSSIBLE LINKAGE WITH GENETIC DETERMINANTS.
Lm = Lincomycin
Sm = Streptomycin
Su - Sulphonaraide compound
SxT = Sulphamethoxazole-trimethoprim
Tp = Trimethoprim
Tc = Tetracycline r
Ap = Ampicillin
Cm = Chloramphenicol.
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3.3. Transformation of E, coli with Plasmid PMA Preparations from P. haemo­
lytica Al Isolates and Analysis of Transformant Clones for Plasmid DMA.
Plasmid DNA from Al strains B2070, CVL33, S/C 82/1 and S/C 84/3, was used 
to transform E, coli strains DHl and JM83, selecting separately for Ap*, 
Tc*^  and, in the case of S/C 84/3, for Cm*^  transformants. Only Ap*^
transformants were obtained, suggesting that Ap"^  was plasmid-mediated. The 
lack of Tc^ and Cm"^  transformants suggested that the plasmid DNA
transformed did not contain determinants for Tc"^  and/or Cm'^ , or that these 
phenotypes were not expressed in B. coll. The frequencies of transformation 
to Ap*^  were expressed as transformants per jig plasmid DNA and are shown in 
Table 11. E, coli JM83 showed a consistently higher transformation 
frequency than E, coli DHl. Transformation frequencies were similar with 
plasmid DNA preparations from strains B2070, CVL33 and S/C 82/1 but were 
noticeably lower with that from strain S/C 84/3, presumably because the 
presence of other species of plasmid DNA reduced the apparent
transformation frequency.
E. coli transformants were analyzed for the presence of plasmid DNA 
following a routine plasmid isolation technique. No plasmid DNA was
detected on ethidium bromide-stained agarose gels and their presence in E. 
coli transformants was only confirmed by transformation of E. coli again to 
Ap^ with the plasmid DNA preparations from E. coli. About 40-60 
transformant clones were obtained per plate, but it was not possible to 
deduce a transformation frequency as the amount of plasmid DNA present was 
not measurable. The Ap^-encoding plasmids from P. haemolytica strains 
B2070, CVL33, S/C 82/1, and S/C 84/3 were designated pPH2, pPH33, pPH821, 
and pPH843 respectively.
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TABLE 11. TRANSFORMATION FREQUENCIES OF E, COLI STRAINS TO AMPICILLIN- 
RESISTANCE BY P. HAEMOLYTICA PLASMID DNA
P. haemolytica 
plasmid DNA source
Competent E. coli 
strain
Transformation frequency 
(Ap* transformants pig DNA”'')*
B2070 DHl 6. 8(±1, 2)xlO=
JM83 1.2(±0.5)xlO*
CVL33 DHl 1. 3(±0. 2)xlO*
JM83 2. 4<±0. 3)xlO^
S/C 82/1 DHl 9. 5(±1. 0)xl0®
JM83 1. 7<±0, 3)xl0®
S/C 84/3 DHl 4. 2C±0. I)xl0=
JM83 5. 2(±0. 2)xlO=
* Each value shown is the mean(±SEM) of observations from at least 
three separate experiments. Transformants were selected on BHI agar 
containing Ap,
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3.4. Mobilization of P. haemolytica Ap* Plasmids from E. coli to P. haemo- 
Ivtica and E. coli by Conjugation and Plasmid DNA Analysis from
Transconlugant s.
Plasmid transfer from P. haemolytica strains B2070, CVL33, S/C 82/1 or S/C 
84/3 to either P. haemolytica or E. coli by conjugation was unsuccessful, 
both in the presence and absence of the broad-host-range helper plasmid 
pRK2013. The large plasmid present in S/C 84/3 was therefore not able to 
mobilize either of the two smaller plasmids present in that strain. The P. 
haemolytica strains therefore did not appear to act as donors of their own 
plasmids in a conjugation system. However, plasmid DNA could be mobilized 
from E. coli (DHl or JM83) Ap* transformants into both P. haemolytica (A2S 
and A2N) and E, coli (JC3272 and C600) by using the transfer functions of 
pRK2013. No transconjugants were obtained in the absence of the helper 
plasmid, indicating that these P. haemolytica Ap* plasmids were not self- 
transmissible (non-conjugative). The frequencies of mobilization of the 
plasmids were expressed as transconjugants per recipient and are shown in 
Table 12. Plasmids pPH2, pPH33 and pPH821 showed similar mobilization 
frequencies and plasmid pPH843 showed a higher frequency, both into P, 
haemolytica and into E, coli. The overall mobilization frequency into E. 
coll was noticeably higher than into P. haemolyt ica. Interestingly, plasmid 
pPH843 was mobilized with the highest frequency into E. coli JC3272 by 
conjugation, yet showed the lowest transformation frequency into E. coli 
DHl or JM83 (Table 11). In a later conjugation experiment with these 
plasmids, P. haemolytica Al strain was used as a recipient after 
spontaneously-derived Sm* and Nal* mutants of this serotype were isolated 
(see Section 2. 1. 1. 1). Relatively higher frequencies of plasmid DNA
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TABLE 12. MOBILIZATION FREQUENCIES OF P. HAEMOLYTICA AMPICILLIN-
RESISTANCE PLASMIDS FROM E. COLI (DHl AND JM83) TRANS-
FORMANTS TO P. HAEMOLYTICA AND E. COLI BY CONJUGATION
E. coli donor 
strain
Helper
plasmid*
Recipient
straint
Mobilization frequency 
(transconjugants recipient"’)§
DHl(pPH2) pRK2013 A2S
JC3272
Ph
Ec
1. 2(±0. 3)xlO"S
2. 8(±0. 5)xlO"^
DHl(pPH33) » } A2S
JC3272
Ph
Ec
1, 3(±0. 5)xlO"= 
3.3(±0.6)xlO"*
DHl(pPH821) f > A2S
JC3272
Ph
Ec
1. 3(+0. 4)xlO"S 
3. 4(±0. 7)xlO"*
DHl(pPH843) A2S
JC3272
Ph
Ec
4. 4(±0. 4)xlQ-^ 
1. 3(±0. 2)xlO"’
JM83(pPH2) » > A2N
C600
Ph
Ec
3. 9(±0. 5)xlO"S
4. 8(±0, 8)xlO"*
JM83(pPH33) A2N
C600
Ph
Ec
5. 3(±0. 6)xlO"S 
5. 4(±0. 7)xlO-*
JM83(pPH821) f ) A2N
C600
Ph
Ec
8. 5(±1. 3)xlO"S 
5. 4(±0, 9)xlO"*
JM83(pPH843) i » A2N
C600
Ph
Ec
1.1(±0.4)xlO"* 
6. 5(±0. 5)xlO-*
* E, coli DH5 was used as the carrier of the helper plasmid when Sm*
recipient strains (A2S and JC3272) were used and E. coli HBlOl was 
used for Nal* recipient strains (A2N and C600). Transconjugants were 
selected on BHI agar with Ap+Sra in the former case and Ap+Nal in the 
latter case. Recipient cell numbers were calculated by plating 
appropriate dilutions on BHI agar plus Sm or Nal respectively,
t Ph, P. haemolytica; Ec, E, coli,
§ Each value shown is the mean(±SEM) of observations from three separate 
experiments.
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mobilization, 7x10”® - 6x10”* transconjugants per recipient, were obtained 
with these Al strains as recipients than with the A2 recipients.
Plasmid DNA analysis of transconjugants of P, haemolytica A2S revealed 
the presence of a single predominant 4. 3-kb band for all the plasmids, but 
a band of similar size was only visible in transconjugants of E. coli JC3272 
containing plasmid pPH843 (Figure 5). This confirmed that the 4. 3-kb 
plasmid present in the original strain S/C 84/3 (Table 10) encoded Ap* and
thus all four Ap* plasmids identified in this study appeared to be
identical in size. E. coli transconjugants showed the presence of plasmid 
pRK2013 (Fig. 6B), which was not shown by P, haemolyt ica transconjugants 
(Fig. 6A) as pRK2013 is a ColEl-based replicon which does not replicate in 
P. haemolytica.
3.5. Mobilization of Transposon-Carrying Plasmids from E. coli to E, coli
and P. haemolytica bv Conjugation.
Attempts were made to transfer the transposon Tn5Cm* from E. coli to P, 
haemolytica strains by conjugation, using the vectors pBR322r : Tn5Cm* and 
pRK404: : Tn5Cm*, either in the presence or absence of the helper plasmid 
pRK2013. No P, haemolyt ica transconjugants exhibiting Cm* were obtained
with these E. coli vectors (Table 13), suggesting that Cm* was not 
expressed in P. haemolytica or TnSCm* was unable to transpose into the P. 
haemolytica chromosome. Other drug resistances (e.g. Tc*, Ap*) carried by 
pBR322 or pRK404 were not examined in this study, but it had previously 
been shown that pRK404 could not be propagated in P, haemolytica (Craig et 
al, , 1989) and pBR322 would not be also expected to replicate in this
species. On the other hand, transposon vectors could be mobilized into E.
FIGURE 6. AGAROSE GEL (0, 8% W/V) SHOWING THE RECOVERY OF PLASMID DNA FROM 
P. HAEMOLYTICA A2S AND E, COLI JC3272 Ap* TRANSCONJUGANTS.
Key to figure:
M = A supercoiled DNA ladder used as the marker DNA.
Group A
1 = Plasmid DNA <pPH2> from P. haemolytica A2S<pPH2) transconjugant.
2 = Plasmid DNA <pPH33) from ,, A2S(pPH33) ,,
3 = Plasmid DNA (pPH82i) from ,, A2S(pPH821) ,,
4 = Plasmid DNA (pPH843) from A2S(pPH843) ,,
Group B
1 = Plasmid DNA <pRK2013 ) from E. coli JC3272(pPH2) transconjugant.
2 = Plasmid DNA (pRK2013 ) from ,, JC3272CpPH33)
3 = Plasmid DNA <pRK2013 ) from JC3272CpPH821)
4 = Plasmid DNAs (pRK2013 + pPH843> from E. coli JC3272<pPH843) ,, ,
The upper faint band Cat -7-kb position) present in all lanes of group A 
probably represents an open circular (OC) form of the 4. 3-kb plasmid.
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TABLE 13. MOBILIZATION OF TRANSPOSON5-CARRYING PLASMIDS FROM DIFFERENT 
E, COLI DONORS TO E, COLI AND P. HAEMOLYTICA RECIPIENTS BY
CONJUGATION
E. coli donor 
strain
Helper
plasmid*
Recipient
straint
Mobilization frequency 
(transconjugants recipient”’)§
DHl(pBR322::Tn5Cm*) pRK2013 JC3272 Ec 1. 1 (±0, 2) X 10“ ’
A2S Ph 0
HBlOlCpBR322: :Tn5Cm*) Ï ) C600 Ec 1. 0(±0. 2) X 10” ’
A2N Ph 0
C600(pRK404: ; TnSCm*) » } JC3272 Ec 1. 8(±0. 5) X 10”’
A2S Ph 0
JC3272(pRK404: : Tn5Cra*) t I C600 Ec 1. 5<±0. 3) X 10”’
A2N Ph 0
* E, coli DH5 was used as the carrier of the helper plasmid when Sra*
recipient strains CJC3272 and A2S) were used and E. coli HBlOl was used 
for Nal* recipient strains (C600 and A2N). Transconjugants were selected 
on BHI agar containing Cm+Sm in the former case and Cra+Nal in the latter 
case. Recipient cell numbers were calculated by plating appropriate 
dilutions on BHI agar plus Sm or Nal respectively,
t Ph, P. haemolytica; Ec, E. coli.
§ Values are the means(±SEM) of two independent determinations.
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coli strains (JC3272 and C600) at a high frequer^ 1.0 to 1.8 x 10”’ 
transconjugants per recipient cell (Table 13). These transposon-carrying 
plasmids by themselves were non-conjugative in nature, because they did not
transfer to E. coli without the help of pRK2013.
3.6. Curing P. haemolytica Strain S/C 84/3 of R Factor (R Plasmid).
Since the large plasmid present in strain S/C 84/3 (Table 10; Fig. 4, lane 
4) could not be demonstrated as an R factor by CaCl^-mediated 
transformation, an attempt was made to cure strain S/C 84/3 of plasmids, 
especially the large one possibly associated with Cm*. Ethidium bromide and 
acridine orange were used as curing agents, and an antibiogram, using six 
antibiotics to which the strain was resistant, was carried out every 20 h 
on portions of the cell culture streaked onto BHI agar (see Section 2.8) to
monitor the loss of any antibiotic resistance (Table 14). The only change
observed with this strain in its antibiotic resistance profile was the 
appearance of a clear and distinct zone of inhibition around the Ap disk 
after 40 h of growth in broth containing either 50 pg of ethidium bromide 
per ml or 75- or 100 pg of acridine orange per ml. This su^ ç^ s^ted that the 
Ap* plasmid (pPH843) from strain S/C 84/3 was eliminated, but there was no 
loss of Cm*. Longer incubation with the drugs caused a complete loss of 
cell viability,
3.7. Detection of B-Lactamase Production and Determination of MICs for 
Plasmid-Containing Ap* P. haemolytica and E, coli Strains.
The four Ap* plasmid-containing wild-type P, haemolytica strains, the 
corresponding Ap* transconjugants of P. haemolytica A2S and the Ap*
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TABLE 14. CURING AND GROWTH EFFECTS OF ETHIDIUM BROMIDE AND ACRIDINE
ORANGE ON P, HAEMOLYTICA STRAIN S/C 84/3
Concentration of drug 
(pg ml”’)
Growth on BHI 
of a sample of
agar and antibiotic sensitivity 
culture after incubation time
20h 40h 60h
Ethidium bromide
0. 0 + + ±
0. 5 + + —
1. 0 + + -
1. 5 + + -
2. 0 + + -
2. 5 + -
5. 0 + —
50. 0 + +* -
Acridine orange
0. 0 + + +
75. 0 + +* -
100. 0 + +* -
Antibiotic sensitivity Ap*, Cm*, Tc*, Ap®, Cm*, Tc*, NT
Sm*, Su*, Tp* Sm*, Su*, Tp*
KEY: +, growth; ±, poor growth; -, no growth; NT, not tested,
* Cells were completely sensitive to Ap at these concentrations of drugs 
after 40h.
For antibiotic designations, see footnote (*) of Table 9.
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transformants of E, coll DHl were tested for ^-lactamase production and for 
MICs with seven p-lactam antibiotics. In addition, E. coll DHl derivatives 
containing the TEM-type p-lactamase plasmid RP4 and the ROB-type p- 
lactamase plasmid pRM3022 were used for comparative purposes. The p- 
lactamase profile and the MIC values for p-lactams are given in Table 15, A 
good correlation was found between the p-lactamase production and the MICs 
of p-lactam antibiotics for the wild-type F. haemolytica isolates and the 
transconjugant strains of F. haemolytlea A2S. Isolate S/C 84/3 was p- 
lactamase-negative and showed much lower MIC values for those antibiotics 
(penicillin group) to which the other original isolates were clearly 
resistant. However, strain A2S(pPH843), which contains plasmid pPH843 from 
strain S/C 84/3, exhibited p-lactamase and MIC profiles similar to those of 
the other transconjugants. The MIC values for both the penicillin and 
cephalosporin groups of antibiotics were markedly increased in each of the 
E. coll DHl transformants, representing an 8 to 256-fold increase for 
transformants with plasmids pPH2, pPH33 and pPH821 and a 64 to >4096-fold 
increase for transformants with plasmid pPH843, over those values obtained 
with the original F. haemolytlca hosts. Similar MIC profiles for the 
penicillin group and somewhat different profiles for the cephalosporin 
group were obtained when E. coll containing either type of the known p- 
lactamase plasmids was compared with E, coll containing the F, haemolytlca 
plasmids. Plasmid-free and p-lactamase-negative E, coll DHl strain showed 
some resistance to all the p-lactam antibiotics tested and the MIC values 
were noticeably higher than those exhibited by the plasmid-free F. 
haemolytlca A2S strain. This suggested an inherent property of the E. coll 
K12 strain for conferring p-lactam resistance. E. coll strains containing 
plasmids pPH2, pPH33 and pPH821 were weakly positive for p-lactamase on
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TABLE 15. BETA-LACTAMASE PROFILE AND MINIMUM INHIBITORY CONCENTRATIONS 
OF BETA-LACTAM ANTIBIOTICS FOR PLASMIP-CQNTAINIHG AMPICILLIN-
RESISTANT STRAINS
p- MIC (pg ml-')
Strain
i RL, V aiu
ase Pe Ap Carb Tic Cex Cet Cer
P. haemolytlca
B2070 + 64 64 54 16 2 4 2
CVL33 + 128 128 128 32 2 4 2
S/C 82/1 64 64 64 16 2 4 2
S/C 84/3 - 2 1 0. 5 0. 5 2 4 1
A2S Cplasmid-f ree) - <0. 25 <0. 25 <0. 25 <0. 25 1 <0. 25 <0. 25
A2S(pPH2), A2S(pPH33^* 
and A2SCpPH821) J
128 64 256 32 2 4 2
A2S(pPH843)* 256 128 256 64 2 4 2
E. coll
DHl(plasmid-free) - 4 2 2 1 4 2 1
DHl(pPH2), DHl(pPH33%t 
and DHl(pPH821) J
± 2048 1024 >2048 2048 16 1024 16
DHl(pPH843)t + >2048 >2048 >2048 >2048 128 2048 128
DHl(RP4) + >2048 >2048 >2048 >2048 8 32 32
DHl(pRM3Q22) + 2048 2048 >2048 >2048 32 64 64
For abbreviations of p-lactam antibiotics, see Section 2. 3 of Materials 
and Methods, p-lactamase presence was determined as outlined in Section
2. 11 and MICs as detailed in Section 2, 10.
♦ Transconjugants, t Transformants.
±, Weakly positive.
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test strips. This may be related to copy number or stability of plasmids in 
E. coli (see Table 17 and Figs. 6B & 8). Beta-lactamase production by both 
transformant and transconjugant strains confirmed that these p-lactamases 
were plasmid-encoded.
3.8. Characterization of 8-Lactamases Encoded by P. haemolytlca PlmamldK
pPH2. pPH33. pPH621 and pPH843.
3.8.1. Beta-lactamase assays to determine the relative rates of 8-lactam 
hydrolysis, specific activities, and inhibition of B-lactamase activity.
The plasmid-encoded P. haemolytlea p-lactamases were extracted from E, coll 
DHl transformants and analyzed to compare them with known or reference p- 
lactamases. The prototype TEM-1 from E. coll strain J53(R6K), TEM-2 from 
DHl (RP4) and ROB-1 from DHl(pRM3022) were used as the reference p- 
lactamases. The substrate and inhibition profiles, and specific activities 
of the reference and the P. haemolytlca p-lactamases are shown in Table 15. 
The TEM- and ROB-type enzymes can be distinguished by their different 
activities against penicillins and cephalosporins as well as by their pi 
values (Rubin et ai., 1981; Medeiros et al., 1986). The substrate and 
inhibition profiles of p-lactamases produced by P. haemolytlca plasmids 
pPH2, pPH33, pPH821 and pPH843 were very similar to those exhibited by the 
prototype ROB-1 (Table 16). This indicated that the P. haemolyt lea p- 
lactamases might belong to the ROB-1 class. These enzymes showed high 
activity against ampicillin and carbenicillin and low activity against 
cephaloridine and cephalothin as compared to the TEM-type enzymes. The ROB- 
1 enzyme activity was markedly inhibited by cloxacillin but not by NaCl. 
The p-lactamase preparation from E. coli containing plasmid pPH843 showed a
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TABLE 16. SUBSTRATE AND INHIBITION PROFILES. AND SPECIFIC ACTIVITIES 
OF E. COLI EXTRACTS CONTAINING BETA-LACTAMASES ENCODED BY 
PLASMIDS pPH2. pPH33. pPH821 AND pPH843 COMPARED WITH THOSE 
OF TEM- AND ROB-TYPE BETA-LACTAMASES
Plasmid 
(p-lactamase 
type)
Relative rate of hydrolysis(%)$
Specif ic 
activity!
% activity in 
presence of§
NaCl Clox 
(lOOmM)(0. ImM)Ap Carb Oxa Clox: Cer Cet Cex
R6K(TEM-1) 115 13 7 2 168 15 11 6. 8 98 80
RP4(TEM-2) 117 14 5 <2 166 15 10 49. 6 98 75
pRM3022(ROB-1) 189 29 2 0 42 4 37 13. 0 100 32
pPH2 178 31 2 0 40 6 38 0. 8 100 41
pPH33 185 32 2 0 43 4 33 0. 76 100 36
pPH821 187 32 2 0 42 5 33 0. 6 100 38
pPH843 196 27 2 0 38 4 30 10. 0 100 28
Values are the means of two independent determinations.
* Activity relative to activity against penicillin G (defined as 100%), 
For abbreviations of p-lactam antibiotics, see Section 2.3 of 
Materials and Methods.
t Expressed as pmoles per min per mg protein with penicillin G as 
substrate.
§ Expressed as a percentage of activity against penicillin G in presence 
of inhibitor.
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higher specific activity than those prepared from E, coli containing the 
other three P. haemolytlca plasmids (Table 16). This is probably related to 
plasmid copy number as pPH843 was the only plasmid DNA visible in 
preparations from E> coll (Fig, 6B, lane 4).
3.8.2. Determination of isoelectric points (pis) of B-lactamases by 
analytical Isoelectric focusing.
The p-lactamases contained in E. coll extracts were analyzed by isoelectric 
focusing for their pi values. The isoelectric focusing patterns of unknown 
p-lactamases encoded by P. haemolyt ica plasmids pPH2, pPH33, pPH821 and 
pPH843 and those of known p-lactamases are shown in Figure 7. The main 
bands of p-lactamase activity produced by the P. haemolytlea plasmids 
(lanes 4-7) focused at the same pi (8, 1) as the prototype ROB-1 activity 
(lane 3), while the TEM-1 and TEM-2 enzymes focused at pis 5.4 and 5.6 
respectively (Medeiros et al. , 1985) (lanes 1 and 2). The accompanying
bands in lanes 1 and 2, and an additional band (pi 8.0) common to all 
enzyme preparations probably represent variant, satellite bands and the 
activity of chromosomal p-lactamase of E. coli, respectively, as reported 
by Matthew et al. (1975) and Medeiros et al, (1985). The pi values 
confirmed that the P. haemolytlca p-lactamases belonged to the ROB-1 class.
3.9. Stability of P. haemolytlca Ap*^  Plasmids in E. coll.
E, coli DHl transformants were tested for loss of plasmids pPH2, pPH33, 
pPH821 and pPH843 by successive subculture on non-selective agar media. The 
loss or stability of these plasmids in E, coll was monitored after each 
subculture by examining their Ap"^  phenotypes and p-lactamase production
FIGURE 7. COMPARATIVE ANALYTICAL ISOELECTRIC FOCUSING PATTERNS OF 
E. COLI EXTRACTS CONTAINING KNOWN p-LACTAMASES AND THOSE 
ENCODED BY THE P, HAEMOLYTICA PLASMIDS.
Key to figure:
1 = Activity and pi of the TEM-1 p-lactamase encoded by plasmid R6K.
2 - Activity and pi of the TEM-2 p-lactamase encoded by plasmid RP4.
3 = Activity and pi of the ROB-1 p-lactamase encoded by pRM3022.
4 = Activity and pi of the p-lactamase encoded by pPH2.
5 - Activity and pi of the p-lactamase encoded by pPH33.
6 = Activity and pi of the p-lactamase encoded by pPH821.
7 = Activity and pi of the p-lactamase encoded by pPH843,
A common additional band (pi 8.0), probably representing the chromosomally-
determined p-lactamase activity of E. coli, is seen in all lanes.
Enzyme preparations from strains containing pPH2, pPH33 and pPH821 were 
concentrated at least 10 times compared to the preparation from strain 
containing pPH843, before loading onto the gel.
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(Table 17). Plasmids pPH2, pPH33 and pPH821 were very unstable in &  coli 
and were lost completely after the second passage (~50 generations) in the 
absence of antibiotic selection. Plasmid pPH843, on the other hand, was 
stable even after 10 passages (~250 generations) in the absence of 
selection.
3. 10. Amplification in E, coli of Plasmid DNA Encoding ROB-1 8-
Lact amase.
As each Ap"^  plasmid from P, haemolyt ica apparently had a low copy number in 
E. coli, attempts were made to amplify the plasmid DNA in E, coli 
transformants. E, coli DHl transformants were grown in various nutrient
media with or without the addition of Cm and the influence of culture
conditions on the yield of the Ap'^  plasmids was observed (Table 18). 
Changes in growth media alone affected the yield of plasmid pPH843, which 
was detected in LB broth and amplified in Terrific broth. This plasmid was, 
in addition, further amplified when exposed to Cm in any broth medium used, 
although Terrific broth gave the highest yield (Table 18; Figure 8). 
Amplification was only evident with the other three plasmids (pPH2, pPH33 
and pPH821) when the host strains were grown in LB or Terrific broth in the 
presence of Cm, and Terrific broth supplemented with 1% yeast nitrogen base 
gave the highest yield (Table 18; Fig. 80. Under these conditions, plasmid 
DNA could be recovered from E. coli in amounts similar to those obtained
from the original P. haemolyt ica isolates or P, haemolyt ica
transconjugants. A similar but slightly less pronounced amplification of 
these plasmids was achieved when Cm was replaced by Tc (data not shown).
Higher yields of plasmids pPH2, pPH33 and pPH821, but less of plasmid
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TABLE 17. STABILITY OF P. HAEMOLYTICA AMPICILLIN-RE51STANCE PLASMIDS IN
E. COLI DHl
Plasmid-containing 
E. coli strain
No. of passages on 
non-selective media
Approximate 
no. of 
generations*
Phenotype!
Apf^ p-lactamase
DHl(pPH2), 
DHl(pPH33) and 
DHl(pPH821) 1 25 NT ±
2 50 -§ -§
DHl(pPH843> 1 25 NT +
10 250 +1T +11
KEY: NT, not tested; ±, weakly positive; +, positive.
*• One generation of E. coll = "20 min.
t Ap*^  and p-lactamase phenotypes were tested as described in Section 2, 13 
of Materials and Methods.
§ Plasmid lost.
IT Plasmid stable.
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TABLE 18. EFFECTS OF AMPLIFICATION PROCEDURES QN P. HAEMOLYTICA
PLASMID DNA IN E. COLI DHl
Ap*
plasmid
Extent of amplification under 
(ODsoo of culture at
different 
time of
growth conditions* 
harvest)
Broth
medium
alonet
BHI broth 
+Cm
Nutrient
broth+Cra
LB broth 
+Cm
Terrif ic 
broth+Cm
Terrific
broth+1%
YNB+Cm
pPH2 + ++ +++
(<2. 48) (1. 3) (0. 84) CO. 97) (1. 4) Cl. 53)
pPH33 - - + ++ +++
((2, 48) (1. 4) <0. 84) (0.96) (1. 32) (1. 35)
pPH821 - - + ++ +++
((2. 46) (1. 3) (0. 83) (0. 94) <1. 3) (1. 4)
pPH843 +/ ++§ +++ +++ ++++ +++++ +++++
(S2.49) Cl. 68) <0. 92) <1. 0) (1. 7) <1. 8)
YNB, Yeast nitrogen base,
* Grading of plasmid DNA amplification was done according to the 
relative intensity of ethidium bromide staining of plasmid DNA in 
agarose gels, ranging from a detectable level (+) to the maximum 
amount (+++++) obtained; ' indicates 'not detectable'.
t BHI broth, Nutrient broth, LB broth, or Terrific broth.
§ Detectable in LB broth only and amplified in Terrific broth.
FIGURE 8. AGAROSE GEL (0. 8%) SHOWING THE YIELDS OF P. HAEMOLYTICA Ap* 
PLASMIDS FROM E. COLI DHl AFTER AMPLIFICATION PROCEDURES.
Key to figure:
M = A supercoiled DNA ladder used as the DNA size marker.
Group A
1 = DNA preparation of plasmid pPH2 from E, coli grown in Terrific
broth alone.
2 = DNA preparation of plasmid pPH33 from E. coli grown in Terrific
broth alone.
3 = DNA preparation of plasmid pPH821 from E. coli grown in Terrific
broth alone.
4 = DNA preparation of plasmid pPH843 from E. coli grown in Terrific
broth alone.
Group B
1 = Plasmid pPH2 from E. coli grown in Terrific broth + Cm.
2 = Plasmid pPH33 from E, coli grown in Terrific broth + Cm.
3 = Plasmid pPH821 from E. coli grown in Terrific broth + Cm.
4 = Plasmid pPH843 from E. coli grown in Terrific broth + Cm.
Group C
1 = Plasmid pPH2 from E. coJi grown in Terrific broth + 1% YNB + Cm.
2 = Plasmid pPH33 from E. coli grown in Terrific broth + 1% YNB + Cm.
3 = Plasmid pPH821 from E. coli grown in Terrific broth + 1% YNB + Cm.
4 = Plasmid pPH843 from E. coli grown in Terrific broth + 1% YNB + Cm.
Ampicillin (50 pg ml~') was added to each of the above broth media used.
The additional upper band(s) (groups B and C) probably represent OC forms 
and/or dimers of the 4. 3-kb plasmid.
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pPH843, were achieved from E. coli JM83 transformants- than from their DHl 
counterparts following identical amplification procedures (data not shown).
The prototype ROB-1 plasmid pRM3022 (4.4 kb) of H. influenzae origin 
was amplified to a similar extent to that of the P, haemolytlca plasmid 
pPH843 in E. coli strain JM83 (Figure 9).
3.11. Development of an Improved and Rapid Method for Plasmid DNA
Purification.
Since the large-scale preparation of purified plasmid DNA was required for 
restriction enzyme analysis, cloning and further characterization purposes, 
an improved and rapid procedure was developed for the large-scale 
purification of CCC plasmid DNA. The new protocol combined a modified 
alkaline-denaturation procedure with a modified version of the acid-phenol 
extraction (see Materials and Methods: Section 2.6.3). Major modifications
were the uses of MgCl% instead of NaCl and vortexing instead of shaking in 
the final purification process. In addition to the smaller plasmids (4.3-
4. 4 kb) used in this study, some large plasmids were also employed in order
to assess the effectiveness of the modified protocol for preparation of 
plasmids over a wide size range,
MgClj2 was chosen in place of NaCl in the present protocol because Mg^ "”, 
a divalent cation, is known to have a high DNA binding capacity and would 
more efficiently precipitate non-CCC DNA (Sander & Ts'o, 1971; Müller et 
al., 1983) (see Discussion: Section 4.8). Several different concentrations
(l-50mM) of MgCl% were used in the low-ionic strength extraction buffer, 
but 1.5mM MgCla (final concentration) was found to be most effective in CCC 
plasmid DNA purification. Figure 10 illustrates the preparation of plasmid
FIGURE 9. AGAROSE GEL (0.8%) SHOWING THE YIELDS OF P. HAEMOLYTICA
PLASMID pPH843 (4. 3 KB) AND //. INFLUENZAE PLASMID pRM3022 
(4.4 KB) FROM E, COLI JM83 AFTER AMPLIFICATION PROCEDURES.
Key to figure;
M = A supercoiled DNA ladder used as the DNA size marker.
Group A
1 = Plasmid pPH843 from E. coll JM83 grown in Terrific broth alone.
2 = Plasmid pRM3022 from E. coli JM83 grown in Terrific broth alone, 
Group B
1 = Plasmid pPH843 from E. coli JM83 grown in Terrific broth + Cm.
2 = Plasmid pRM3022 from E, coli JM83 grown in Terrific broth + Cm. 
Group C
1 = Plasmid pPH843 from JM83 grown in Terrific broth + 1% YNB + Cm.
2 ~ Plasmid pRM3022 from JM83 grown in Terrific broth + 1% YNB + Cm.
Ampicillin (50 pg ml"'') was added to each of the above broth media used. 
The upper bands (lane 2, group C) probably represent a "step ladder" of 
CCC molecules with different numbers of supercoil turns (Kieser, 1984).
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PRM3022 ( 4-4 kb) 
PPH 843 ( 4 3 kb)
FIGURE 10. AGAROSE GEL ELECTROPHORESIS OF LARGE-SCALE PLASMID DNA 
PREPARATIONS EXTRACTED BY THE MODIFIED ALKALINE-LYSIS 
PROCEDURE AND THEN FURTHER PURIFIED BY THE MODIFIED ACID- 
PHENOL EXTRACTION METHOD.
Key to figure:
Group A: Plasmid pPH843 (4. 3 kb)
1 = Extracted by the modified alkaline-lysis method,
2 = Purified by acid-phenol extraction using 75mM NaCl,
3 = Purified by acid-phenol extraction using 1. 5mM MgCl^.
Group B: Plasmid pRM3022 (4. 4 kb)
1 = Extracted by the modified alkaline-lysis method.
2 - Purified by acid-phenol extraction using 75mM NaCl.
3 = Purified by acid-phenol extraction using 1. 5mM MgCl^.
Group C: Plasmids pRK2013 <48 kb) and pPH843 (4. 3 kb)
1 = Extracted by the modified alkaline-lysis method.
2 = Purified by acid-phenol extraction using 75mM NaCl.
3 = Purified by acid-phenol extraction using 1.5mM MgCl^ .
Group D: Plasmid RP4 <54 kb)
1 = Extracted by the modified alkaline-lysis method.
2 = Purified by acid-phenol extraction using 75mM NaCl.
3 = Purified by acid-phenol extraction using 1.5mM MgCl^,
Group E; Plasmid pUW964 (73 kb)
1 = Extracted by the modified alkaline-lysis method.
2 = Purified by acid-phenol extraction using 75mM NaCl.
3 - Purified by acid-phenol extraction using 1. 5mM MgCl^.
I = A supercoiled DNA ladder used as the DNA size marker.
II = FIndlll-digested X DNA used as the DNA size marker.
Five to seven microlitres from a total amount of 500 pi of crude or 
purified plasmid DNA samples derived from one large-scale preparation 
were run in each lane.
When i/indlll-digested X DNA fragments were used as size markers, the 
supercoiled equivalent plasmid DNA size was determined by the method of 
Platt & Taggart (1987),
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DNA by the modified alkaline-lysis method (lane 1, each group) which was 
then purified by acid-phenol extraction (lanes 2 and 3, each group). The 
difference between purification of CCC plasmids with 75mM NaCl (lane 2, 
each group) and with 1. 5mM MgCl^ (lane 3, each group) can be clearly seen. 
The use of NaCl produced a diffuse DNA smear in each case and removed CCC 
plasmid DNA molecules of higher molecular weight either partially (lane 2, 
group C) or completely (lane 2, groups D and E). The use of MgCl^, on the 
other hand, allowed good yields and complete purification of CCC plasmids 
ranging from 4.3 to 73.0 kb in size.
3. 12. Comparative Restriction Endonuclease Analysis of ROB-1 8-Lactamase-
Enoding Plasmids.
Plasmid DNA was extracted from E. coli transformants, purified by the above 
protocol, and subjected to digestion with 42 restriction endonuclease 
enzymes. Twelve enzymes were found to cut P. haemolytlca plasmids pPH2, 
pPH33, pPH821 and pPH843 giving fragments of identical size (Table 19) and 
the calculated size of each of the plasmids was found to be 4.2 kb. These 
enzymes were: Pstl, ApgLl, Aval, Fspl286I (1 fragment each); Hlnfl, Seal (2 
fragments each); Dral, Thai (3 fragments each); Cfol, Sau3hl, Taql (5 
fragments each); and Alul (10 or more fragments). The plasmids were thus 
cleaved by only six of the 6-bp recognition sequence enzymes used. 
Representative restriction digests of plasmid pPH843 are shown in Figure 
llA; the unique sites for Pstl, ApaLI, Aval and Bspl286I (all have a 6-bp 
recognition sequence) were confirmed by double digestion (lanes 7-9). The 
other two enzymes with a 6-bp recognition sequence were Seal and Oral. 
Enzymes with a 6-bp recognition sequence which did not cut the plasmid DNA
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TABLE 19. RESTRICTION END0MUCLEASE-DIGE5TI0N PROFILE OF THE P, HAEW- 
LYTICA AMPICILLIN-RESISTANCE PLASMIDS pPH2. pPH33. pPH821 
OR pPH843 (ALL HAD AN IDENTICAL RESTRICTION PROFILE)
Restriction endonuclease 
enzyme*
No. of 
f ragment(s) Size of fragment(s) (kb)
Pstl 1 4. 2
ApeLl 1 4. 2
Aval 1 4. 2
5spl286I 1 4. 2
Hlnfl 2 4. 14, 0. 06
Seal 2 4. 14, 0. 06
Dral 3 3. 9, 0. 24, 0. 06
Thai 3 3, 4, 0. 53, 0. 27
Cfol 5 3. 33, 0. 35, 0. 27, 0. 18, 0. 065
Sau3Al 5 1. 84, 1. 1, 0. 9, 0, 26, 0. 1
Taql 5 2. 56, 1, 0, 0.29, 0.23, 0.12
Aim lot 1.7, 
0. 18,
0. 53, 
0. 1,
0. 3, 0. 28, 0. 23, 0. 2, 
0. 08, 0. 06
* Recognition sequence of the enzyme is shown in Table 7 of Materials and 
Methods,
t The sub-total of the sizes of fragments obtained by Alul (3.66 kb) 
indicates that one or more of the fragments were doublets, i.e. 
comigrated on a 2% (w/v) agarose gel. This is evident from the relative 
brightness of bands shown in Fig. 113 (group 10).
FIGURE 11. RESTRICTION ENZYME DIGESTION PATTERNS OF ROB-1 p-LACTAMASE- 
ENCODING PLASMIDS OF P. HAEMOLYTICA AND H. INFLUENZAE ORIGIN 
(1.8-2% AGAROSE GEL).
Key to figure;
A; Representative restriction digests of pPH843 with 9 enzymes 
1 = Taql. 2 = Cfol. 3 = Thai.
 ^ ~ Hinfl. 5 = Seal. 6 = Pstl (or ApaLI or Aval
or Sspl286).
7 = ApaLI+Pstl. 8 = Aval ^ stl, 9 = Pspl286I + PstI.
M = 1 kb DNA ladder used as molecular size standard.
B; Restriction digests of pPH33. pRM3022 and pPH843 with 3 
enzymes
Group 10 = Alul, Lane a = pPH33.
Group 11= 5au3AI, Lane b = pRM3022.
Group 12 = Dral, Lane c = pPH843.
M = 1 kb DNA ladder (for fragment sizes, see panel A above).
The faint high molecular-weight bands in lanes 1, 7, 10a and 11c are
presumed to be partially-digested products.
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were; Acyl, Apal, BanHl, Bglll, Bscl, SssHII, Clal, EcdRl, EcdRV, Haell, 
Hindi, HindLll, Hpal, Kpnl, Marl, PviRl, Sad, Sail, Smal, Spbl, StuL, 
Xbal, Xhol and Xholl.
The prototype ROB-1 plasmid pRM3022 from H. influenzae presented 
apparently identical restriction fragment patterns to those of pPH843 with 
all the enzymes tested except Alul, Sau3kl and Dral. With these three 
enzymes slight differences were found (Figure IIB), whereby pRM3022 had two 
extra Alul sites and an additional Sau3Al and Dral site. Fragment sizes of 
pRM3022 produced by these three enzymes are given in Table 20. Two of the 
fragments produced by Dral (0.24 and 0.06 kb), 4 of the fragments by Sau3AI 
(1. 1, 0.9, 0,26, and 0. 1 kb) and 9 of the fragments by Alul (0.53, 0.3,
0.28, 0.23, 0.2, 0.18, 0,1, 0.08, and 0.06 kb) were common to both types of 
ROB-1 plasmids. This suggested that a close relationship existed between 
these plasmids.
3. 13. DNA Hybridization between ROB-1 Plasmids.
Hybridization experiments were carried out to assess the degree of homology 
between the ROB-1 plasmid from P. haemolytlca (pPH843) and that from H,
Influenzae (pRM3022). All fragments of pRM3022 obtained by Sau3AI digestion 
hybridized to Sau3AI-digested ^^P-labelled pPH843, except one fragment 
(Figure 12, panel A, lane 2, arrowed), which showed only very weak
hybridization (Fig. 12, panel B, lane 2, arrowed). This indicated a high
degree of homology between the two ROB-1 plasmids, but suggested that a
part of the DNA sequence from the Haemophilus plasmid was not present in 
the Pasteurella plasmid,
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TABLE 20. RESTRICTION FRAGMENTS QF THE PROTOTYPE ROB-1 BETA-LACTAMASE 
PLASMID pRM3022 (4.4 KB) BY THE ENZYMES DRAl. SAU3M AND ALUL
Restriction No. of
enzyme f ragments Siz:e of f ragments (kb)
Dral 4 3. 4, 0. 7, 0. 24, 0. 06
5a u3 AI 6 1. 35, 1, 1, 0. 9, 0. 69:, 0. 26, 0. 1
Alul 12* 1. 4, 0, 53, 0. 36, 0. 3, 0. 28, 0. 23,
0. 2, 0. 18, 0. 14, 0. 1, 0. 08, 0. 06
* The sub-total of the sizes of fragments obtained by Alul (3.86 kb) 
indicates that one or more of the fragments were doublets, i.e. 
comigrated on a 2% (w/v) agarose gel, as is evident from the relative 
brightness of bands shown in Fig. 1 IB (group 10).
FIGURE 12. HOMOLOGY BETWEEN THE ROB-1 PLASMIDS FROM P. HAEMOLYTICA AND 
H. INFLUENZAE
Key to figure;
Panel A: Ethidium bromide-stained agarose gel (1.8% w/v)
1 = Plasmid pPH843 digested by 5au3AI.
2 = Plasmid pRM3022 digested by Saudhl,
M = Representation of 1 kb DNA ladder as molecular size marker.
Panel B: Autoradiograph of a Southern blot of the same gel 
shown in panel A 
DNA was transferred to Hybond-N membrane and hybridized with 
3^P-labelled 5au3AI-digested pPH843 (see Materials and Methods: 
Section 2. 16).
Arrow (panel B, lane 2) shows a band exhibiting only faint hybridization, 
equivalent to the 0. 69-kb fragment of pRM3022 (arrow, panel A, lane 2).
134
bp M ^  1
1636
1018
135
3. 14. Restriction Mapping of Plasmid pPH843.
A restriction map of plasmid pPH843 was constructed by using 9 of the 
restriction enzymes that cleaved this plasmid. The enzymes used were; Psfl, 
Sspl286I, ApaLI, Aval, Seal, Z?ral, Thai and Tapi. Enzymes Alul and
SaiQhl Were not used in mapping due to problems involving either high 
frequency of digestion (Alul) or partial digestion (5au3AI) of the plasmid 
DNA (see Fig. IIB, lanes 10c & 11c respectively). In addition, enzyme Cfol 
was omitted for ease of interpretation and only Tapi was used as a producer 
of 5 fragments. DNA fragments were generated by digestion with a single 
enzyme or with a combination of two different enzymes and are shown in 
Figures 13A, 13B and 13C, Restriction fragments produced by single
digestion were compared with those produced by double digestion involving 
the same enzyme, by running them side by side in agarose gels. The size of 
each fragment was estimated and the relative restriction site(s) of each 
enzyme was located, on a circular structure of. pPH843, by a trial-and-error 
search. The estimated sizes of fragments of pPH843 obtained by double
digestion are given in Table 21. The size of each restriction fragment 
fitted well into a circular map of the 4. 2-kb plasmid pPH843 (Figure 14). 
The ampicillin-resistance (Ap^ ) gene (or bla> region and the possible 
origin of replication (oriV) were identified in subsequent cloning 
experiments. All Thai, Oral and Hinfl sites were shown to be grouped
together in the same region, at or near the putative bla gene. The segment 
of the map opposite to the Ap'^  gene appeared to contain all the Tapi sites 
along with the unique sites for Pstl and Aval. The unique sites located for 
enzymes 5spl286I and ApaLI were very close to each other and positioned
near to the Ap*^  gene. The positions of the two Seal sites were located on
FIGURE 13A. AGAROSE GEL (1,8%) SHOWING DNA FRAGMENTS OF PLASMID pPH843 
PRODUCED BY SINGLE OR DOUBLE DIGESTION WITH RESTRICTION 
ENZYME(S).
Key to figure:
M = A mixture of (pX174 RF DNA/hbelll fragments and XDNA/ 
HlndLll fragments used as molecular size standards. 
pPH843 DNA fragment(s) produced by
1 = Pstl (or Pspl286I or ApaLI or Aval).
2 = Pstl + Pspl286I.
3 = Pstl + Oral.
4 = Pspl286I + Oral,
5 - Pral.
6 = Thai.
7 = Pstl + Thai.
8 = Pspl286I + Thai.
9 = Oral + Thai.
136
8 9 MM  1
>2000
A
FIGURE 13B. AGAROSE GEL (1.8%) SHOWING DNA FRAGMENTS OF PLASMID pPH84-3
PRODUCED BY SINGLE OR DOUBLE DIGESTION WITH RESTRICTION
ENZYMECS).
Key to figure;
M = A mixture of (|>X174 RF DNA/Paelll fragments and XDNA/ 
Hindlll fragments used as molecular size standards 
(for fragment sizes, see Fig, 13A). 
pPH843 DNA fragments produced by 
to = Taql,
11 = Taql + Pstl.
12 = Taql + Pspl286I.
13 = Taql + Dral.
14 = Taql + Thai.
A common faint band seen in all lanes represents an artefact and the 
uppermost bands in lane 14 represent a portion of either uncut or 
partially cut pPH843 DNA molecules.
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FIGURE 13C. AGAROSE GEL (1.8%) SHOWING DNA FRAGMENTS OF PLASMID pPH843 
PRODUCED BY SINGLE OR DOUBLE DIGESTION WITH RESTRICTION 
ENZYME(S).
Key to figure:
M = 1 kb DNA ladder used as molecular size standard, 
pPH843 DNA fragments produced by
15 = ApaLI + Pstl.
16 = ApsLl + Pspl286I.
17 = ApaLl + Oral,
18 = Aval + Pstl,
19 = Aval + Pspl286I.
20 = Aval + Oral,
21 = Hina.
22 = Hina + Pstl.
23 = Hina + Pspl286I.
24 = Hina + Oral,
25 = Seal,
26 = Seal + Pstl.
27 = Seal + Sspl286I.
28 Seal + Oral.
The faint bands in lanes 15 and 16 represent the products of partial 
digestion.
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TABLE 21. RESTRICTION FRAGMENTS QF PLASMID pPH843 DNA GENERATED BY
DOUBLE DIGESTION WITH RESTRICTION ENZYMES
No. of
Restriction enzymes fragments Size of fragments (kb)*
Pstl + Sspl285I 
Pstl + Dr al 
Pspl286I + Dral 
Pstl + Thaï 
Sspl286I + Thaï 
Dral + Thaï 
Taql + Pstl 
Taql + Pspl286I 
Taql + Dral
Taql + Thaï
ApaLI + Pstl 
ApaLI + Dspl286I 
ApaLI + Dral 
Aval + Pstl
2
4
4
4
4
6
6
6
8
8
2
2t
4
2
2.8, 1.4
2.25, 1.65, 0.24, 0.06
3, 05, 0, 85, 0. 24, 0. 06 
(1. 85, 1. 55), 0. 53, 0. 27 
2.95, 0.53, 0.45, 0.27
3. 4, 0. 4, 0. 13, 0. 11, 0. 1, 0. 06
2. 56, 0. 75, 0. 29, 0. 25, 0. 23, 0. 12
1.91, 1.0, 0.65, 0.29, 0.23, 0.12
1.5, 1.0, 0.76, 0.29, (0.24,0.23),
0. 12, 0. 06
1.1, 1.0, 0.66, 0.53, 0.29, 0.27,
0. 23, 0. 12
2.75, 1.45
4. 15, 0. 05t
3. 1, 0. 8, 0. 24, 0. 06
3. 65, 0. 55
Continued on next page
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TABLE 21 (Continued)
Restriction enzymes
No. of 
f ragments Size of fragments (kb)*
Aval + Bspl286I 2 3. 35, 0. 85
Aval + Dral 4 2. 2, 1.7, 0.24, 0.06
Hinfl + Pstl 3 2. 55, 1. 59, 0, 06
Hinfl + Pspl286I 3 2. 99, 1. 15, 0. 06
Hinfl + Dral 5§ 3. 82, 0. 24, (0. 06, 0. 06)
Seal + Pstl 3 2. 85, 1. 29, 0. 06
Seal + Dspl286I 3 2. 69, 1. 45, 0. 06
Seal + Dral 5 3. 54, 0. 3, 0.24, (0.06,0.06)
* Restriction fragments shown in parentheses comigrated on a 1.8% (w/v) 
agarose gel (Figs. 13A, 138, 130.
t A band of 0. 05 kb was invisible on the 1. 8% (w/v) agarose gel shown in
Fig. 13C (lane 16), but was visible when the digest was deliberately
overloaded.
§ This digest should theoretically yield 5 fragments, but 4 fragments were
detected on the gel, indicating that one small fragment of about 20 bp
was missing.
FIGURE 14. A RESTRICTION MAP OF P. HAEMOLYTICA PLASMID pPH843.
Key;
Ap** = Ampicillin-resistance gene. 
oriV = Origin of vegetative replication. 
mob = Transfer mobility gene.
The circular map was drawn to scale (in kb) by using the MacVector® 
software (Apple Computer Inc., CA). One of the Dral sites was used as the 
zero reference point. Data indicate that all Dral, Thai and Hinfl sites are 
located within the Ap'' gene and the Dspl286I site within oriV (see Sections 
3. 15. 3 and 3. 15. 4).
The Pstl site is assumed to be located within the mob region (see Sections 
3. 15. 2 and 3. 15, 5).
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the other side of of the Ap*^  gene, as determined by the deletion 
experiments (Section 3.15,2).
3.15. Construction of Shuttle Cloning Vectors for P, haemolytlca.
For the development of a shuttle vector for P, haemolytica^ plasmid pPH843 
was chosen because of its greater stability and higher capacity for 
amplification in E. coli as well as its higher mobilization frequency into 
P. haemolytlca. From the restriction map (Fig. 14), a strategy was devised 
to convert the plasmid into a series of cloning vectors.
E, coli vector pIC20H (Marsh et al,, 1984), derived from pUC19, was 
used as a source of the a-peptide coding region (iacZ' ) of the g- 
galactosidase-encoding gene and the multiple cloning site (MCS). Insertion 
of the iacZ'+MCS fragment into a small sized plasmid molecule makes it an 
ideal cloning vector, by providing a large number of unique restriction 
sites and the property of recombinant selection through histochemical 
screening (see Introduction: Section 1,4.4). pIC20H was preferred to the
pUC19 or pUC18 vectors because of its greater range of unique cloning 
sites, A restriction map of pIC20H is shown in Figure 15, Eighteen 
different restriction enzyme sites are available in the MCS. All enzymes 
have unique restriction sites except Hindlll, Xbal and 5acl which have two 
sites each. New restriction enzyme sites added by this portion of the 
pIC20H vector (compared to the pUC vectors) were: Clal, EcdRV, Bglll, Xhol
and Nrul,
There were no restriction enzyme sites present on both pPH843 and 
pIG20H which were identical to or compatible with each other and which 
could have been used to cut out a fragment from pIC20H containing iacZ'
FIGURE 15. A RESTRICTION MAP OF E. COLI PLASMID VECTOR pIC20H.
The circular structure of the map (in bp) was adapted from that of the 
pUC18/pUC19 vector (Sambrook et al,, 1989) and the positions of the 
restriction enzyme sites were worked out from the computer-analyzed 
restriction data (GMBA08, pIC20H, Mapsort 1, 1991).
The restriction sites for the enzymes Dral, Haell, ApaLI and Acyl (each has
3 cleavage sites), used to cut pIC20H for cloning purposes in the present
rrûct
study, are shown in tar^elon the map.
One of the Ha elI sites was taken as the starting or ending reference point 
(0 or 2722 position).
Key:
amp'' = Ampicillin-resistance gene (positions 988-1766). 
ori = Origin of replication.
- lac promoter.
IacZ' = A part of the p-galactosidase-encoding gene of the lac operon.
iaci = Regulatory gene for the lac operon.
Arrows (4) indicate the direction of transcription.
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and MCS for direct cloning into the corresponding sites on pPH843. 
Therefore, different cloning strategies were adopted to overcome this 
problem.
3. 15.1. Cloning strategy using the large Dral fragments from both 
pPH843 and pIC2QH.
In a preliminary attempt to clone iacZ’ and MCS (plus iacI) from pIC20H 
into the F. haemolytlca plasmid pPH843, a 2011-bp Dral fragment lacking 
most of the Ap^  ^gene from pIC20H (positions 1130-1822) (Fig. 15) was mixed 
with the 3.9-kb Dral fragment from pPH843 (Fig. 14) and subjected to blunt- 
end ligation in the presence of bacteriophage T4 DNA ligase (Materials and 
Methods; Section 2. 17.5). After overnight incubation at 16‘^C, the ligation 
mixture was transformed into E, coll JM83 and selection made for blue 
colonies on LB+Ap+X-gal agar. No transformants were obtained. Agarose gel 
electrophoresis of the ligated products revealed that the DNA fragments had 
formed oligomers to some extent (Figure 16A). The lack of transformants on 
the selective plate suggested that the 3.9-kb Dral fragment of pPH843 is 
devoid of essential gene functions (perhaps Ap'^  or oriV).
The ligation experiment was repeated following dephosphorylation of 
either one or other of the DNA fragments with calf intestinal phosphatase 
(CIP) to prevent self-ligation and to encourage recombination. The same 
results were achieved.
In a further experiment, the 3. 9-kb Dral fragment was recircularized by 
T4 DNA ligase and transformed into E. coll. Production of no transformants 
supported the idea that this fragment lacked at least one of the genes 
essential for growth on selective media.
FIGURE IB. AGAROSE GEL (0.8% W/V) ELECTROPHORESIS OF LIGATION MDCTURE
SHOWING APPARENT RECOMBINATION BETWEEN THE VECTOR AND INSERT 
FRAGMENTS OR SELF-LIGATION OF EITHER THE VECTOR OR THE INSERT 
RESULTING IN OLIGOMER FORMATION.
Key:
A; Ligation between the 3.9-kb pPH843/DraI and 2-kb pIC20H/DraI 
f ragments
M = Supercoiled DNA ladder as size marker.
1 = Mixture of ligated (circular monomer or oligomer) and unligated
(linear; arrowed) DNA products.
2 = Control mixture of linearized vector (3. 9 kb) and insert (2. 0 kb)
DNAs (both arrowed) without T4 DNA ligase.
B; Ligation between the 4. 2-kb pPH843/Fs/?1286I and 485-bp pIC20H/Haell 
f ragments
3 = Mixture of ligated (circular recombinant or oligomer) and unligated
(linear; arrowed) DNA products.
4 = Control mixture of linearized vector (4. 2 kb) and insert (485 bp)
DNAs (both arrowed) without T4 DNA ligase.
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3.15.2. Reclrcularlzatlon of the large fragments of pPH843 produced by 
endonuclease enzymes Hinfl, Seal. TTzal. Cfol. Taql. HafiSAI and AluL and 
their propagation In E, coli on Ap-containing media.
In the light of the previous experiments (preceedlng section), it was felt 
necessary to recircularize the large fragments of pPH843 generated by Hinfl 
(4.14 kb), Seal (4.14 kb), Thai (3.4 kb), Cfol (3.33 kb), Taql (2.56 kb),
Sau3AI (1. 84 kb) and Alul (1. 7 kb) in order to check if they contained
sufficient genetic material for propagation in the presence of Ap. Each of 
these fragments was religated and transformed into E. coli and selection 
made for Ap"^  clones to see whether these deleted plasmid molecules were
able to replicate and propagate in E, coli. Since it was very unlikely that
the smaller fragments produced by these enzymes contained both the oriV and 
the Ap'^  genes, only the largest fragments were selected.
Ap'^  transformants were obtained only with the religated 4. 14-kb Seal
fragment and the 2. 56-kb Taql fragment of pPH843. Plasmid DNA analysis of
the transformants showed the presence of plasmid DNA of the predicted size. 
The other fragments did not yield detectable transformants, suggesting that 
one or more of the cleavage sites of each of the enzymes Hinfl, Thai, Cfol, 
Sa u3AI and Aliil int erf erred with an essential gene function, depriving 
those large fragments of either orlV or Ap"^  or both. On the other hand, the 
4, 14-kb Seal and the 2.56-kb Taql fragments apparently contained both oriV 
and Ap^ , and were thus considered suitable as the basis for a cloning
vector. These two functional, but deleted, derivatives of pPH843 were
designated pPH843AScaI and pPH843ATaqI respectively, However, the plasmid 
pPH843ATaqI could not be mobilized with the helper plasmid pRK2013 from E. 
coli JM83 (Sm^ ) to P. haemolytlca A2N (Nal*^ ). This indicated that
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pPH843ATaqX had lost the native mobilization (.mob) function site or origin 
of transfer replication CoriT) and could be used as a mob~ control in a 
conjugation experiment.
As seen in the pPH843 restriction map (Fig. 14), the unique sites for 
Pstl and Aval lie outside the 2.56-kb Taql fragment. Therefore, these two 
unique sites and all the Taql sites appeared to be located in the remaining 
1.64-kb region (positions 1.06-2.7) which was non-essential for propagation 
of pPH843 in the presence of Ap and might therefore be suitable for 
insertion of other determinants. However, this region probably contained 
the mob site. The unique sites for 5spl286I and ApaLI were located inside 
the 2. 56-kb Taql fragment.
3.15.3. Identification of the ROB-1 B-lactamase (Ap*^ ) gene In plasmid 
pPH843.
Since pPH843 had proved to be a ROB-1 p-lactamase plasmid, the location of 
the p-lactamase gene was identified on the basis of recent reports on ROB-1 
p-lactamase plasmids from H, influenzae and P. haemolytlca, and from the 
findings of the deletion experiments in this study.
The ROB-1 p-lactamase gene from H. Influenzae and P. haemolytlca was 
shown to be cleaved by SaUSAl at 4 sites (Levesque et ai. , 1987), by Hinfl
at 2 sites (Livrelli et al., 1991), by Dral at 3 sites and by Alul at a 
single site (Juteau & Levesque, 1990; Livrelli et al,, 1991). The ROB-1 p- 
lactamase gene from P. haemolytlca has been sequenced recently and an open 
reading frame (ORF) of 915 bp was detected (Livrelli et al,, 1991).
The findings in the present study, as described in the preceeding 
section (3.15.2), were consistent with these reports. The enzymes Dral,
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Thai and Hinfl (and also Sau3hl and Alul at an unknown number of sites, not 
shown on the pPH843 map) appeared to cleave and thereby inactivate the p- 
lactamase gene of plasmid pPH843. Thus, the ROB-1 p-lactamase gene seemed 
to span a region of about 0. 9 kb, the only region of the plasmid containing 
these restriction sites, as shown in Fig. 14.
3.15.4. Detection of the oriV region of pi ««mi d pPH843.
Since the unique sites for Bspl286I and ApaLI are located inside the
essential region of pPH843 but outside the p-lactamase gene, they were 
tested for the presence of oriV. pPH843 DNA was cleaved by either Bspl286I 
or ApaLI giving a 4. 2-kb linear fragment with 3'-protruding or 3'-recessed 
ends respectively. The fragments were made blunt-ended by removing 
("trimming") the protruding ends with bacteriophage T4 DNA polymerase or by 
"filling in" the recessed ends with Klenow fragment of E. coll DNA 
polymerase I in the presence of dNTPs (Materials and Methods; Section 
2. 17. 4), and then religated with T4 DNA ligase. Transformation of E. coll 
with the religated products yielded transformant clones with the ApaLI 
fragment but not with the Hspl286I fragment. This suggested that the
Sspl286I site was intragenic (oriV) and that cleavage at this site 
disrupted the functions of oriV by shifting its reading frame due to the 
trimming reaction. This was further confirmed, when the 485-bp Haell 
fragment from pIC20H (containing iacZ'+MCS+iacI ) was cloned into the 
Hspl286I site of pPH843. Both the vector and the insert fragments were 
treated with T4 DNA polymerase in the presence of dNTPs to remove their 3’- 
protruding termini and were then ligated. Agarose gel electrophoresis of 
the ligated DNA products showed that ligation between the fragments took
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place apparently accompanied by self-ligation of the individual fragment 
(Fig, 16B). Transformation results demonstrated that neither the 
recombinant nor the circularized vector and insert fragments produced 
detectable transformant clones (blue or white). This suggested that, since 
the 485-bp Haell fragment did not contain oriV of pIC20H (Fig. 15), the 
vector pPH843/Hspl286I (A3') fragment must have lost its oriV. Since the 
Hspl285I and ApaLI sites are very close to each other, the oriV gene 
presumably spanned the Hspl286I site, but was directed away from the ApaLI 
site (Fig. 14).
Taken together, these data indicated that three restriction enzyme 
sites on pPH843 might be suitable for cloning: the Pstl site for cloning in 
the 485-bp Haell fragment of pIC20H, the ApaLI site for cloning in the 
979-bp ApaLI fragment, and one of the Taql sites for cloning in the 2032-bp 
Acyl fragment (Taql and Acyl produce compatible cohesive ends) (Figs, 14 
and 15).
3.15.5. Construction of vector pAKA15 and its mob-containing derivative 
pAKA15"l.
A schematic diagram showing the cloning strategies for the construction of 
pAKA15 and its jMoZT'-derivative pAKA15-l is shown in Figure 17. The 3' - 
protruding ends of both the 4. 2-kb Pstl fragment of pPH843 and the 485-bp 
Haell fragment of pIC20H were removed by T4 DNA polymerase in the presence 
of dNTPs and the fragments subjected to blunt-end ligation. The ligated 
products were transformed into E, coll JM83 and selection was made for blue 
recombinant clones on LB+Ap+X-gal agar. Only 5 blue colonies were obtained 
against the background of a large number of white colonies. Plasmid DNA
FIGURE 17. SCHEMATIC DIAGRAM SHOWING THE CONSTRUCTION OF VECTOR pAKAlS 
AND ITS DERIVATIVE pAKA15-l.
Key:
Ap’ = Ampicillin-resistance gene.
Km'' = Kanamycin-reslstance gene.
IacZ'- The a-peptide-encoding gene sequence of p-galactosidase. 
lad = Regulatory gene for g-galactosidase.
MCS = Multiple cloning site.
oriV = Origin of vegetative replication.
oriT = Origin of transfer replication.
CIP = Calf intestinal phosphatase.
The plasmids are not drawn to scale. Arrows indicate the direction of 
transcription. Restriction sites shown in brackets were destroyed by DNA 
polymerase during subcloning.
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analysis of blue colonies revealed a recombinant plasmid construct (~4. 7 
kb)» which was designated pAKA15 (Figure 18A). The construct was confirmed 
by the predicted fragment sizes obtained by restriction enzyme analysis of 
the plasmid (Figs, 18B; 18D, lane 1), Since, there is no restriction site
for Bgll or BanHl in pPH843, cleavage of this plasmid by Seal in 
combination with either of these enzymes will produce one large fragment 
(4. 14 kb) plus a minor fragment (0.06 kb) (as seen on 1.8% gel in Fig, llA, 
lane 5). However, cleavage of pAKA15 by the same combination of enzymes
will give rise to two larger fragments (3.2 kb & 1,4 kb for Bgll as seen in
Fig. 18B, lane 1; and 3. 1 kb & 1.5 kb for BanHl as in Fig. 18D, lane 1) 
plus the minor Seal fragment (0,06 kb, not visible on 0,8% gel), as the 
insert of this construct contains unique sites for Bgll and Sa^I, The Pstl 
and the Haell sites were destroyed by DNA polymerase during the trimming 
reaction at the ligation points (Fig. 17). A similar restriction pattern 
will thus be obtained with Pstl when used in conjunction with Seal (Fig.
18B, lane 2) because of the presence of unique Pstl site in the insert, The
entire 485-bp insert could not be recovered from this construct by using 
Haellt whereas a major portion (358 bp) of the insert was recovered by 
using Pvull (Figure 19, lanes la and lb) which cuts twice (at positions 54 
and 412) within the 485-bp Haell fragment (see Fig. 15).
A preliminary attempt to mobilize pAKAlS into P. haemolytlca by 
conjugation using a triparental cross with the helper plasmid pRK2013 was 
unsuccessful. This indicated that cloning the insert into the Pstl site of 
pPH843 may have disrupted the mob functions of this plasmid. Therefore, an 
attempt was made to subclone the mob site (i.e. oriT) from a broad-host- 
range plasmid into the Seal site of pAKA15 (Fig. 17), a region previously 
shown not to affect pPH843 functions (Section 3,15.2). The large Seal
FIGURE 18. AGAROSE GELS (0.8%) SHOWING THE ANALYSIS OF MINIPREP PLASMID DNA 
FROM RECOMBINANT CLONES CONTAINING THE CONSTRUCTS pAKA15 AND 
pAKA15-l RESPECTIVELY,
Key:
A; Construct pAKAlS from recombinant clones 
M = Supercoiled DNA ladder as size marker,
0 = Original plasmid pPH843 (control),
1-5 = Plasmid DNA from recombinant blue clones.
B: Confirmation of pAKAlS bv restriction analysis 
M - XDNA///indIII fragments as size markers,
1 = pAKAlS digested by Bgll + Seal,
2 = pAKAlS digested by Pstl + Seal.
C; Construct pAKA15-l from recombinant clones 
M = Supercoiled DNA ladder as size marker.
0 = pAKAlS (control).
1-8 = Plasmid DNA from recombinant clones.
$ (No, 7) indicates a recombinant plasmid of predicted size,
D; Confirmation of pAKA15-l bv restriction analysis 
M = XDNA/f/indlll fragments as size markers,
1 = pAKAlS digested by PaMlI + Seal (control).
2 = pAKA15-1 digested by BanHl + Seal,
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FIGURE 19. AGAROSE GEL (1.2%) SHOWING THE PARTIAL OR COMPLETE RECOVERY 
OF THE INSERTS FROM THE CONSTRUCTED CLONING VECTORS pAKA15, 
pAKAie AND pAKA17.
Key to figure:
ia - pAKA15 digested by Haell,
lb - pAKA15 digested by Pvull,
2 = pAKA15 digested by ApaLl.
3 = pAKA17 digested by Pvul.
M = 1 kb DMA ladder used as molecular size standard.
The upper bands (lane la)'probably represent concatemers of the undigested 
pAKAlS molecule.
The small white arrow (>) shows either the whole insert (lane 2; 979 bp) or 
a part of the insert (lane lb: 35Ô bp; lane 3: 1826 bp) of the constructs.
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fragment of pAKA15 <~4.6 kb, blunt-ended) was dephosphorylated with CIP to 
prevent recircularization. A 760-bp fragment containing the oriT of RK2 
CGuiney & Yacobson, 1983) was isolated from pILL514 (see Methods and 
Materials: Section 2.4) by BanRl digestion and the 3'-recessed ends of this 
fragment were filled in by Klenow polymerase in the presence of dNTPs to 
make them blunt-ended. After ligation of the ~4.6-kb Seal fragment and the 
modified 760-bp BsiriU. fragment, E, coli XL-1 blue (Table 6) was transformed 
with the ligated products yielding one dozen of blue colonies on an 
LB+Ap+X-gal agar plate. This E, coll strain was chosen for its proposed 
better transformation and for comparison with the routinely-used S. coll 
strain JM83. Plasmid DNA analysis of blue colonies showed the plasmid DNA 
molecules of different sizes and included the desired recombinant plasmid 
(Fig. 180. This recombinant was digested with a combination of BaaHl and 
Seal, giving a single fragment (Fig. 18D). It confirmed that both the Baiàïî 
and the Seal sites were lost due to the "filling in" reaction at the 
insertion points and that the recombinant was cleaved only at the unique 
BanHl site present in the MGS. The mobr-derivative of pAKA15 was designated 
pAKA15-l.
Conjugation experiments to mobilize pAKA15-l from E, coll into P, 
haemolytIcdt using the routine triparental procedure with pRK2013, yielded 
a large number of transconjugant colonies, but these did not grow following 
further subculture on selective media.
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3.15.6. Construction of vector pAKAlS and Its mob-containing derivative 
pAKAlG-1.
A schematic diagram showing the cloning strategies for the construction of 
pAKA16 and its mob^-derivative pAKA16-l is shown in Figure 20. The 4. 2-kb 
ApaLI fragment of pPH843 and the 979-bp ApaLI fragment from pIC20H 
containing the lacZ' and MCS determinants (Fig, 15) were subjected to 
cohesive-end ligation using T4 DNA ligase. Transformation of E. coli JM83 
with the ligated products produced a large number of blue transformant 
clones on LB+Ap+X-gal agar. A random selection of 20 blue clones were 
analyzed for plasmid DNA, and almost all clones showed a common DNA band 
equivalent to that of the expected construct (~5.2 kb) (Figure 21A). The 
construct was designated pAKA16 and confirmed by the predicted sizes of DNA 
fragments obtained by restriction analysis (Fig, 21C, lane 1). The 979-bp 
insert was easily recovered from pAKAlB by using ApaLI (Fig. 19, lane 2).
An attempt was again made to insert the oriT of RK2 at the Seal site of 
pAKAlG (Fig. 20). The ~5.1-kb Seal fragment of pAKA16 was dephosphorylated 
and the 760-bp BanHl fragment (containing the oriT of RK2) from pILL514 was 
treated with Klenow enzyme. Following ligation of the two fragments, 
transformatiomn of E. coll JM83 with the ligated products generated about 
100 blue clones on LB+Ap+X-gal agar. Plasmid DNA analysis of 20 clones 
selected at random revealed the presence of recombinant of the expected 
size (~5,9 kb) in several clones (Fig. 21B). Such a mob^-recombinant 
derivative of pAKA16 was designated pAKA16-l. Double digestion of pAKA16-l 
with BanHl and Seal generated only one fragment (Fig. 21C, lane 2), again 
indicating that the restriction sites for these two enzymes were destroyed 
at the ligation points in the new derivative.
FIGURE 20. SCHEMATIC DIAGRAM SHOWING THE CONSTRUCTION OF VECTOR pAKAlG 
AND ITS DERIVATIVE pAKA16-l,
Key;
Ap*' ~ Ampicillin-resistance gene.
Km’ = Kanamycin-rsistance gene.
iacZ'= The oc~peptide-encoding gene sequence of 3-galactosidase. 
lad = Regulatory gene for p-galactosidase,
MCS = Multiple cloning site.
oriV = Origin of vegetative replication.
oriT = Origin of transfer replication.
CIP = Calf intestinal phosphatase.
The plasmids are not drawn to scale. Arrows indicate the direction of 
transcription. Restriction sites shown in brackets were destroyed by DNA 
polymerase during subcloning.
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FIGURE 21. AGAROSE GELS (0. 8%) SHOWING THE ANALYSIS OF MINIPREP PLASMID DNA 
FROM RECOMBINANT CLONES CONTAINING THE CONSTRUCTS pAKA16, 
pAKA16-l, AND pAKA17.
Key;
A: Construct pAKAI6 from recombinant clones 
M = Supercoiled DNA ladder as size marker.
0 = Plasmid pPH843 (control).
1 - 1 9  = Plasmid DNA from recombinant blue clones (out of 20 analyzed).
B: Construct pAKA16-l from recombinant clones 
M = Supercoiled DNA ladder as size marker.
0 = pAKA16 (control).
1-8 = Plasmid DNA from recombinant clones (out of 20 analyzed).
* (Nos. 5 & 8) indicate recombinant plasmids of predicted size.
C; Confirmation of pAKAlB and pAKAlG-1 bv restriction analysis
M = XDNA///indIII fragments as size markers,
1 = pAKA16 digested by BamL + Seal.
2 = pAKA16-l digested by BanHl + Seal.
Dt Construct pAKA17 from recombinant clones 
M - Supercoiled DNA ladder as size marker.
0 = plasmid pPH843 (control).
1-9 = Plasmid DNA from recombinant blue clones.
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Attempts at mobilization of pAKA16 and pAKA16-l into P, haemolytlca by 
the routine conjugation procedure produced innumerable transconjugant 
colonies which were again unstable on subculture on selective media.
3.15.7. Construction of vector pAKA17.
Since the large Taqi fragment (2.56 kb) of plasmid pPH84-3 was shown to lack 
the mob functions (Section 3. 15.2), a partial Taqi digest (4.2 kb) of the 
whole plasmid was ligated to the large 2032-bp Acyl fragment (Taqi and 
Acyl give compatible cohesive ends) of pIC20H (Fig. 15), with the 
assumption that the mob gene of pPH843 would be retained if the plasmid was 
cut only at one Taqi site at either the 1.06 or the 2.7 position (Fig. 14). 
The resulting construct was designated pAKA17. A schematic diagram 
illustrating the construction of pAKA17 is shown in Figure 22.
The 2032-bp Acyl fragment of pIC20H was dephosphorylated before 
ligating to the Taqi partial digest of pPH843. If not dephosphorylated, 
this fragment of pIC20H was found to recircularize and regenerate the Ap'^  
phenotype of pIC20H which produced a high background of blue colonies on 
LB+Ap+X-gal agar. The ligated products were transformed into E, coll JM83 
and 9 blue clones obtained were analyzed for the predicted size (6.2 kb) of 
the recombinant plasmid construct pAKA17 (Fig, 21D, lanes 1-7). Two smaller 
derivatives of plasmid were obtained in the analysis (Fig. 21D, lanes 8-9).
The 2032-bp insert could not be isolated from pAKA17 by digestion with 
Acyl, presumably because this enzyme site was lost due to the rearrangement 
of the base sequence at the Taqi-Acyl cloning site. Taqi was not used for 
the recovery of insert because this enzyme has several cleavage sites on 
different parts of pAKA17 including lacZ'. However, a major portion (1826
FIGURE 22. DIAGRAM ILLUSTRATING THE CONSTRUCTION OF VECTOR pAKA17.
Key:
Ap^ = Ampicillin-resistance gene. 
oriV = Origin of replication.
JacZ’= The a~peptide-encoding gene sequence of p-galactosidase. 
lad = Regulatory gene for p-galactosidase.
MCS = Multiple cloning site.
CIP = Calf intestinal phosphatase.
The plasmids are not drawn to scale. Arrows indicate the direction of 
transcription. Restriction sites shown in brackets were lost during 
subcloning.
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bp) of the insert was recovered by using Pvul (Fig. 19, lane 3) which cuts 
twice (at positions 443 and 1339) within the 2032-bp Acyl fragment (Fig.
15),
A conjugation experiment to mobilize pAKAl? into P, haemolytlca again 
showed innumerable transconjugant colonies, none of which grew on further 
subculture.
No attempt was made to subclone the oriT into pAKA17, Instead, 
mobilization of the constructs into an E, coli recipient (JC3272) was 
attempted in order to determine if the instability of P. haemolytlca 
transconjugant clones was due to the host recipient. Results from this 
experiment gave between 500 and 2000 transconjugant colonies with pAKAlG, 
pAKA17 and pPH843 which, when selected colonies were subcultured, grew 
normally on selective plate.
3.15.8. Determination of the orientation of the inserts of vector 
constructs pAKAlS. pAKA16 and pAKA17.
Determination of the orientation of the lacZ' determinant would show the 
orientation of the insert in each construct. A Bgll site is located at one 
end of the lacZ* gene within each insert (see Fig. 15) and two Seal sites 
(in the original plasmid pPH843) are present outside the insert fragment of 
each construct. This allowed the orientations of the inserts in pAKA15 and 
pAKA16 to be readily assessed using these two enzymes. An extra Seal site 
at one end and additional PstI and Aval sites in the MCS at the other end 
of the insert of pAKA17 could be used to orientate this insert, Double 
enzyme digestion of pAKA15 and pAKAlB each with Bgll and Seal, and single 
enzyme digestion of pAKA17 with either Seal or PstI or Aval produced DNA
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fragments (Figure 23) which facilitated the determination of the insert- 
orient at ion. The sizes of the Bgll-Seal, Seal-Seal, Pstl-Pstl and Aval-Aval 
fragments of the constructs were estimated and compared with the predicted 
sizes of those fragments in relation to two different orientations of the 
inserts (Table 22). The data confirmed the orientation of the inserts in 
pAKAlS and pAKA16, and showed that the insert of pAKA17 only fitted in one 
orientation into the Taql-1. 06 position on the pPH843 map. The orientation 
of the lacZ' and MCS determinants predicted from the data in Table 22 is as 
shown in Fig. 17 (pAKAlS), Fig, 20 (pAKAlB) and Fig, 22 (pAKA17),
FIGURE 23. AGAROSE GEL ELECTROPHORESIS OF THE RESTRICTION ENZYME 
DIGESTS OF CONSTRUCTS pAKA15, pAKA16 AND pAKA17 FOR 
DETERMINATION OF THE ORIENTATION OF THEIR INSERTS.
Key to figure;
M = 1 kb DNA ladder used as molecular size marker.
1 = pAKA15 digested by Bgll + Seal.
2 = pAKAlB digested by Bgll + Seal.
3 = pAKA17 digested by:
a = Seal 
b = PstI 
c = Aval.
In lane 2, the 2.8- and 2. 3-kb fragments comigrated on the 1.8% (w/v) 
agarose gel. Their sizes were estimated by running the digest in a low
percentage agarose gel (0. 7% w/v) shown on the right-hand panel of the
figure. The 0. 06-kb Seal fragment is seen as a faint band in lanes 1, 2 
and 3a on the 1. 8% gel.
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TABLE 22. COMPARISON OF THE ESTIMATED SIZES OF FRAGMENTS OF pAKAlS. pAKAlB
THEIR PREDICTED SIZES IN RELATION TO TWO DIFFERENT ORIENTATIONS
OF THE INSERTS
Construct Enzyme(s)
Estimated 
fragment sizes (kb)
Predicted 
fragment sizes (kb)
pAKAlS 3.2, 1.4, 0.06 3,32, 1.3, 0.06 
2.86, 1.76, 0.06
pAKAie %iI+ScaI 2. 8, 2. 3, 0. 06 2. 8, 2. 3, 0. 06 
3,65, 1.47, 0.06
pAKA17* Seal 5.8, 0.35, 0.06 5. 72, 0. 45, 0. 06 
3. 8, 2. 4, 0. 06
PstI 5.0, 1.2 5. 1, 1. 12 
3.54, 2.69
Aval 4.5, 1.7 4.6, 1.62 
3. 29, 2. 94
* The predicted sizes of fragments of pAKA17 generated by these enzymes 
are only shown for the insert cloned into the TagI-1.06 position of 
pPH843 (see Figs, 14 & 22). All other T’agi positions did not fit with 
the calculated values.
4. DISCUSSION
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4. 1. Antibiotic Resistance in P. haemolytlca Isolates.
In this study, typable and untypable isolates of P. haemolyt ica were 
examined for resistance to 16 antimicrobial drugs and each isolate showed 
multiple drug resistance to at least 3 antibiotics (Table 9). A common 
feature exhibited by this bacterial species was resistance to either Sm or 
Su, or to both of them. This has been observed in all previous studies (see 
Table 2) as well as the present one. It should be noted, however, that only 
resistance to a low concentration of Sm was tested and it is possible that, 
had higher concentrations been used, resistance may not have been so
widespread. Resistance to Lm was also common to the isolates studied here, 
which corresponds with the findings of Allan et al, (1985a), Boyce & Morter 
(1986), Chang et al, (1987) and Shoo (1989) in bovine isolates of P. 
haemolytlca. Resistance to g-lactam antibiotics (e.g. Ap and Pe) and Tc was 
only found in bovine isolates of the A1 serotype (Tables 5 and 9). It is 
interesting to note that Ap^ , in each case, was associated with Tc^ . This 
observation is consistent with the reports obtained from most of the
previous studies on multiple drug resistance in P. haemolytlca (Table 2). 
Resistance to these drugs may well be due to selection pressure exerted by 
these antibiotics, used extensively for routine treatment of cattle or in 
cattle feed as growth-promoters. Only one of 35 isolates was found to be 
resistant to Cm. Cm resistance in Pasteorella spp. is rare, and only one 
Cm"^  strain each of P. multoclda (Rossmanith et al,, 1991) and P. 
haemolytlca (Amstutz et al, , 1982) has been reported. Only 2 of 141 P.
haemolytlca isolates were resistant to Cm in the study of Chang & Carter
(1976). The use of this drug in food-producing animals has been banned for 
several years, which might have effectively removed it as an environmental
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selective factor. Nevertheless, the results of some long-term studies 
suggest that multiple drug-resistant P. haemolytica has become the 
prevalent organism, capable of maintaining itself for long periods of time 
in the source population of cattle (Amstutz et al, , 1982; Paies et al, ,
1982; Morter, 1983; Haghour et al,, 1987).
No significant differences were found in antibiotic resistance profiles
between the isolates of P. haemolytica with regard to serotype (Al, A2, T4, 
TIO or untypable), animal source (bovine or ovine), health status of the
animal (pneumonic or healthy), antibiotic therapy of the animal (treated or
untreated) and the site of isolation (nasopharynx or lungs). This 
observation is similar to that of Shoo (1989), who found no differences in 
antimicrobial susceptibility patterns between the isolates from healthy and 
diseased calves or between the isolates from serotypes Al and A2. In 
contrast, Allan et al, (1985a) observed significant differences in 
antibiotic susceptibilities to Pe, Ap and Tc between the nasopharyngeal 
isolates and the lung isolates. However, no differences in susceptibility 
patterns were found between the isolates from antibiotic-treated and 
untreated animals in their study. This may be due to the short period of 
time elapsed between antibiotic administration and isolation of bacteria.
4.2. Presence of Plasmids and Their Relationships to Antibiotic Resistance
Phenotypes in P. haemolytlca.
Plasmids were detected in eight isolates of P. haemolytica (6 of bovine and 
2 of ovine origin) and all but one of the plasmid-bearing strains were 
isolated from pneumonic, or from animals in contact with pneumonic, cattle 
or sheep. Therefore, the plasmid data obtained in this study is more biased
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towards the disease isolates. But the association of plasmids with disease 
in cattle or sheep is not clear-cut, because one P, haemolytlea isolate 
(G/T 85/15), derived from a healthy bovine source, harboured an identical 
plasmid profile to that found in a pneumonic bovine isolate (D/I 85/1) 
(Table 10), It would be necessary to work with a greater number of 
isolates to make an assessment on the significance of plasmids with regard 
to disease. However, it is possible that apparently cryptic plasmids may in 
fact encode features that allow or sustain infections.
Plasmid DNA was identified in four serotype Al, three serotype A2 and 
one untypable strains of P. haemolytlca (Table 10). The plasmid-bearing 
isolates of the same serotype showed similar plasmid profiles which clearly 
differed from the profiles exhibited by the other serotypes. Distinct 
plasmid profiles among different serotypes of P. haemolytica have been 
previously noted by Briggs & Frank (1984) and Boyce 8t Morter (1986). This 
study has shown some variation in plasmid pattern within the A2 isolates 
(Table 10), which may have been due to different animal sources (B664 was a 
sheep isolate and D/I 85/1 and G/T 85/15 were bovine isolates), However, 
the number of plasmid-containing strains studied was not sufficient to make 
a sound Judgement on this variation relating to different animal sources.
The multiple drug-resistance profiles (Ap^ , Tc^ , Srn^ , Lrn^ , Su^) of 
plasmid-containing Al isolates found in this study are very similar or 
identical to those of the P. haemolytlca Al isolates examined in other 
studies (Allan et al, , 1985a; Boyce St Morter, 1986; Haghour et al, , 1987;
Chang et al, , 1987; Rossmanith et al, , 1991). Only plasmid-containing
isolates of Al serotype exhibited resistance to Ap, Tc and/or Cm (Table 
10), which suggested that these may have been plasmid-associated 
phenotypes. However, only Ap'^  was shown conclusively to be plasmid-mediated
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by subsequent transfer studies. Serotype Al is predominant in bovine 
pasteurellosis and accounts for over 80% of P, haemolytlca isolates (Frank, 
1989). Although all of the Ap^ plasmid-containing strains in the present 
study were from pneumonic or in-contact calves, the significance of this is 
difficult to assess without further examination of a larger number of 
isolates. Small, non-conjugative plasmids encoding resistance to p-lactam 
antibiotics, particularly penicillins, have also been isolated from P, 
haemolytlca Al strains in the USA (Chang et al, , 1987), France (Livrelli at
al, , 1988a; 1991) and Germany (Schwarz et al. , 1989b), In the UK, multiple
resistance to antibiotics, including Ap and Pe, has been reported (see 
Table 2) (Wray & Morrison, 1983; Allan et al. , 1985a; Shoo, 1989), but a
detailed analysis of an Ap^ plasmid has been described only for one strain 
of P, haemolytica (Craig et al,, 1989). This plasmid, pPH33, is one of the
four Ap^ plasmids of similar size obtained from the cattle isolates from
different locations in the UK and examined here in this project.
One interesting observation is that Ap'^  plasmids only occurred in P. 
haemolytlca strains (Chang et al. , 1987; Livrelli et al, , 1988a; 1991;
Schwarz et al, , 1989b; Craig et al, , 1989) and plasmids in P, multoclda
strains (Berman & Hirsh, 1978; Silver et al, , 1979; Hirsh et al, , 1981;
1985; 1989; Schwarz et al, , 1989a). There appears to be not a single report
on Ap*^  plasmid from P. multoclda and only one report of an Sm"^- plasmid in a 
P. haemolytlea T-type strain (Zimmerman & Hirsh, 1980). The reason for such 
species-specific R plasmid evolution is not understood. It seems to be 
relevant to mention in this connection that the possible reason for not 
finding in this study the Sm'^  (8.3 kb) and Tc^ (8.6 kb) plasmids, reported 
by Zimmerman & Hirsh (1980) (see Table 4), may be due to serotype variation 
or the choice of antibiotics used in treatment in the two different
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countries.
Although Tc"^  co-existed with Ap*^  in each of the plasmid-bearing Al
isolates, the resistance determinant for Tc*^  was not found capable of
transfer by transformation to E. coll. This might be due to the fact that 
Tc^ was not expressed in E. coll or that it was chromosomally-mediated. The 
latter possibility is supported by the observation that this phenotype was 
also found in two plasmid-less Al strains (Tables 9 and 10). The occurrence 
of Tc"^  in Ap*^  plasmid-containing isolates as well as in plasmid-lacking 
isolates of P, haemolytlca was also noted by Schwarz et al, (1989b). The 
unique Cm^ phenotype In strain S/C 84/3 appeared to be associated with a 
large plasmid (~20 kb) (Table 10). This plasmid was only found in the Cm*^  
strain, but its association with Cm^ could not be confirmed. No transfer of 
Cm"^  to E. coll was detected by transformation. This may have been due to
the high molecular weight of the plasmid, its inability to express in E,
coll or again that it was chromosomally-mediated. The genetic determinant 
of Cra*^ thus remains obscure.
The plasmids present in the A2 and untypable isolates (Table 10) were 
cryptic in nature at least with regard to antibiotic resistance. 
Interestingly, no R plasmids have yet been described in the A2 serotype of 
P, haemolytlca, a common sheep pathogen. This phenomenon may have been due 
to the least amount of exposure of the A2 isolates to antibiotic selection 
pressure, because of the fact that sheep are not routinely treated with 
antibiotics (Gilrnour & Gilraour, 1969) and that the A2 Isolates occur in 
cattle pneumonia mainly as secondary pathogens (Frank, 1989).
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4.3. Characterization of P. haemolytlca Ampiclllln-Resistance PlasmlHfi.
Four Ap^ plasmids were identified and characterized in this study. All of 
them had a similar size (~4.3 kb), an identical restriction endonuclease 
profile and a gene specifying the ROB-1 p-lactamase enzyme, but plasmid 
pPH843 showed different behaviour from the other three plasmids in several 
aspects. Plasmids pPH2, pPH33 and pPH821 were essentially indistinguishable 
with respect to their transfer efficiencies (Tables 11 and 12), 
amplification properties (Table 18) and MICs with various p-lactam 
antibiotics (Table 15). Plasmid pPH843 had an apparently lower copy number 
in the wild-type P, haemolytlea strain S/C 84/3 (Fig. 4, lane 4) which was 
reflected in a p-lactamase-negative phenotype on test strips and low MIC 
values. Transformation frequency was consistently lower with plasmid DNA 
preparations from strain S/C 84/3 containing pPH843, probably because of 
the presence in the strain of other plasmid species which were likely to 
interfere with pPH843 entry into competent E, coll during the 
transformation process. In contrast, an E. coll DHl transformant containing 
pPH843 was strongly p-lactamase positive on a test strip, showed a 
strikingly high increase in MIC values for p-lactams (Table 15), presented 
an apparently high copy number of plasmid DNA after amplification (Fig. 8) 
and yielded the highest transfer frequency by conjugation (Table 12). It is 
possible that the co-existing plasmids in P. haemolytlea strain S/C 84/3 
suppressed the copy number of pPH843. This was substantiated by the 
observation that when this plasmid was transferred from the original host 
strain (via E, coll) to another P, haemolytica strain, A2S (serotype A2), 
the 8-lactamase phenotype was positive and the MIC values were comparable 
to those for the other Ap'^  plasmids in P. haemolyt lea (Table 15). It is
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interesting in this respect to note that each of the plasmids expressed 
Ap^ in the P, haemolytica A2 strain, yet no natural antibiotic resistance 
associated with a plasmid was found in three plasmid-bearing A2 isolates 
(Table 10) or has been reported elsewhere. This is in keeping with the 
observations that each serotype appears to maintain a distinct plasmid 
profile and that transfer of plasmids between serotypes may not readily 
occur in nature.
Plasmids pPH2, pPH33 and pPH821 were very unstable in E, coll in the 
absence of Ap compared to plasmid pPH843 (Table 17). The lower specific 
activities of p-lactamases specified by the former three plasmids (Table
16) may be due to their instability in E, coll. Similar instability of the 
ROB-1 p-lactamase-encoding plasmid (4.4 kb) of H. influenzae origin in E, 
coli HBÎ01 has been observed in the absence of continued Ap selection 
(Medeiros et al, , 1986; Livrelli et al. , 1988b). Interestingly, plasmid
pPH843 was detectable in plasmid DNA preparations from E, coll JC3272 
transconjugants (Fig. 68, lane 4), but not in those from E. coll DHl or 
JM83 transformants, suggesting host strain differences in terms of plasmid 
content. This is in keeping with a previous report which observed that the 
stability of plasmids differed from E, coll to E. coli (Kumar et al, , 
1991). When amplified by manipulation of the growth conditions, pPH843 
showed a distinctly higher yield or copy number than the others (Fig. 8). 
Since the restriction profiles of all four plasmids were identical (Table 
19), they offered no clue to the greater stability and higher amplification 
in E. coli of pPH843 compared to the other three plasmids. However, this 
might have been the consequence of derepression of regulatory sequences of 
the plasmid, taking place in the E, coll host.
The MIC values of p-lactam antibiotics for E, coli, containing the P.
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haemolytlca Ap” plasmids, were noticeably increased over the values 
obtained with P. haemolytlca hosts (Table 15). The differences are 
comparable to or higher in most cases than those reported by Livrelli et 
al, (1988a) for a ROB-1 p-lactamase-encoding Ap"^  plasmid of similar size 
isolated from bovine Pasteurella strains and subsequently transferred to E. 
coll. Differences In MICs between the plasmid-free P. haemolytlca and E. 
coll strains (Table 15) could be due to differences in outer-membrane 
permeability or the native chromosomally-encoded p-lactamase present in E, 
coll K-12 (Matthew et al, t 1975). Zimmerman & Hirsh (1980) described a 
bovine isolate of P. haemolytlca with a plasmid-associated p-lactamase 
which had high activity against cephaloridine in cell extracts. The present 
data indicate little resistance to the cephalosporin class of p-lactams by 
the original and transconjugant P. haemolytlca strains, but higher 
resistance by E, coll transformants containing the Ap"^  plasmids, 
particularly pPH843,
E, coll DHl transformants containing plasmids pPH2, pPH33 and pPH821 
respectively were weakly positive for 3-lactamase on test strips (Table 15) 
and showed no detectable plasmid band on gels (Fig. 8A, lanes 1-3), yet 
gave high MICs. Similar observations were made by Livrelli et al, (1988a, 
1988b). These authors either failed to detect, or detected a faint band of, 
the ROB-1 3“lactamase plasmid in E, coll HBlOl transformants, which still 
showed high MICs for 3-lactam antibiotics,
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4.4-. Plasmid DNA Transfer to P, haemolytica.
Plasmid DNA transfer was not possible by the conventional CaCl^-mediated 
transformation into P. haemolytica (Craig et al,, 1989) and into the 
related species, P. multocida (Jablonski et al,, 1992) and A, 
pleuropneumoniae (Lalonde et al,, 1989). These workers, however, introduced 
DNA into the respective organism by electroporation, a method designed to 
circumvent natural barriers to the entry of DNA by creation of holes or 
pores in the recipient cells. Conjugation is, however, considered as the 
best alternative method for plasmid DNA transfer, as it has a high 
frequency of transfer and permits the ready use of mobilizable shuttle 
vectors for transfer of cloned genes, derived from foreign sources, between 
E, call and another host bacterium.
The Ap^ plasmids described in this study are small and not self- 
transmissible, but could be mobilized into P. haemolytica or E. coli from 
an E. coli source (but not from the original P. haemolytica strains) by 
conjugation, using the transfer functions (tra) of pRK2013. The inability 
to transfer plasmid DNA directly from P. haemolytica by this method is due 
to the fact that the helper plasmid pRK2013 is a ColEl-based replicon and 
hence unable to replicate in P. haemolytica donor strains, It could not 
therefore provide the necessary transfer apparatus (i.e. fra) for 
conjugation. In this connection, it is interesting to note that Inc? 
plasmid pRK2013 was seen to co-exist with Ap*^  plasmid pPH843 (Fig. 6B, lane 
4) and three other similar plasmids (Fig, 6B, lanes 1-3; not seen due to 
low copy number) in the same E, coli transconjugant strain. This indicates 
that the P. haemolytica plasmids do not belong to the IncP group, but lack 
of time did not permit a thorough study on Inc grouping of the P.
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haemolytlca plasmids.
All Ap"^  plasmids were obtained from P. haemolytlca A1 isolates of 
bovine origin, but they were easily transferred by conjugation to strains 
of the A1 and A2 serotypes (FAl and FA2 respectively) of ovine origin. This 
indicates that different serotypes and animal sources do not present
barriers to plasmid DNA transfer among P. haemolytica isolates, although 
higher frequency of isogenic transfer was noticed within the same serotype.
Thus, the plasmid transfer methods of conjugation and electroporation
(Craig et ai., 1989) for P. haemolytica have been established in this 
laboratory.
No self“transmissible plasmids have yet been described in P. haemo­
lytica. An attempt to transfer the large plasmid (~20 kb) present in P. 
haemolytica strain S/C 84/3 (Table 10) to other strains of P. haemolytica 
or E. coll was unsuccessful. This plasmid appeared to be associated with 
Cm*^ , a unique phenotype shown by only S/C 84/3 within the whole collection 
of isolates (Table 9). The plasmid neither transferred itself under Cm
selection, nor mobilized either of the two smaller plasmids present in the 
same strain; since one of these plasmids encodes Ap*^  and would have 
produced Ap*^  transconj ugants if it had been mobilized, On the other hand, a 
large conjugative plasmid and a plasmid with mobilizing function have been 
described in P. multocida (Hirsh et al, , 1981; 1989). Plasmid DNA
preparations from S/C 84/3 could not transform E, coli to Cm*^ . The 
predicted nature of the large plasmid of S/C 84/3 thus remained unsolved, 
but might be revealed upon transfer by electroporation; which could be an 
objective for future experiments.
An attempt to transform P. haemolytica by the static aerobic procedure 
(see Materials and Methods; Section 2,7.2) did not succeed. This method of
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DNA transfer was successfully applied to encapsulated isolates of //. 
influenzae, where the capsular material did not inhibit the transformation 
process (Rowji et al,, 1989). The failure to transform P. haemolytica by 
this procedure may have been due to differences in the capsular structures 
between the two types of bacteria or that competence induction could not be 
initiated by this method in P. haemolytica.
In the present work, it was not possible to effect Tn5 mutagenesis of 
P. haemolytica, by using a suicide plasmid (pBR322) or a broad-host-range 
vector (pRK404) as the Tn5 delivery vehicle in the conjugation system 
(Table 13). Similar observations were made with Tn5 mutagenesis by Craig et 
al, (1989) who also failed to introduce non-Pasteureiia broad-host-range 
plasmids (pRK290 and pSa4) into P. haemolytlca even by electroporation, 
suggesting a lack of propagation of non-native or foreign DNA in this 
bacterium. This indicates that P. haemolytica might possess an active DNA 
restriction system or that the exogenous plasmids were unable either to 
replicate in P. haemolytica or to express their antibiotic resistance 
genes. The failure to obtain electrotransformants of P, multocida with non­
native plasmids (pBR322 and pUC19) has also been reported (Jablonski et 
al,, 1992), whereas, Nnalue & Stocker (1989) succeeded in transfer of 
transposon-carrying chimeric plasmid vectors (pRKTVS and pUW964), but not 
naturally-occurring broad-host-range plasmids (R388 and RP4), into this 
species by filter mating.
Attempts to transfer non-Pasteurella plasmids into P. haemolytica 
following heat treatment (42.5*^0 of the recipient cells before mating, a 
device employed to inactivate restriction systems for enhancing plasmid 
transfer to Gram-positive corynebacteria (Schëfer et al,, 1990), did not 
work in this study. This may be due to loss of viability of P. haemolytica
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recipient cells by heat treatment or the presence of a thermotolerant 
restriction system, if any.
Large, conjugative R plasmids (~45 kb), encoding 3-lactamase, Tc
resistance, or Cra-acetyltransferase, are often found in Haemophilus species 
and large, F-like indigenous cryptic plasmids have also been detected in N, 
gonorrhoeae and haemophili, which caused intra- and interspecies spread of 
the small R plasmids (Brunton et al,, 1986). It is, therefore, evident that
the overall transfer capacity of P. haemolytlca plasmids is much less
prominent compared to that of the plasmids found in other related Gramr-
negative bacteria. This is probably due to the smaller size of most of the 
P. haemolytica plasmids, which is not sufficient for encoding both 
conjugation ability and conjugative pili. In spite of that, the transfer of 
Ap*^  plasmids between E, coli and P. haemolytica by transformation and
conjugation (Tables 11 and 12) suggests the potential for spread of drug 
resistance in nature among the bacteria in vivo. In the light of this, it
is even more remarkable that no such Ap*^  plasmids have been found in A2
serotypes. Perhaps without continued antibiotic selection, these plasmids 
are unstable and do not persist in these strains. However, these plasmids 
specifying the ROB-1 3-lactamase (see following section) may be regarded 
as useful markers for epidemiological studies on P. haemolytica A1 
infections.
4.5. Characterization of P. haemolytica 8-Lactamases.
Beta-lactamase production in penicillin- or ampicillin-resistant P. 
haemolytica isolates was reported in the UK (Wray & Morrison, 1983; Shoo,
1989), Germany (Schwarz et al., 1989b) and USA (Zimmerman & Hirsh, 1980),
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but not characterized in detail. However, the 3-lactamase produced by a 
bovine isolate of P. haemolytlca A1 (Wray & Morrison, 1983), which is one 
of the four Ap'^  strains used in this study (CVL33), was attributed to have 
a high isoelectric point (pi), high activity against penicillin and low 
activity against cephaloridine and carbenicillin. These findings are in 
reasonable agreement with the results obtained here for the 3~lactamase 
characterization (Fig, 7; Table 16).
The ROB- and TEM-type 3-lactamases in Gram-negative bacteria are 
generally plasmid-mediated (Medeiros, 1984), and the sensitivity and 
substrate profiles of these two types of enzymes have been reported to be 
similar (Gutjt'mann et al., 1988), which was confirmed in the present study 
(Tables 15 and 16), The ROB-1 3“lactamase has been differentiated from the 
TEM-1 enzyme by its higher pi and its ability to hydrolyze ampicillin more 
rapidly and cephaloridine more slowly (Rubin et al. , 1981). The 3"
lactamases elaborated by P. haemolytlca were found to be encoded by 
plasmids (Table 15) and the substrate profiles and isoelectric focusing
data (Table 16 and Fig. 7) confirmed that these enzymes were 
indistinguishable from the ROB-1 3“lactamase, The ROB-1 enzyme was first 
discovered in H. Influenzae of human origin (Rubin et al. , 1981) and later
in A. pleuropneumonlae of animal (porcine) origin (Medeiros et al. , 1986)
in the United States, The ROB-1 enzyme in Pasteurella species was first 
reported in France (Livrelli et al., 1988a). This novel enzyme was further 
identified in clinical isolates of H. Influenzae (Daum et al,, 1988) and 
Thai isolates of H. ducreyi (Maclean et al. , 1992) in the United States,
and in isolates of H. Influenzae (Livrelli et al, , 1988b) and P.
haemolytlca (Livrelli et al, , 1991) in France. This study presents the
first report in Britain of the ROB-1 3-lactamase detected in P.
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haemolytica. These reports indicate that the ROB-1 enzyme has so far been 
identified only in members of the family Pasteurellaceae (Table 23), The 
ROB-1 p-lactamase may thus be used as an identifying marker for ampicillin- 
resistant species of the Pasteurellaceae.
The present findings in the UK confirm the widespread nature of ROB-1 
p-lactamase-producing strains among the clinical isolates of P. haemolytica 
Al serotype. The fact that the ROB-1 p-lactamase plasmids examined here 
could be easily mobilized by conjugation (from E, coli') (Table 12) may 
explain the spread of such plasmid-encoded enzymes. But it does not explain 
the apparent absence of these plasmids in serotypes other than Al.
As reported by Livrelli et al. (1988a), the original ROB-l-producing H. 
Influenzae strain F990 was isolated in 1980, whereas, P. multocida LNPB 9 
(producing plasmid-encoded ROB-1) was isolated in 1978 and P, aerogenes 
ATCC 27883 (producing chromosoraally-encoded ROB-1) was isolated before 
1973. These authors have, therefore, suggested that the ROB-1 p-lactamase 
may have evolved in Pasteurella strains of animal origin. Recently, the 
ROB-1 enzyme has been analyzed at the molecular level and its predicted 
amino acid sequence showed a high degree of homology with class A p- 
lactamases from Gram-positive bacteria (Juteau & Levesque, 1990; Livrelli 
et al, , 1991), This enzyme therefore could be an evolutionary link between
the p-lactamases of Gram-negative and Gram-positive organisms.
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TABLE 23. PLASMID-MEDIATED ROB-1 BETA-LACTAMASES FOUND IN DIFFERENT
MEMBERS OF THE PASTEURELLACEAE
Ref erence
Bacterial
species
Plasmid*
Source
Designate Size (kb)
Rubin et al,, (1981) H, influenzae Human Pr o b 4, 4
Medeiros et al, (1986) A. pleuropneumonlae Porcine pVMlOS 5. 4
H, Influenzae Human pMG301 4, 4
Livrelli et al, (1988a) P. haemolytlca Bovine 4. 4
P, mul tocida Bovine . . . 4. 4
Livrelli et ai. (1988b) H, influenzae Human pCFF242 4. 4
Daum et al. (1988) H, influenzae Human (NI) (NI)
Livrelli et al, (1991) P, haemolytica Bovine . . . 4. 1/4. 4
Maclean et al, (1992) H, ducreyi Human pTH126 5, 4
Azad et al. (1992b) P, haemolytlca Bovine pPH843 ~4. 3
* (Nl) = Not investigated.
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4,6. Molecular Characterization and Relationships of the Beta-Lactamase 
<R0B-1)-Encc?dlnff Plasmid# from P. haemolytica and //. influenzae.
The ROB-1 p-lactamase-specifying Ap*^  plasmids found in members of the 
family Pasteurellaceae were consistently small in size (Table 23) and 
similar plasmids from P. haemolytica were estimated at 4, 1-4.5 kb in 
different studies (see Table 4) (Livrelli et al. , 1988a; 1991; Schwarz et
al. , 1989b; Craig et al. , 1989), The size of the g-lactamase plasmids in
the present study appeared to be 4. 3 kb, but this was eventually 
recalculated to be 4, 2 kb in the course of their molecular analysis. It is 
likely that all the Ap” plasmids described here and previously are of the 
same size and distributed widely among isolates of P. haemolytica. 
Differences in isolation techniques of plasmid DNA, different experimental 
conditions and molecular-weight markers may have accounted for the 
variation in calculated plasmid sizes (see Table 4).
The four ROB-1 p-lact amase plasmids used in this study were all 
identical by restriction endonuclease fragment patterns. Similarly, 3” 
lactamase plasmids from nine German isolates (Schwarz et al, , 1989b) and
those from five French isolates (Livrelli et al, , 1991) of P. haemolytica
were shown to be identical to each other by restriction analysis and/or 
Southern blot hybridization.
The restriction profile of the Ap*^  plasmids (Table 19), particularly 
the restriction map of the representative plasmid pPH843 (Fig. 14), 
revealed a low frequency of common restriction enzyme sites and aggregation 
of a relatively larger number of sites in the Ap"^  gene on the map. Such a 
phenomenon has been reported by Mayer & Robbins (1983), who established a 
map of the 7.1-kb 3-lactamase-encoding plasmid from N. gonorrhoeae and
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observed a higher frequency of restriction sites in the bla gene, derived 
from TnA Surprisingly, only a very few and relatively uncommon enzymes 
with a 6-nucleotide recognition sequence cleaved both types of plasmid DNA. 
However, the number of restriction enzymes (12) shown to cleave the plasmid 
DNA in the present study was greater than those (7, also used here) used by 
Livrelli et al, (1991) to cut similar ROB-1 p-lactaraase-encoding plasmids 
from P, haemolytica. Enzymes cutting such plasmids not reported by Livrelli 
et al, (1991) were; Pstl, ApsLl, Bsp\28Sl, Thai and Cfol.
Restriction enzyme analysis and hybridization experiments in this study 
demonstrated that the prototype ROB-1 3-lactamase-encoding plasmid pRM3022 
from H. influenzae and those isolated from P, haemolytica strains shared 
multiple fragments, but that they were not identical. Plasmid pRM3022 was 
slightly larger (4.4 kb) than the P. haemolytica plasmids (4.2 kb) and this 
was reflected in the presence of extra AluL, SaU3Al and Oral sites (Fig. 
IIB) and only weak hybridization of one 0.69-kb SaiQAl fragment to pPH843 
(Fig. 12, arrowed). As the hybridization was performed under high 
stringency conditions, this suggests that a major portion of the DNA 
sequence of this fragment is not present in pPH843. Livrelli et al, (1991) 
have recently reported homology between the ROB-1 3-lactamase plasmids from 
eight Pasteurella isolates in France and two Haemophilus strains (one was 
French and the other was the original ROB-l-producing isolate) by 
restriction endonuclease and hybridization analyses, using only Saudhl 
fragments. These authors isolated 4, 1-kb plasmids from seven Pasteurella 
strains and 4. 4-kb plasmids from two H. influenzae and one P, haemolytlca 
strains, and observed multiple homologous fragments common to these 
plasmids. However, they did not report the lack of hybridization of any 
SaiQhl fragment (as has been observed here), because the relatively larger
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Haemophilus plasmid (Rrob/ pRM3022) (4, 4 kb) was used as the hybridization 
probe in the study of Livrelli et al. (1991), as opposed to P. haemolytica 
plasmid (pPH843) (4. 2 kb) used as a probe in the present study.
The available data from this and previous studies strongly suggest that 
a close relationship exists between the ROB-1 p-lactamase-producing 
plasmids from two different species and that one plasmid might have evolved 
from the other by deletion, or by recombination with pre-existing cryptic 
plasmids in the respective strains. Relationships have also been 
established between the ROB-1 plasmids from H. influenzae, H. ducreyi 
(human) and A. pleuropneumonlae (animal) strains isolated in the USA, 
France and Thailand (Medeiros et al, , 1986; Livrelli et al. , 1988b; Maclean
et al. , 1992). These observations confirm the close relationships among
ROB-1 p-lactaraase plasmids, regardless of source, species and geographical 
origin, and signify their epidemiological importance. Similarly, a TEM-type 
p-lactamase-encoding plasmid from H. influenzae isolated in Germany was 
found to be closely related (65%-100% DNA homology) to various R plasmids 
from the same species obtained from a broad geographical range (Laufs & 
Kaulfers, 1977),
Sizes of ROB-1 p-lactamase plasmids were shown to be 4.4 kb from H. 
influenzae (Rubin et al, , 1981; Medeiros et al, , 1986; Livrelli et al, ,
1988b), 4, 1 to 4,4 kb from Pasteurella spp. (Livrelli et al, , 1988a; 1991),
and 5.4 kb from A, pleuropneumoniae (Medeiros et al, , 1986) and H, ducreyi
(Maclean et ai,, 1992) (see also Table 23). A value of 4,2 kb was obtained 
for the P, haemolytica plasmids in this study. The possibility that the 
ROB-1-encoding genetic element (probably a transposon) might have been 
inserted by transposition into the resident cryptic plasmid pool of the 
individual bacterial species is supported by the report that the TEM-1 p-
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lactamase plasmids from Haemophilus parainfluenzae, H. influenzae, H, 
ducreyi and N. gonorrhoeae arose by insertion of a transposon from the TnA 
family into small cryptic plasmids (Brunton et al, , 1986). The ROB-1 p-
1actamase gene from P, haemolytica was thought to be part of a transposable 
element (Livrelli et al,, 1991); but it is unlikely that this gene has been
derived from TnA specifying the TEM-type p-lactamase, because the ROB-1- 
encoding gene is not structurally related to the TEM gene (Medeiros et al, , 
1986; Levesque et al, , 1987; Daum et al, , 1988),
It has been postulated that the ROB-1-encoding plasmid had an animal 
reservoir and originated in Pasteurella species (Livrelli et al, , 1988a;
1991). This might have been disseminated as a complete replicon from 
Pasteurella organisms to other members of the Pasteurellaceae, Such a 
hypothesis is strongly supported by the observation in the hybridization 
experiments that a portion of the DNA sequence ('-0.7 kb) from the 
Haemophilus plasmid is not present in the Pasteurella plasmid (Fig. 12). 
This additional DNA sequence could be the remnants of a small resident 
cryptic plasmid in H, influenzae, which served as a foundation and received 
the ROB-1 determinant from the anticipated source. The ROB-1 gene in 
Pasteurella, in turn, might be derived, as a transposable element, from 
Gram-positive organisms, because the ROB-1 p-lactamase has been shown to be 
highly related to the p-lactamases from Gram-positive bacteria (Juteau & 
Levesque, 1990; Livrelli et al,, 1991).
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4.7. Amplification of Plasmid DMA In E, coli.
Previous investigators have reported that the recovery of P. haemolytica 
Ap*^  plasmids from E. coli transformants was either poor (Livrelli et al. , 
1988a; Craig et al, , 1989) or non-existent (Zimmerman & Hirsh, 1980).
Livrelli et al, (1991) analyzed plasmid DNA from wild-type P. haemolytica 
strains (especially strain LNPB 1899, which contained only one plasmid) 
throughout their study, presumably because of negligible yields of plasmid 
DNA from E. coll, Zimmerman & Hirsh (1980) could not conclusively correlate 
Ap” or p-lactamase production with a specific plasmid owing to their 
failure to demonstrate the plasmid from E. coli transformants. However, 
these authors easily recovered Sm^ (8, 3 kb) and Tc*^  (8. 6 kb) plasmids of 
the same P, haemolytica strain from an E. coli background. These 
observations suggest that such Ap*^  plasmids are either unstable or 
replicate to a very low copy number in E. coli which may possess weak
machinery for replication of the exogenous plasmid. Similar results were
initially obtained in the present study, but all Ap^ (ROB-1) plasmids of P,
haemolytica origin were eventually amplified in E, coli by manipulation of 
the growth conditions (see Results: Section 3,10; Table 18).
It has been known for many years that plasmids of the ColEl-type can be 
amplified in E, coli by inhibition of protein synthesis with Cm (Clewell, 
1972) or amino acid starvation (Clewell & Helinski, 1972; Schroeter et al,,
1988). No strong evidence is yet available on the amplification of other 
types of plasmids by this process, except a report by Chang & Cohen (1978) 
who used Cm or spectinomycin (Sp) to amplify hybrid plasmids derived from 
the P15A replicon, which was shown to be ancestrally related to ColEl.
Pasteurella plasmids are unlikely to be of the ColEl-type, because a
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plasmid with this origin of replication (pRK2013) did not replicate in P. 
haemolytica (Fig. 6A; lanes 1-4). Surprisingly, therefore, the P, 
haemolytica ROB-1 plasmids in this study could be amplified by Cm or Tc as 
efficiently as the ColEl plasmids. Sequence analysis may eventually relate 
these plasmids to ColEl, but since the type of replicon of the P. 
haemolytica plasmids is as yet unknown, the amplification properties 
suggest that these plasmids at least lack the rop (repression of primer) or
rop-like gene, The rop gene in a ColEl plasmid is normally located close to
oriV, and the gene product (called Rop protein) reinforces the negative 
regulation of plasmid DNA replication by inhibition of RNA primer 
transcription and thereby controls the plasmid copy number (Cesareni et 
al, , 1982), Cm, Tc or Sp are inhibitors of protein synthesis and play
similar roles in plasmid amplification. Inhibition of protein synthesis 
causes a gradual termination of chromosomal DNA synthesis consistent with 
completion of a round of replication and no initiation of new rounds. In 
contrast, however, plasmid DNA continues to replicate at the expense of
proteins or replicative enzymes synthesized before inhibition of protein 
synthesis and which remain in excess in the cell, and plasmid DNA 
accumulates as noncomplexed, CCC molecules (Clewell, 1972; Clewell &
Helinski, 1972).
More recently, amplification of plasmid pBR322 in E, coli was reported 
without blocking protein synthesis by using amino acid and Fe^^ supplements 
(Angelov & Ivanov, 1989). In all the above cases, the extent of 
amplification depended on the growth medium used. In this work, LB broth 
and Terrific broth proved most useful, probably due to the absence in these 
media of glucose which influences the formation of DNA-protein relaxation 
complexes during plasmid DNA replication in E, coli (Clewell & Helinski,
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1972). LB broth or the presence of phosphates in the growth media (as in 
Terrific broth; see Appendix 19) has been reported to increase the 
stability and/or the copy number of certain plasmids (Kumar et al, , 1991).
These authors also noted that the increase in plasmid copy number was 
associated with glucose and ammonia limitation in the media. Here, the 
highest amplification of plasmids was observed in Terrific broth as growth 
medium (Table 18; Fig. 8), which was specially formulated for plasmid and 
cosmid production (Tartof & Hobbs, 1987). The reason for obtaining the best 
yield of plasmids from yeast nitrogen base (YNB)-supplemented Terrific 
broth is not clear, but might be due to the presence of multivitamins, 
amino acids and metal ions, including Fe^ '^ . However, the further addition 
of amino acids and/or Fe^^ to YNB-supplemented Terrific broth reduced the 
amplification rate of plasmids, which contrasts with the findings of 
Angelov & Ivanov (1989). Use of more than 1% YNB in Terrific broth caused 
cell death, as was evident from clumping of apparently deformed cells
suspended in the medium, This might have been the result of toxicity due to
metal ions, when used in excess in the form of YNB.
The detection and the extent of amplification of the P. haemolytlca 
plasmids differed among the different E. coli strains such as JC3272
(recA"*"), DHl (recA") and JM83 (recA'*’) (Figs. 6B, 8 and 9). These
observations are in agreement with the findings of Chang & Cohen (1978) who 
found a significant difference in the amplification of plasmids between 
recA~ (.E. coll JC1569) and recA'*’ iE. coli C600) strains.
The prototype ROB-1 p-lactamase-encoding plasmid pRM3022 (see Materials 
and Methods; Section 2, 4) showed similar behaviour in E. coli to the P. 
haemolytica plasmids with regard to DNA isolation, which again emphasizes 
the close relationship between these plasmids. pRM3022 was amplified in E.
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coli in an almost identical manner (Fig. 9) when analyzed and compared with 
the other ROB-1 plasmids (Figs, 11 and 12), This work and other reports 
thus indicate that these small ROB-1 p-lactamase plasmids need to be 
amplified in E. coli in order to obtain a good yield of plasmid DNA for 
further characterization and cloning purposes. The in vivo amplification 
procedure has also facilitated the isolation of pPH843-derived constructed 
vectors (Results: Sections 3.15,5-7) from the E. coli backgrounds, and was 
essential for the development and analysis of the vectors. Thus the 
amplification procedures described here have practical implications in the 
molecular analysis of plasmid DNA.
4.8. Rapid Purification of Plasmid DNA by the Modified Acid-Phenol 
Extraction Method (A Developed Protocol).
The aim of the development of new protocol for purification of plasmid DNA 
was to rapidly prepare large amounts of purified DNA, which are required 
for restriction analysis, cloning experiments and further characterization 
of plasmids.
The original acid-phenol extraction method of Zasloff et al, (1978) was 
based on the selective extraction of chromosomal and non-CCC DNA molecules 
into the acidified phenolic phase leaving CCC forms in the upper aqueous 
phase. Apart from the use in molecular analysis, purification of CCC 
plasmid DNA also helps to identify the actual number of plasmid species 
present in a bacterium, because it is often unclear on gels whether a 
particular DNA band is the OC form of one plasmid or the CCC form of 
another, larger, plasmid.
Several modifications were made here to the original protocol of
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Zasloff et al, <1978), These Included the use of; i) MgCl^ instead of NaCl 
in the low-ionic strength buffer, ii) undistilled phenol instead of 
distilled phenol, iii) vortexing for 1 min instead of shaking for 2-3 min, 
iv) only one acid-phenol extraction instead of up to four extractions, v) a 
single extraction with chloroform-isoamyl alcohol instead of four 
extractions with anhydrous ether to remove phenol, and vi) room temperature 
instead of 0-4®C. Furthermore, in the modified protocol, purified CCC DNA 
was finally precipitated in 0. 3M sodium acetate (pH 6.0) and ethanol.
The roles of MgCl^ and NaCl in the protocol were compared; the latter 
chemical was shown to generate a diffuse DNA smear in each case and also 
removed CCC plasmids of higher molecular weight (Fig. 10). This suggested 
that NaCl might allow degradation of high molecular-weight DNAs to small 
linear fragments, which were not efficiently extracted into phenol. This is 
in agreement with Zasloff et al, (1978) who reported that small oligo- 
ribonucleotides and linear DNA fragments of less than 1.5 kb could not be 
removed by their procedure.
The physical basis of acid-phenol extraction of CCC DNA molecules and 
Mg^^-DNA interactions were described by Müller et al. (1983), Both phenol 
and acid pH at low ionic strength denature non-CCC DNA molecules by 
converting them into single-stranded linear forms which are extracted from 
the water phase into the phenolic phase due to their hydrophobic nature and 
charge compensation by Mg^ "^  ions. Moreover, it is likely that divalent Mg^"*" 
ions bind to and interact with denatured DNA, which has exposed phosphate 
groups, more than monovalent Na"^  ions. Mg^"*" ions were reported to have a 
high affinity for binding to DNA and they were also found to be important 
for the stabilization of DNA conformation (Sander & Ts*o, 1971). At 
present, no explanation can be given for the selective loss of CCC plasmids
188
of higher molecular weight (Fig. 10, groups C-E, lane 2) in the presence of 
Na"** ions. Vortexing was a crucial step in obtaining a good yield of 
purified CCC molecules, because more than one extraction with acid-phenol, 
as indicated by Zasloff et al, (1978), in the presence of NaCl resulted in 
further loss of CCC DNA. However, a single extraction with MgCl^ in place 
of NaCl was sufficient for complete purification of CCC plasmid DNA forms. 
Crude plasmid DNA preparations at both high (Fig, 10, groups A and B, lane 
1) and low (groups C-E, lane 1) concentrations, without adjustment to 10 
Aaeo units/ml as suggested by Zasloff et al. (1978), could be purified 
equally well by the present protocol. A plasmid of 73 kb (group E, lane 3) 
was readily purified by this procedure, whereas a plasmid of 38 kb was the 
largest purified by Zasloff et al. (1978).
Kieser (1984) and Olsen (1990) reported improved methods for the small- 
scale preparation of plasmid DNA free from chromosomal DNA and suitable for 
restriction analysis. However, both methods used alkaline dénaturation in 
the presence of SDS at high temperatures (56‘=’-70°C). This is not suitable 
for the large-scale preparation of plasmid DNA due to the high viscosity of 
the lysed bacterial pellet and the fact that certain strains of E. coli, 
such as HBlOl, release large amounts of carbohydrate during heating and 
this severely interferes with the final purification process (Sambrook et 
al, , 1989). On the other hand, the protocol developed in this study is a
simple, rapid and large-scale one which can offer a ready alternative, for 
CCC plasmid DNA purification, to either caesium chloride-ethidium bromide 
density gradient centrifugation (Radloff et al,, 1967), which is time-
consuming, or commercially available purification kits, which are 
expensive. Furthermore, it can be reasonably expected that the involvment 
of MgCl-H in the plasmid purification process may improve the quality of DNA
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for restriction enzyme analysis, because of the fact that ions are an
obligate requirement for most endonuclease activity.
4.9. Construction of Cloning Vectors for P. haemolytica.
Since attempts to transfer a variety of suicide or broad-host-range plasmid 
vectors into P, haemolytica strains were not successful in the present and 
previous work in this laboratory, the construction of an endogenous 
replicon-derived shuttle vector for P. haemolytica was considered a 
necessity for transfer of cloned DNA and transposon-mutagenesis studies. 
The stability, high amplification in E. coli and high transfer frequency to 
P. haemolytica of pPH843, made it an ideal plasmid for the construction of 
a shuttle vector. Using the restriction map data (Fig. 14), this plasmid 
was modified into a series of possible cloning vectors (pAKA15, pAKA15-l, 
pAKA16, pAKA16-l and pAKA17) by insertion of a fragment from pIC20H which 
contained the ladZ oc-peptide coding region and an Î^ S, and, in the case of 
pAKA15-l and pAKA16-l, a fragment from pILL514 which contained the oriT of 
RK2 (Figs. 17, 20 and 22). During preliminary cloning and deletion
experiments, it was found that the Pstl, ApaLI, Taql and Seal sites of 
pPH843 did not interfere with the essential functions of plasmid 
replication and Ap^ , and hence were used for insertion of the foreign DNA 
fragments. The 2. 56-kb Taql fragment of pPH843 (i.e. pPH843ATaqI) (Fig. 14) 
was found capable of replication and expression of Ap resistance in E, 
coli, but incapable of mobilization. This indicated that the remaining 
portion of pPH843, bounded by the Taql sites (positions 1,06-2.7), might 
contain a part or whole of the mob gene. The mob gene was further localized 
to the region surrounding the Pstl site (Fig. 14) because insertion of the
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HaéLl fragment from pIC20H into this site in pPH843 also abolished 
mobilization by pRK2013, This ability was restored by insertion of the mob 
region from pILL514.
Naturally-occurring plasmid pPH843 was cleaved by only a few restriction 
enzymes with a 6-bp recognition sequence and the cloning vectors 
constructed in this project contain 16 unique restriction sites with 
insertional inactivation of p-galactosidase activity for recognition of 
recombinant clones in E, coli, Lalonde & 0*Hanley (1989) developed a 
shuttle vector, pYG53, for A, pleuropneumoniae by ligating only the MCS 
from pUClQ to the wild-type plasmid pYGlO (Cm*^ ). Since these authors 
neither cloned the JacZot-reporter gene from pUC19 nor an additional 
antibiotic-resistance gene into the shuttle vector, the procedures they 
used for recombinant selection were not clear. Moreover, the subsequent 
insertion of the oriT into the MCS of pYG53, to construct the mobilizable 
derivative (pYG54), hampered the versatility of the MCS. Thus the two most 
desirable features of the pUC vectors, direct screening of recombinants and 
a versatile MCS, were lost. All the essential features of the pUC/pIC 
vectors were preserved in the vectors constructed for P, haemolytica.
Very recently, a broad-host-range expression vector, based on the 
RSFlOlO replicon and a Cm*^  gene from plasmid pSa, was developed for A, 
pleuropneumoniae and P, haemolytica in which the vector was introduced and 
propagated by electroporation (Frey, 1992). This report contrasts with the 
findings of Craig et al, (1989) who failed to propagate a plasmid of pSa 
replicon (pSa4) and that of RSFlOlO replicon (pKT230) in P, haemolytica by 
transformation or electroporation. Lalonde & O'Hanley (1989) also made the 
observation that RSFlOlO-derived vectors could not be introduced into A, 
pleuropneumoniae or were very unstable in this host. Frey (1992), however.
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demonstrated the stability of the expression vector in A, pleuropneumonlae, 
although not in P. haemolytica, The author made the point that the 
stability of the vector was associated with the use of the minimal 
autonomous replicon of RSFlOlO which may thus not be susceptible to a 
restriction system present in P, haemolytica.
Attempts to mobilize the vector constructs from E. coli into P. 
haemolytica by conjugation, using the IncP helper plasmid pRK2013 gave 
disappointing results. A large number of colonies of P, haemolytica 
recipients developed on transconjugant-selection plates in each case 
(except pAKA15), but they did not grow upon further subculture on Ap- 
containing media. The barrier associated with the failure to obtain true 
and stable transconj ugant s of P, haemolytica may be the possession of a 
restriction/ modification system by P. haemolytica, acting on the vector 
DNA derived from pIC20H or pILL514 which contains restriction enzyme sites 
not present in the wild-type plasmid pPH843. In later experiments, attempts 
were again made to mobilize the constructs into P. haemolytica from E, coli 
SMIO, which contains the transfer functions of the IncP plasmid RP4 
incorporated into the chromosome (Simon et aJ. , 1983), Transconjugants were
obtained for each of the constructs except pAKA15, but were again found to 
be unstable on subculture (Dr. J, G. Coote, personal communication). These 
observations are consistent with those found earlier. Transconjugants 
obtained from the crosses with E, coli as recipients were found to be 
stable and could be subcultured on the original selection medium used in 
conjugation. This strongly suggests the presence in P. haemolytica of a 
restriction system that has to be by-passed by the incoming plasmid DNA. 
Assaying P. haemolytica for the presence of restriction endonucleases would 
make an interesting area for further investigation, This can be done by
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preparing crude extracts from the bacterium and examining them for 
endonuclease activity on a standard DNA (e.g. bacteriophage X DNA) 
(Schleif, 1980). A similar observation with a restriction barrier was made 
with C. jejuni (Miller et al. , 1988), but it was shown in later experiments 
that successful transfer of E. coil-derived plasmid DNA to C. jejuni was 
strain-dependent (Wassenaar et ai., 1991). Similar problems with 
heterologous DNA transfer into Legionella pneumophila (Marra & Shuman,
1989) and Erwinia carotovora (Relia et ai., 1989) were overcome by
isolation of restriction-deficient strains for use as recipients. 
Restriction mutants were derived by random screening in the former case and 
by chemical mutagenesis, using ethyl methanesulfonate in the latter case. 
Similar procedures could also be applied to P. haemolytica in order to 
isolate restriction-deficient mutants; again an area for future 
investigation. Finally, use of restriction- and modification-deficient E, 
coli strains for DNA cloning should also alleviate such a problem. It would 
be interesting to see if these vectors can be transferred to P. multocida 
and whether are stable in this species.
The molecular basis of conjugation in Gram-negative bacteria involves: 
i) nicking and initiation of DNA transfer at the nic or oriT site of the 
plasmid molecule, ii) single-stranded DNA transfer from donor to recipient 
with the 5' terminus leading, and iii) complementary-strand synthesis in 
the recipient to produce a complete replicon (Willetts & Wilkins, 1984; 
Derbyshire & Willetts, 1987). It was later postulated that this type of 
transfer should not be affected by the presence of a double-strand-specific 
restriction enzyme in the recipient cells (Trieu-Cuot et al, , 1991). In
this connection, a hypothesis can be made regarding the initial growth of 
the unstable P. haemolytica transconj ugant s in the present study. The Ap>^
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gene of the transferred plasmid DNA might be expressed, allowing growth of 
the transconjugants, immediately before the complete synthesis of a 
complementary strand forming duplex DNA. This DNA would, however, be 
eventually cleaved in vivo by the double-strand-specific restriction 
endonuclease possibly at a site distant from the Ap*^  gene. Thus, sufficient 
p-1actamase would be made in the initial transeonJugants to allow growth, 
but subsequent destruction of the p-lactamase gene or disruption of the 
Integrity of the plasmid would prevent subculture of transconjugant cells 
in the presence of Ap.
It would be of interest in this regard to check if the initial 
transconjugants can be subcultured in the absence of Ap selection. If this 
is so, it means in effect that the plasmid construct is a suicide vector 
which may allow transfer of cloned genes and subsequent recombination with 
the P. haemolytica chromosome before it is destroyed, Initial growth of the 
transconjugants in the presence of Ap will thus identify clones which can 
then be screened for allelic exchange of cloned P. haemolytica DNA.
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APPENDIX 1: BRAIN HEART INFUSION (BHI) BROTH OR AGAR
Brain heart infusion, dehydrated* (Oxoid) : 37 g
Distilled H^O : 1 litre
♦Formula (per litre);-
Calf brain infusion solids — 12,5 g
Beef heart infusion solids — 5.0 g
Proteose peptone (Oxoid L46) — 10,0 g
NaCl — 5.0 g
Dextrose — 2.0 g
Na^HPO* (anhydrous) - 2.5 g
pH = 7. 4
Dissolved in distilled H^O and sterilized by autoclaving for 20 min at 15 
pounds per square inch (p.s.i.) at 121°C on liquid cycle. For solid medium, 
1, 2% agar (Technical No. 3, Oxoid) was added before autoclaving. The blood 
supplement was added to solid medium, after it was allowed to cool to 50^ 0.
NUTRIENT BROTH OR AGAR
Nutrient broth, dehydrated* (Oxoid) ; 25.0 g
Distilled H^O : 1 litre
♦Formula (per litre):- 
Lab-Lemco powder — 1.0 g
Yeast extract — 2.0 g
Peptone — 5.0 g
Nad — 5.0 g
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APPENDIX 1 (Continued)
Dissolved in distilled H^O and sterilized by autoclaving for 20 min at 15 
p, s. i. (121°C>. For solid medium, 1.2% agar (Technical No. 3, Oxoid) was 
added before autoclaving.
LURIA-BERTANI (LB) BROTH OR AGAR
Tryptone (Oxoid)
Yeast extract (Oxoid) 
NaCl (AnalaR®, BDH) 
Distilled H3.O
1 0  g
5 g
1 0  g
1 litre
The solutes were dissolved in distilled H^O by shaking and the pH was 
adjusted to 7.0 with NaOH. For solid medium, 1.2% agar (Technical No. 3, 
Oxoid) was added before autoclaving for 20 min at 15 p. s, i. (121*0.
MUELLER HINTON MEDIUM
Mueller Hinton agar, dehydrated* (Difco) ; 38.0 g
Distilled H^O : 1 litre
♦Formula (per litre);-
Beef infusion — 300.0 g
Bacto-casamino acids — 17. 5 g
Starch — 1.5 g
Bacto-agar — 17.0 g
Dissolved in distilled H^O and autoclaved at 20 p. s. i. for 20 min. The 
blood supplement was added after the media was cooled to 50*C.
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APPENDIX 2; PREPARATION OF ANTIBIOTIC SOLUTIONS
Stock solutions of antibiotics were made at the following 
concentrations <% w/v): Ap and other 3-lactams (2.5%), Tc (1%), Cm (1%), Km 
(2.5%), Tp (4%), Sm (2.5%) and Nal (0.25%).
Ampicillin, carbenicillin and other 3-lactam antibiotics were dissolved 
in distilled H^O by adding a drop of 40% NaOH and filter sterilized by 
passing the solutions through an acrodisc of 0. 45 pm pore size (Gelman 
Sciences). Streptomycin and kanamycin solutions were also made up in 
distilled HjaO and filter sterilized. Chloramphenicol was dissolved in 
ethanol, and tetracycline, trimethoprim and nalidixic acid were dissolved 
in equal volumes of ethanol-water (1: 1) and were not filter sterilized. All 
antibiotic solutions were stored at -20*C. Nalidixic acid crystals formed 
during storage were dissolved by heating to 70*C in a water bath before 
use, Ampicillin solution was used within 2-3 days of preparation.
APPENDIX 3: LYSIS BUFFER FOR PLASMID DNA EXTRACTION
TEG buffer (per litre):- 
25mM Tris : 3.028 g 
lOmM EDTA : 3.722 g 
50mM glucose : 9. 008 g 
Dissolved in distilled H^ O, the pH was adjusted to 8.0 with HCl, filter- 
sterilized or autoclaved for 15 min at 10 p. s. i. and stored at 4*C. To 
prepare a complete lysis buffer, 4 mg of lysozyme (Sigma) was added per ml 
of TEG buffer immediately before use.
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APPENDIX 4: ALKALINE 5D5 SOLUTION
Small-scale Large-scale 
2N NaOH : 0.2 mi 5.0 ml
20% SDS ; 0. 1 ml 2.5 ml
HjeO : 1. 7 ml 42. 5 ml
APPENDIX 5: ACIDIFIED POTASSIUM ACETATE SOLUTION
Small-scale Large-scale 
5M K-acetate : 1.5 ml 21.0 ml
Glacial acetic acid : 288 pi 4.05 ml
HaO : 712 pi 10.0 ml
APPENDIX 6 ; BUFFERED-SATURATED PHENOL/CHLOROFORM
Buffei— saturated phenol was prepared as follows;- 
To crystalline phenol CFormachem, Strathhaven, UK) was added 0. 1% 8 - 
hydroxyquinoline and then an equal volume of 0.5M Tris. HCl buffer (pH 8.0) 
was added to saturate the phenol. The mixture was stirred on a magnetic 
stirrer for 15 min and the lower phenolic phase was separated and removed 
to a fresh bottle by using a separation funnel (Quickfit, UK). The 
extraction process of the phenol was repeated (~3 times) by using an equal 
volume of 0. IM Tris. HCl (pH 8.0) until the pH of the phenolic phase (as 
measured with pH paper) or of the buffer phase (as measured with a pH 
meter) was >7.8 (equilibrium). The phenol preparation was stored in a 
light-proof (brown) bottle at 4*C, with an overlay of 0. IM Tris. HCl (pH 
8 . 0 ) containing 0 . 2 % (v/v) p-mercaptoethanol.
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Chloroform refers to a mixture of chloroform and isoamyl alcohol (24; 1 
v/v). The chloroform denatures proteins while isoamyl alcohol reduces 
foaming during the extraction of plasmid DNA.
APPENDIX 7: TRIS-EDTA (TE) BUFFER. pH 8 .0
Per litre of distilled H^O:- 
lOmM Tris ; 1.212 g 
ImM EDTA ; 0. 372 g 
Dissolved in H^ O, the pH was adjusted to 8.0 with HCl, sterilized by 
autoclaving at 15 p. s. i. (121*0 for 20 rain and stored at 4*C.
APPENDIX 8 : PREPARATION OF RNase STOCK SOLUTION
Pancreatic RNase A (Sigma) was dissolved in TE (pH 8.0) at a 
concentration of 10 mg per ml (1% w/v) and heated to 100*C for 15 min in a 
boiling water bath to destroy any DNase, The solution was allowed to cool 
slowly to room temperature, dispensed into aliquots and stored at -20*C.
APPENDIX 9: PEG-NaCl SOLUTION
Per litre of distilled H%0;-
13% (w/v) polyethylene glycol 800 (Sigma) ; 130.0 g
1. 6 M NaCl : 93.5 g
Dissolved in H^O by using a magnetic stirrer, filter-sterilized and stored 
at room temperature.
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APPENDIX 10: TBE BUFFER
Per litre of distilled H^O;-
5X stock solution 
89mM Tris base ; 53,9 g
89mM boric acid : 27, 5 g
2mM EDTA ; 20. 0 ml of 0.5M EDTA (pH 8. 0)
Dissolved in distilled H^O by gently stirring with a magnetic stirrer and 
stored at room teperature.
APPENDIX 11: TAE BUFFER
Per litre of distilled H^O:-
IQX stock solution 
4-0mM Tris base : 48. 4 g
40mM Glacial acetic acid ; 11.4 ml
ImM EDTA r 20, 0 ml of 0. 5M EDTA (pH 8. 0)
Dissolved in distilled H^O by using a magnetic stirrer and stored at room 
temperature.
APPENDIX 12: GEL-LOADING BUFFER
40% (w/v) sucrose 
0. 25% (w/v) bromophenol blue 
Dissolved and mixed well in sterile distilled Hj^ O and stored in aliquots at 
4*0.
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APPENDIX 13; FRAGMENT SIZES OF DNA MARKERS
Supercoiled 
DNA Ladder
X DNA/#indIII 
Fragments
9 X1 7 4  RF DNA/ 
Haelll Fragments
1 Kb DNA 
Ladder
16. 2 kb
14. 2 kb
12. 1 kb
10. 1 kb
8. 1 kb
7. 0 kb
6. 0 kb
5. 0 kb
4. 0 kb
3. 0 kb
2, 1 kb
23, 1 kb
9. 4 kb
6. 6 kb
4. 4 kb
2. 3 kb
2. 0 kb
0. 56 kb
0, 13 kb
1353 bp 12216 bp
1078 bp 11198 bp
872 bp 10180 bp
603 bp 9162 bp
310 bp 8144 bp
271 bp 7126 bp
281 bp 6108 bp
234 bp 5090 bp
194 bp 4072 bp
118 bp 3054 bp
72 bp 2036 bp
1636 bp
1018 bp
517 bp
506 bp
396 bp
344 bp
298 bp
220 bp
201 bp
154 bp
134 bp
75 bp
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APPENDIX 14: SOC MEDIUM
A) SOC base
Per litre of distilled H^O;-
2 % tryptone ; 2 0 , 0  g
0. 5% yeast extract : 5.0 g
lOmM NaCl : 0.58 g
2. 5mM KCl ; 0.18 g
The solutes were dissolved by shaking and the pH was adjusted to 7.0 with 
NaOH. The broth was sterilized by autoclaving for 20 min at 15 p.s.i. and 
stored at 4*0.
B) SOC additive
Per 10 ml H^O CIOOX concentrate):- 
20mM glucose : 2.0 g
lOmM MgCl^, 6 H2 O : 2.03 g
lOmM MgSOa, 7H=0 : 2.46 g
The solutes were dissolved by using a magnetic stirrer, filter-sterilized 
(0. 45 pm acrodisc) and stored at 4*0. SOO additive was added to SOO base in 
a ratio of 1 ; 1 0 0  just before use.
APPENDIX 15; PREPARATION OF DOUBLE DILUTIONS OF ANTIBIOTICS FOR MIC PLATE
A 20 ml stock solution of p-lactam antibiotic was prepared at
the concentration of either 20480 pg ml"'', 10240 pg ml"',
5120 pg ml"' or 2560 pg ml"',
(Continued on next page)
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Serial double dilutions of stock solutions were made as follows:-
Antibiotic solut ion Sterile 
+ H^O 
(ml)
Intermediate 
concentration - 
(pg ml"')
Final concentration 
in agar plates 
(pg ml-')Volume(ml) pg ml-'
10 2560 . . . 256
10 2560 10 1280 128
10 1280 10 640 64
10 640 10 320 32
10 320 10 160 16
10 160 10 80 8
10 80 10 40 4
10 40 10 20 2
10 20 10 10 1
10 10 10 5 0. 5
APPENDIX 16; 0. IM POTASSIUM PHOSPHATE BUFFER. pH 7.0
IM stock solution each of K^HPO^ (174.18 g per litre) and KH^PO^
(136.09 g per litre) were prepared separately in two bottles. Then 0. IM 
phosphate buffer, pH 7.0 was made up by adding together 61.5 ml of IM 
KzHPOa and 38. 5 ml of IM KH^PO^ stock solutions and making the volume up to 
1 litre with distilled H^ O.
APPENDIX 17: IODINE REAGENT
Iodine reagent is a mixture of:
(Continued on next page)
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0,0166N iodine
0. 06M potassium iodide
2M sodium acetate buffer (pH 4.0)
A 20X stock solution of 0. 0Î66N iodine (42, 13 g per litre) and 0, 06M 
potassium iodide (199.2 g per litre) was prepared and stored in a brown 
bottle at room temperature. The stock solution was diluted to IX (i.e. 1:20
v/v) with 2M Na-acetate buffer (pH 4.0) just before use.
APPENDIX 18: BRADFORD REAGENT
100 mg of Cooraassie Brilliant Blue G-250 was dissolved in 50 ml of 95% 
ethanol. The solution was mixed with 100 ml of 85% (w/v) phosphoric acid, 
diluted with distilled to 1 litre, filtered and stored at room 
temperature.
APPENDIX 19: TERRIFIC BROTH
A) Basal medium
To 900 ml of distilled H-^ O were added;- 
Tryptone ; 12 g
Yeast extract : 24 g 
Glycerol : 4 ml
B) Additive
To 100 ml of distilled H^O were added:- 
0. 17M KHaPOa : 2.31 g
0.72M KaHPOa : 12. 54 g
Both basal medium and additive were made up separately, sterilized by 
autoclaving and mixed together when cooled to 60*C or less.
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APPENDIX 20: COMPOSITION OF REACTION BUFFERS
The composition given below is IX or the working concentration.
REact^l: 50mM Tris. HCl (pH 8.0)
lOraM MgCla
REact™2: 50mM Tris. HCl (pH 8.0)
lOmM MgCls 
50mM NaCl
React™3; 50mM Tris, HCl (pH 8.0)
lOmM MgCla 
lOOmM NaCl
REact™4: 20mM Tris, HCl (pH 7.4)
5mM MgClz 
50mM KCl
REact™6: 50raM Tris. HCl (pH 7. 4)
6mM MgCla 
50mM KCl 
50mM NaCl
REact"8: 20mM Tris. HCl (pH 7.4)
lOmM MgCla
React™10: lOOmM Tris. HCl (pH 7.6)
lOraM MgCla 
150mM NaCl
Assay buffer 1: 25mM Tris. HCl (pH 7.7)
(Stratagene) lOmM MgCl^
ImM DTT 
100 pg/ml BSA
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APPENDIX 20 (Continued)
Bscl buf fer: 
(NBL)
Buffer A; 
(Boehringer 
Mannheim)
Xholl buffer: 
<ABL)
6mM Tris. HCl (pH 7. 6) 
150mM NaCl 
6mM MgCla
6mM 2-mercaptoethanol 
33mM Tris-acetate 
66mM K-acetate 
lOmM Mg-acetate 
0. 5mM DTT 
pH 7. 9
6mM Tris. HCl (pH 8. 0) 
lOmM MgClz 
ImM DTT
100 pg /ml BSA 
0.01% TRITON X 100
APPENDIX 21; PREPARATION OF DENATURED SALMON SPERM DNA (10 mg ml"')
50 mg of salmon sperm DNA (Sigma type III, Na-salt) was dissolved in 5 
ml of distilled H^O and, if necessary, stirred on a magnetic stirrer for 2- 
4 h at room temperature. The DNA was sheared by repeated passage (rapidly 
-12 times) through a 17- or 19-gauge hypodermic needle, then boiled for 10 
min and stored at -20*C.
100 pi of the DNA solution was heated to 100*C in a boiling water bath 
for 5 min and then chilled quickly in ice-water before use.
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APPENDIX 22: PREHYBRIDIZATION/HYBRIDIZATION SOLUTION
Prehybridization or hybridization solution (10 ml) (high 
stringency conditions) was prepared as follows:-
Stock solution Volume
20X SSC
50X Denhardt’s solution* 
100% deionized formaraide 
20%(w/v) SDS 
Sterile distilled H^O
2. 5 ml 
1.0 ml 
5. 0 ml 
0. 25 ml 
1.25 ml
Final concentration
5X
5X
50%
0. 5% (w/v)
To final volume.
* 50X Denhardt's solution
l%(w/v) BSA (bovine serum albumin, Fraction V; Sigma) 
l%(w/v) Ficoll (Type 400, Pharmacia) 
l%(w/v) PVP (polyvinylpyrrolidone. Sigma)
Dissolved in distilled H^ O, filtered through Whatman paper and stored at 
-20*C,
APPENDIX 23: PREPARATION OF LABELLED DNA PROBE (50 pi)
Plasmid DNA was digested with a restriction enzyme and then purified by 
phenol:chloroform extraction followed by ethanol precipitation. The 
purified DNA was redissolved in distilled H^O and brought to volume of 34 
pi, denatured by heating to 100*0 in a boiling water bath for 5 min, cooled 
immediately in ice-water and then incubated at 37*0 for 10 min. The 
following were then added to a fresh microfuge tube in the given order:-
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DNA solution ; 34 pi
OLB (Oligo-labelling buffer)* : 10 pi
l%(w/v) BSA (Sigma) : 2 pi
Klenow fragment of DNA polymerase I
(Gibco-BRL) ; 2 pi
[%-==?]dATP (10 pCi/pl) (Amersham) ; 2 pi
The reaction was mixed well and incubated overnight at room temperature.
* OLB (Oligo-labelling buffer)
OLB was made up as follows;-
Solution 0; 1.25M Tris. HCl (pH 8.0)
0.125M MgCla.
Solution A: 1 ml solution 0
18 pi p-mercaptoethanol 
5 pi dGTP (lOOmM in TE)
5 pi dCTP (lOOitiM in TE)
5 pi dTTP (lOOmM in TE).
Solution B: 2M Hepes (pH 6.6, using 4M NaOH).
Solution C; Hexadeoxynucleotides (Pharmacia) sus­
pended in TE to 90 OD units per ml. 
Solutions A, B and C were mixed in the ratio of 100:250:150 and stored at 
” 20*0.
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APPENDIX 24: T4 DNA LIGASE BUFFER
Working concentration (IX);-*
50mM Tris. HCl (pH 7. 6) 
lOmM MgClz 
1 mM ATP 
ImM DTT
5%(w/v) PEG-800 
Supplied by Gibco-BRL and stored frozen at -20*C.
APPENDIX 25: PREPARATION OF LB+X-GAL MEDIA
20 mg of X-gal (5-brorao-4-chloro-3-indolyl-p-D-galactopyranoside) 
(Sigma) was dissolved per ml in dimethyl formamide (Sigma) just before use, 
200 mg of IPTG (isopropyl-g-D-thiogalactopyranoside) (Sigma) was 
dissolved per ml in distilled water, filter-sterilized and stored at -20*C.
1 ml of X-gal and 100 pi of IPTG (each 100 pg ml”' final concentration) 
were added to 200 ml of melted LB agar, mixed by gentle rotation or 
inversion of the bottle and then poured into petri dishes (-15 plates).
